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Abstract 
Mammalian cells are widely used today in the large-scale production of recombinant 
proteins for therapeutic and diagnostic applications. In particular, the Glutamine Synthetase-
NSO (GS-NSO) system under study is an industrially significant cell line that has been used 
to produce several important therapeutic antibody products currently available in the market. 
With continually increasing demand for monoclonal antibodies, the study of environmental 
variables such as culture pH, temperature and medium osmolarity plays a key role in the 
improvement of antibody production yields. In particular, hyperosmolarity is an 
economically viable factor that has been previously reported to enhance both specific 
antibody productivity and overall antibody production in GS-NSO cells. The central goal of 
this study is therefore to develop an understanding of the intracellular effects of 
hyperosmotic conditions on the GS-NSO antibody production process; so as to improve 
antibody production yields. 
A new 'hybrid' model describing the GS-NSO antibody production process is first 
developed using GS-NSO data available in literature. The model, constructed using both 
unstructured and structured elements, describes the growth, metabolism and extracellular 
antibody production characteristics of GS-NSO cells. A global sensitivity analysis (GSA) of 
the model is subsequently carried out, leading to the identification of parameters that 
significantly influenced antibody production rates, including the specific mRNA 
transcription rates, specific polypeptide translation rates and the mRNA degradation rates, 
thereby providing part of the basis for the experimental study. 
The experimental study on GS-NSO cells under normal and hyperosmotic conditions 
is focused on two key areas: firstly, based on the GSA findings, the intracellular behaviour of 
IgG mRNA and polypeptide chains are analysed. Secondly, to obtain a clearer understanding 
of the underlying mechanism of hyperosmolarity, the cell cycle trends and energy levels of 
the cells have also been monitored. Experimental results show that hyperosmotic conditions 
induce GO/GI cycle arrest in GS-NSO cells, but do not increase intracellular energy levels 
despite an increase in glucose uptake rates. Additionally, estimates of the key parameters 
identified by GSA are derived successfully from the intracellular mRNA and polypeptide 
chain analyses. The estimated parameter values also indicate that the enhancement of mRNA 
specific transcription rates is the key reason for the higher specific antibody productivities 
observed under hyperosmotic conditions. The hybrid model is subsequently updated by the 
estimated values of key parameters and is validated by both intracellular and extracellular 
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experimental data. Finally, the model successfully predicts the optimal hyperosmotic 
induction time for a biphasic culture (as verified by experimental data), thereby 
demonstrating its potential applicability in product optimisation strategies. 
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Chapter 1 
Introduction 
1.1 	Background and motivation 
The production of monoclonal antibodies for therapeutic and diagnostic purposes constitutes 
a significant part of the current biotechnology industry, with worldwide sales projected to 
reach US$22.5 billion in 2009 [b2b conference flyer., 2004]. Industrial production of 
monoclonal antibodies is currently carried out mainly in mammalian cell culture systems, 
including the Chinese Hamster Ovary (CHO), SP2/0, and NSO cell lines [Chu and Robinson, 
2001]. This is due to their ability to carry out complex post-translational modifications and 
protein folding in an authentic manner [Hauser, 1997], which is essential for retaining the 
biological activity of the product in contrast to other expression systems, such as bacteria or 
yeast cells. As a result of this unique characteristic, products in development have been 
reported to lean towards being mammalian cell culture-based in the near future [Ransohoff et 
al., 2004], further highlighting their importance in the biopharmaceutical industry. 
Among the mammalian cell culture systems used in large-scale antibody production, 
the Glutamine Synthetase-NSO (GS-NSO) system, utilised in this study, is an industrially 
significant cell line that has been used in recent years for the production of many important 
therapeutic antibodies, including Synagis TM, Zenapax® [Lonza Press Release., 1998a, 1998b] 
and MylotargTM [Wyeth Pharmaceuticals Inc., 2005]. One of the key advantages of the GS-
NSO cell system is its ability to synthesise glutamine, an amino acid essential for cell growth, 
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intracellularly, thus negating the need for an exogenous glutamine supply. The resulting 
reduction in ammonia accumulation thus alleviates the inhibitory effects of ammonium ions 
on cell growth and antibody production. 
Hyperosmotic culture conditions 
The antibody production process in mammalian cells tends to be affected by changes in the 
environmental conditions of the culture. Such environmental factors include culture pH, 
temperature and osmolarity. In particular, hyperosmotic culture conditions have been 
reported to show a significant positive effect on the antibody production rate of GS-NSO 
cells [Duncan et al., 1997; Wu et al., 2004]. Being easily induced by the addition of salts 
such as sodium chloride or potassium chloride also increases the economic potential of its 
use to improve antibody production rates. However, the reduction in cell growth caused by 
hyperosmotic pressure often leads to a dilution of its positive effect on antibody productivity. 
The trade-off between growth and productivity is therefore an important consideration for 
the implementation of hyperosmotic culture conditions in product optimisation strategies. 
Potential advantages of a modelling approach 
The continual increase in demand for recombinant therapeutic products has also led to 
predictions of a shortage in plant manufacturing capacity in the biopharmaceutical industry 
within the next five years [Ransohoff et al., 2004]. In order to reduce the discrepancy 
between supply and demand, key aims of the industry are focused on improving efficiency of 
the antibody production process in mammalian cells, as well as the reduction of the time-to-
market [Zhou and Titchener-Hooker, 1999]. At present, cell culture experimentation is the 
main means of improving antibody production yields industrially. It generally involves trial 
and error optimisation of culture parameters, which result in large numbers of experiments 
that tends to be expensive and time-consuming [Jacquez, 1998]. In view of the situation, the 
utilisation of mathematical models is proposed as a means of presenting preliminary 
experimental information in a logical and systematic manner, thereby allowing for the 
identification of any key relationships between process parameters, variables and product 
output rates [Bailey, 1998]. In-depth analyses of these models can help identify parameters 
19 
CHAPTER 1. INTRODUCTION 
with significant effects on antibody production that can then be singled out for more detailed 
studies, thus guiding the design of experiments. This approach would therefore lead to a 
possible reduction in the required number of experiments with time- and cost-saving 
implications. 
In this study, the effects of hyperosmotic conditions on the GS-NSO antibody 
production process will be evaluated through modelling and experimental means. The study 
involves first developing a mathematical model capable of predicting antibody production in 
GS-NSO cells and then conducting an experimental study on cells cultivated under normal 
and hyperosmotic conditions. The main objectives of the study are outlined in the next 
section. 
1.2 	Thesis Objectives 
The central goal of this thesis is to undertake a combined experimental and modelling 
approach in understanding and improving the antibody production process in GS-NSO cells 
under normal and hyperosmotic culture conditions. Within the central goal, there are four 
main objectives. Firstly, a model capable of describing the mechanism of antibody 
production in GS-NSO cells is to be developed. Secondly, a global sensitivity analysis is to 
be carried out on the model in order to identify key parameters affecting the antibody 
production rate. The third objective is to investigate the intracellular antibody production 
process through an experimental study on the cells at normal and hyperosmotic culture 
conditions. Design of the experimental study will be guided by the global sensitivity analysis 
findings obtained from the second objective. Results derived from the experiments will 
subsequently be incorporated into the model. Finally, the practical applicability of the model 
is to be demonstrated by its use in the development of an antibody production optimisation 
strategy based on the use of hyperosmotic conditions. 
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1.3 	Thesis Outline 
In Chapter 2 of this thesis, a review of antibody production in mammalian cells is provided. 
This includes an overview of the industrially important cell systems used for large-scale 
therapeutic monoclonal antibody production, a brief introduction to the development process 
of the GS-NSO cell line, a detailed description of the antibody production mechanism in GS-
NSO cells, as well as a summary of the findings on the effects of hyperosmotic pressure on 
various cell culture systems. Pertinent developments in the types of mathematical models 
used to represent cell growth and antibody production and model analysis techniques will 
also be discussed in this chapter. In Chapter 3, the mathematical model developed for 
describing antibody production in GS-NSO cells and its underlying assumptions is presented. 
The results obtained from the developed model is compared to existing experimental data 
and output from a single-cell model originally developed for hybridoma cells. Details of the 
global sensitivity analysis (GSA) used for in-depth study of the GS-NSO antibody production 
model and its subsequent role in extension of the model to hyperosmotic culture conditions 
are discussed. In Chapters 4 and 5, the experimental study conducted on GS-NSO cells under 
both normal and hyperosmotic conditions is described. Chapter 4 will focus on growth, 
metabolism and antibody production processes in GS-NSO cells under both osmotic 
conditions. The chapter also includes a study of the cell cycle and cellular energy trends for 
normal and hyperosmotic cultures. Based on the findings of GSA, transcription and 
translation processes are identified as being key to antibody production. Chapter 5 will 
therefore describe the behaviour of mRNA molecules and intracellular IgG polypeptide 
concentrations with respect to culture time and medium osmolarity. Chapter 6 consists of the 
incorporation of the experimental findings into the antibody production model. The 
incorporated model is then used to develop a strategy involving the use of hyperosmotic 
culture conditions, based on the trade-off between decreased cell growth and increased 
antibody productivity. The proposed strategy is then assessed through experimental 
validation. Finally, the conclusions obtained from this study and recommendations of 
potential areas for future research in this field are summarised in Chapter 7. 
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Literature Review 
The major role that mammalian cell systems play in the industrial production of monoclonal 
antibodies today has been highlighted in Chapter 1. In this chapter, an overview of the 
different mammalian cell systems currently used for recombinant antibody production 
industrially will first be given, with particular focus on the GS-NSO cell system (Section 
2.1). Additionally, in order to improve antibody production yields in mammalian cells, 
having an insight to the antibody production mechanism within these cells is also an 
important consideration. Section 2.2 will therefore provide a detailed description of the 
intracellular antibody production pathway, as well as a discussion of the observations and 
results derived from literature about each individual step in the pathway. Section 2.3 
summarises briefly the main product optimisation approaches currently employed before 
focusing specifically on the reported effects of hyperosmolarity on cell growth, metabolism 
and antibody production in various mammalian cell culture systems. Finally, Section 2.4 
includes a review on the major cell culture models that currently exist in literature and a brief 
discussion on the relevant analysis techniques adopted to study them in more detail. 
2.1 	Industrial monoclonal antibody production — mammalian cell culture systems 
Three principal mammalian cell lines are currently being used for the production of nearly all 
commercially available recombinant monoclonal antibody products: CHO and the myeloma cell 
lines: SP2/0 and NSO [Chu and Robinson, 2001]. This is evident from Table 2.1, which 
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summarises the Food and Drug Administration (FDA) and European Union (EU) approved 
therapeutic monoclonal antibody products as of 2005 [Reichert et al., 2005]. In particular, the 
NSO cell line, transfected with the glutamine-synthetase (GS) gene has been used to produce a 
number of recent antibody therapeutic products (SynagisTM, Zenapax® [Lonza Press Release., 
1998a, 19981)] and MylotargTM [Wyeth Pharmaceuticals Inc., 2005]), highlighting its importance 
in the biopharmaceutical industry. 
2.1.1 The GS-NSO cell system 
Development of the NSO expression system 
A detailed description of how the NSO cell line was derived can be found in Barnes et al. 
[2000]. This section provides a brief summary of the NSO developmental process. The 
development of the NSO cell line began in 1962 with the discovery that injection of mineral 
oil into BALB/c mice induced tumours [Potter and Boyce, 1962]. It was found that one of 
the tumours, MOPC21, secreted IgG1 [Potter et al., 1965], which became the basis for the 
establishment of a continuous tissue culture line by Horibata and Harris [1970]. After a 
series of transplantations in mice, the cells were grown in vitro in suspension cultures and 
known as P3K cells [Barnes et al., 2000]. Subsequent cloning and re-cloning of these cells 
resulted in two cell lines which were then further developed. One of the cell lines, termed 
289-16, only synthesised light antibody chains [Ramasamy et al., 1974], and was 
subsequently renamed NSI/1 [Cowan et al., 1974]. The cells were further cloned and 
selected for resistance to 8-azaguanine. The resultant cell line, P3/NSI/1-Ag4-1, only 
expressed intracellular K light chains [Kohler and Milstein, 1976]. Finally, the cells were 
cloned again to generate a sub-line known as NSO/1 (Non-Secreting), which did not secrete 
or produce any heavy or light Ig chains naturally [Galfre and Milstein, 1981]. This cell line 
was able to produce Ig molecules only when the desired foreign Ig genes were transfected 
into the cell. Hence, the desired Ig product would be the only Ig species present in the 
extracellular medium. 
Due to their origins as immunoglobulin-producing tumour cells, NSO cells have a 
high efficiency in the production and secretion of proteins. In addition, NSO cells are grown 
in suspension cultures, hence making the adaptation process from serum to serum-free, and 
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subsequently protein-free medium much easier. This is particularly crucial in large-scale 
antibody production, as it reduces both the costs of the downstream purification process and 
of the growth medium [Barnes et al., 2000]. 
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Product Brand Name Cell Line Year Approved 
Abciximab ReoPro SP2/0 1994 
Adalimumab* Humira Unspecified 2002 
Alemtuzumab* Campath-1H CHO 2001 
Basil iximab Simulect Myeloma 1998 
Bevacizumab* Avastin CHO 2004 
Cetuximab Erbitux Myeloma 2004 
Daclizumab* Zenapax GS-NSO 1997 
Efalizumab Raptiva CHO 2003 
Gemtuzumab 
ozo2amicin* 
Mylotarg GS-NSO 2000 
Ibritumomab 
tiuxetan* 
Zevalin CHO 2002 
Infliximab Remicade SP2/0 1998 
Muromonab- Orthoclone OKT3 Ascites 1986 
CR3* 
Omalizumab* Xolair CHO 2003 
Palivizumab Synagis GS-NSO 1998 
Rituximab Rituxan CHO 1997 
Tositumomab* Bexxar Unspecified 2003 
Trastuzumab Herceptin CHO 1998 
Table 2.1. List of FDA and EU-approved therapeutic monoclonal antibody products as of 
2005. (Adapted from Reichert et al., 2005 with additional information from the FDA website, 
2006 and drug prescription sheets of products with (*) in table) 
25 
CHAPTER 2. LITERATURE REVIEW 
Glutamine and glutamine-synthetase (GS) 
Glutamine is an amino acid whose cellular metabolism and function is crucial to mammalian 
cells. It participates in a significant number of metabolic pathways, including protein synthesis, 
purine and pyrimidine biosynthesis, ammonia formation, the biosynthesis and degradation of 
amino acids, amino sugars and certain co-factors [Barnes et al., 2000]. In addition, glutamine has 
been reported to be a source of energy for mammalian cells [Reitzer et al., 1979]. In vivo, 
glutamine is synthesised by a large number of cells that contain the enzyme glutamine synthetase 
(GS). GS catalyses the reversible synthesis of glutamine from glutamate and ammonia, in a 
reaction that requires the hydrolysis of ATP [Elliott, 1951]. However, most mammalian cells in 
vitro contain extremely low levels of endogenous GS, which results in their inability to produce 
glutamine [Barnes et al., 2000]. As a result, glutamine has to be added to the culture medium for 
cell growth to occur, hence causing the production and accumulation of ammonia in the culture. 
Free ammonium ions formed during the catabolic breakdown of glutamine can inhibit growth and 
production of cell cultures [Butler and Spier, 1984], often resulting in lower antibody 
productivity. 
Principles of the GS-NSO system 
As explained previously, mammalian cells in culture require an exogenous source of glutamine 
or exogenous GS in order to survive. However, by incorporating a GS gene in a plasmid vector 
containing the gene of a heterologous protein (usually the desired antibody product), and 
subsequent transfection into the NSO cells, the need for an external glutamine source can be 
eliminated. The selection of cells which have successfully taken up the plasmid and are stably 
expressing the GS gene (and thus also the heterologous protein) can be made in glutamine-free 
medium, as only cells with the GS gene will be able to survive [Barnes et al., 2000]. The growth 
of GS-NSO cells in glutamine-free medium results in a much lower accumulation of free 
ammonia, as shown by Zhou et al. [1997]. In addition, a recent report has indicated that GS-NSO 
systems can produce up to 5.1 g/L of total monoclonal antibody product [Birch, 2005], making it 
one of the more prominent systems for the large-scale production of recombinant antibodies at 
present. As the number of studies into this cell line are relatively limited in comparison to other 
cell systems such as hybridoma and CHO systems, more insight into the GS-NSO system will 
contribute towards an overall better understanding of the antibody production mechanism, as well 
as provide useful information which may lead to a better optimised production process. 
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2.2 	Antibody Production in Mammalian Cells 
2.2.1 The Antibody Production Pathway 
In mammalian cells, the antibody production process consists of two main parts: synthesis of 
the antibody molecule in the endoplasmic reticulum (ER), and its transport to the 
extracellular medium. Antibody synthesis in mammalian cells takes place mainly in the ER. 
The process begins in the nucleus, where the DNA sequences for the heavy (H) and light (L) 
IgG polypeptide species are transcribed onto messenger RNA (mRNA). The correctly 
transcribed mRNA will be translated in association with membrane-bound polyribosomes in 
the rough ER [Bibila and Flickinger, 1991a]. The growing polypeptide chain is co-
translationally translocated via a protein translocation channel across the ER [Sakaguchi, 
1997]. Initial glycosylation of the polypeptide chain occurs, where a number of 
oligosaccharides are covalently attached to the polypeptide. Further modifications of these 
oligosaccharides take place subsequently. The polypeptide chains are then folded and the 
assembly of the antibody molecule, consisting of two identical H and L chains follows. This 
process is shown schematically in Figure 2.1. 
Subsequently, only correctly assembled antibody molecules are transported out of 
the ER and into the Golgi complex, where further glycosylation reactions take place. These 
reactions convert the molecules into functional proteins [Savage, 1997]. The functional 
antibodies are finally packed into secretory vesicles and secreted to the extracellular medium 
(Figure 2.2). 
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Figure 2.1. Intracellular antibody synthesis process. (Adapted from Oh et al., 1993) 
Figure 2.2. Intracellular antibody transport and secretion to medium. (Adapted from 
McKinney et al., 1995) 
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2.2.2 Individual Pathway Steps and the Antibody Production Rate 
The relationships between the various steps in the antibody production pathway and the 
antibody production rate are crucial for the identification of the rate-limiting step(s) in the 
pathway. The following sub-sections provide a summary of the observations and results 
obtained from literature about each individual step. 
Transcription 
In a study of CHO cells, Pendse et al. [1992] found a limited correlation between transfected 
mRNA transcript abundance and the rate of protein secretion. It was also found that while 
there was a positive relationship between the level of transcription and specific protein 
production rates, the increase in the production rate did not correlate with the high level of 
gene transcription attainable [Dorner and Kaufman, 1990; Merten et al., 1994]. Similar 
observations were also made in a study on hybridoma cells carried out by Lee and Lee 
[2000], where it was found that specific antibody production rates increased by a much 
smaller factor than the increase in transcription levels as the osmotic pressure was increased. 
However, Leno et al. [1992] (hybridoma cells) could not identify any correlation between the 
specific antibody production rate, qAb, and the amounts of H and L chains mRNAs at any 
stage of the culture. These observations imply that while an increase in transcription rates 
may correlate with increased antibody production, transcription is unlikely to be the rate-
limiting step in the process. 
Translation and translocation 
Translation is a relatively high energy-consuming step as compared to transcription. As a 
result, feeding strategies aimed at increasing energy production in cells tend to lead to 
increased translation of H and L chain mRNAs into polypeptide chains. This is therefore 
likely to lead to an increase in specific antibody production rate. Bibila and Flickinger 
[1992a; 1992b] stated that translation was likely to be the controlling step for antibody 
secretion rates in slow growing hybridoma cells, based on simulations carried out using their 
structured kinetic model for antibody production. McKinney et al. [1995] made the same 
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postulate in another study on a hybridoma cell line. Lee and Lee [2000] also found 
experimentally that the increase in qAb during the exponential phase of the culture agreed 
more closely with the increase in H and L chain translation rates. 
The translocation process occurs co-translationally in mammalian cells. As a result, 
translocation rates are often based on translation rates [Gonzalez et al., 2001]. However, the 
current literature search has not revealed any significant studies into the translocation of H 
and L polypeptides across the ER membrane. 
Folding and assembly 
The folding and assembly process is also a high energy-consuming step. This is due to the 
interaction of incompletely folded H and L chains with molecular chaperones such as GRP 
78 and GRP94, which prevent incorrectly folded and assembled antibody molecules from 
leaving the ER. Consequently, energy (in the form of ATP) is required to dissociate the 
completely folded and assembled antibody molecules from the molecular chaperones 
[Dorner and Kaufman, 1994; Gething and Sambrook, 1992]. Bibila and Flickinger [1992b] 
predicted that the folding and assembly of H and L chains are likely to be rate-controlling 
under fast growth conditions, based on simulations using their kinetic model. While there has 
not been a substantial amount of data on the folding and assembly rates in antibody 
production, many studies have hypothesised that it is one of the controlling steps in the 
production pathway [Gonzalez et al., 2001; McKinney et al., 1995; Oh et al., 1993]. 
Transport from ER to Golgi 
The antibody transport rate from the ER to the Golgi complex appears to correlate with the 
folding and assembly rate, giving rise to the possibility that antibody transport is in fact 
governed by its rate of assembly [McKinney et al., 1995]. However, in general, antibody 
transport from the ER to the Golgi has been assumed to follow the bulk flow mechanism 
[Bibila and Flickinger, 1991b; Wieland et al., 1987], in which the rate of transport is 
dependent on the antibody concentration in the ER. In addition, model simulations by Bibila 
and Flickinger [1992a; 1992b] seem to suggest that the antibody production rate does not 
vary by a substantial amount when the transport rate constant changes. Based on the above 
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observations, it appears that transport of antibody molecules from the ER to the Golgi is not 
a rate-limiting step in the antibody production process. 
Golgi processing (further glycosylation) 
There has been little experimental data concerning further processing in the Golgi complex. 
This may be attributed to the fact that different glycosylation reactions are required for the 
production of different antibodies. Moreover, the use of different cell lines for the production 
of the same antibody also results in a variation in the glycosylation patterns. However, it has 
been found that the time required for processing in the Golgi remains more or less constant, 
at 20 minutes for the production of different proteins [Bibila and Flickinger, 1991b]. In 
addition, it appears that the inhibition of sialylation (a glycosylation reaction) has no 
significant effect on the kinetics of immunoglobulin secretion [Thorens and Vassalli, 1986]. 
Furthermore, in a review on glycosylation, Goochee and Monica [1990] stated, "aberrant 
glycosylation does not prevent secretion of IgG". 
While glycosylation in the Golgi complex is responsible for the correct functioning 
of the antibody molecule, it is unlikely to be a rate-limiting process. This is based on the 
observation that the Golgi processing time for different proteins is approximately constant. 
In addition, as dissimilar antibody molecules are glycosylated differently across various cell 
lines, it is difficult to generalise the processing steps involved. 
Transport from Golgi to extracellular medium (ECM) 
The transport from the Golgi to the ECM also does not appear to significantly affect the 
specific antibody secretion rate [Bibila and Flickinger, 1992a], based on the assumption that 
transport occurs by the bulk flow mechanism. 
In summary, the above observations suggest that the most likely candidates for the rate-
limiting steps in antibody production are: i) translation and ii) the folding and assembly step. 
It is possible that both steps may be responsible for the determination of qAb, as both 
processes require substantial amounts of energy (in the form of ATP), which is a likely 
limiting factor in the antibody production process. 
31 
CHAPTER 2. LITERATURE REVIEW 
2.3 	Optimisation of Antibody Production and Hyperosmolarity 
2.3.1 Current Product Optimisation Approaches 
Many different approaches have been proposed to improve antibody production yields from 
mammalian cells. These approaches aim to accomplish two main objectives: (i) to improve 
specific growth rates and thus viable cell density in the culture, as well as extend its 
longevity and (ii) to increase specific antibody productivity (qAb). Cell cultures possessing a 
combination of both of these features will usually achieve high volumetric production rates 
[Birch and Racher, 2006], which are then likely to result in larger final antibody titres. 
Maximisation of cell density and culture longevity 
A key research area in cell culture product optimisation is the study of using different culture 
configurations to increase cell density and extend culture longevity, with an aim to 
maximising the "cumulative volumetric cell hours" [Dutton et al., 1998]. The authors 
defined "cumulative volumetric cell hour" as the accumulated amount of time that viable 
cells spend in the culture medium, during which they are actively producing the antibody 
product. Three culture configurations that have been used to maximise the "cumulative 
volumetric cell hour" are the fed-batch, perfusion and cell immobilisation cultures [Sun, 
2000]. These configurations will be further described below. 
A fed-batch culture is primarily a batch process in which cells are inoculated in 
culture medium and the antibody product is either periodically harvested or harvested at the 
end of the culture. However, nutrients and other ingredients are continuously or 
intermittently fed into the system throughout the various stages of the culture to improve cell 
growth and prolong the culture. In addition, a proportion of culture medium is removed 
constantly or at specific time points to delay the accumulation of metabolites such as lactate 
and ammonia thus leading to increased culture longevity. 
In a perfusion culture, culture medium is fed continuously into the bioreactor 
containing the cells while the same amount of cell-free culture supernatant is removed from 
the system. This results in a higher cell density, as well as an increased productivity. 
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However, the culture conditions must be well controlled so that the culture environment can 
be kept optimal. 
The immobilisation of cells can help prevent mechanical damage of cells in large-
scale suspension cultures, thereby leading to sustained cell viabilities and subsequently 
improved antibody productivity [Seifert and Phillips, 1999]. This technique can also be used 
effectively to separate the cells from the culture medium in perfusion cultures. However, a 
key disadvantage of the immobilised culture system lies in the difficulty in directly 
monitoring of viable cell concentration in the culture. Instead, the cell density has to be 
estimated indirectly through the measurement of other parameters, such as the glucose 
uptake rate [Rodrigues et al., 1999]. 
There have also been many studies on optimal nutrient feeding strategies and the 
minimisation of metabolites that restrict cell growth and productivity. The supplementation 
of nutrients, such as glucose and glutamine, in fed-batch culture has extended culture 
longevity and improved cell growth, as limiting nutrients are replenished continuously 
[Bibila and Robinson, 1995]. In addition, step increases in the amount of glucose and 
glutamine in a continuous system has also been reported to increase cell growth [Miller et 
al., 1989a„ 1989b]. 
Attempts to increase culture longevity are focused on the inhibition of apoptosis in 
cell cultures. This can be achieved through the over-expression of anti-apoptotic genes 
[Mercille and Massie, 1998; Simpson et al., 1998], as well as the supplementation of specific 
factors (Interleukin-6) to the culture medium [Chung et al., 1997]. 
Maximisation of specific antibody 	 , qAb 
To 	
, ,Ab 
 improve qAb, several factors have been added into the culture medium, including 
autocrine factors [Pendse and Bailey, 1990] and monocyclic nucleotides [Dalili and 011is, 
1988]. The adaptation of cells to serum- and protein-free media has also been proven to 
increase qAb [Lambert and Merten, 1997]. 
However, while it has been found that serum- and protein-free media improves qAb, the 
reason behind the change remains unknown. Moreover, the addition of factors is 
comparatively more expensive than implementation of environmental stresses, by changing, 
for example, temperature, pH or osmolarity [Zhou, 2002]. Deviation from normal 
33 
CHAPTER 2. LITERATURE REVIEW 
physiological conditions (usually 37°C, pH 7.0 and osmolarity of 290-310 mOsm/kg [Bogner 
et al., 2004]) in cell cultures tends to elicit regulatory responses from cells, as they attempt to 
`re-normalise' their intracellular environment. This allows the change in environmental 
conditions to act as a form of stress to the cells, causing them to activate various metabolic 
and signalling pathways, which may in turn result in different protein production rates. 
Environmental stresses have been previously utilised in product optimisation strategies as a 
means of improving antibody productivity [Kaufmann et al., 1999; Yoon et al., 2004] and 
represents another major research area in cell culture-based antibody production. In this 
study, the focus will be on evaluating the effects of hyperosmotic culture conditions on the 
antibody production process in GS-NSO cells. Subsequently, a biphasic culture strategy 
based on hyperosmotic conditions will also be explored, which will aim to combine 
enhanced specific antibody productivities with an improvement in viable cell density values. 
2.3.2 Osmolarity 
Osmolarity is an important environmental variable and one that is easily altered by the 
addition of readily available and economical salts such as sodium chloride (NaC1) into the 
culture. Various studies have been carried out to assess the potential of osmotic stress in 
improving antibody production rates. In general, it has been found that hyperosmotic stress 
leads to an increase in qAb, but results in a simultaneous decrease in cell growth rate [Zhou, 
2002]. The actual extent of change differs for different cell lines - in some cell lines, the 
increase in qAb offsets the detrimental effect on cell growth at hyperosmotic pressure, hence 
leading to increased antibody production levels. Conversely, in other cell lines, this trend is 
inversed - the decline in cell growth erodes any improvement in qAb, thereby leading to an 
unchanged or lower antibody production level. 
This inverse relationship between qAb and cell growth rate presents one of the major 
obstacles involved in manipulating osmotic pressure to improve antibody production levels. 
To overcome this conflict, supplementary methods have been suggested, including the use of 
osmoprotectants and the gradual adaptation of cells to hyperosmotic pressure by step 
increases. These strategies have been successful to a certain extent: osmoprotectants such as 
glycine betaine have improved cell growth but resulted in a smaller increase in qAb, while 
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gradual adaptation of cells to hyperosmotic pressure has reduced the detrimental effect on 
cell growth. In the next subsection, detailed effects of hyperosmolarity on the various aspects 
of mammalian cell cultures will be further described so as to provide a clearer picture of the 
possible mechanisms through which antibody productivity is improved. 
Effects of osmotic pressure on cellular functions 
Cell growth and antibody production 
Hyperosmotic pressure appears to have a general effect across many mammalian cell lines in 
terms of cell growth and specific antibody productivity (qAb). Cell growth is suppressed; the 
specific growth rate and maximum cell viable concentration decreases with increasing 
osmolarity, while qAb is increased. For example, in a study on hybridoma cells, Ozturk and 
Palsson [1991b] found that the specific growth rate decreased by a factor of about 2 when 
the culture osmolarity was increased from 290 (control osmolarity) to 435 mOsm/kg. 
Conversely, qAb increased by more than 2-fold over the same rise in osmotic pressure. 
Similarly, Ryu et al. [2001] carried out osmolarity experiments on Chinese Hamster Ovary 
(CHO) cells and found that specific growth rate was halved when the osmotic pressure was 
raised from 302 mOsm/kg (control) to 469 mOsm/kg. In addition, qAb was increased by more 
than 2-fold as osmolarity increased. The same trend was observed in a study on GS-NSO 
cells [Duncan et al., 1997], when the osmolarity was increased from 275 (control) to 400 
mOsm/kg. 
As a result of the decrease in growth rate, the increase in qAb does not necessarily 
lead to an increase in total antibody production. Hence, hyperosmotic pressure may have a 
positive, unchanged or negative effect on total antibody titre (see Table 2.2). To reduce the 
negative effect of reduced cell growth, cells have been adapted gradually to hyperosmotic 
medium. Oh et al. [1993] compared the specific growth rate between cells that are subjected 
to osmotic shock and cells which have been adapted to hyperosmotic pressure for hybridoma 
cells. The results showed that the fall in specific growth rate was reduced by 20% for 
adapted cells as compared to unadapted cells when osmolarity was increased from 300 to 
350 mOsm/kg. The maximum cell concentration also vastly improved. These changes 
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enabled the maximum antibody titre, at 350 mOsm/kg, to increase by 76% for adapted cells. 
This example highlights the potential of hyperosmotic pressure as a cost-effective measure in 
improving antibody production yields. 
Cell metabolism 
Glucose and glutamine are the main energy sources in mammalian cell cultures and are most 
commonly analysed in literature. Cellular metabolism rates are analysed based on the uptake 
of these nutrients, as well as the specific production rate of lactate (by-product of glucose 
metabolism) and ammonia (by-product of glutamine metabolism). 
Glucose metabolism  
It has been widely reported that the specific uptake rate of glucose, qgin, increased with 
increasing osmotic pressure for hybridoma, CHO and GS-NSO cells [Duncan et al., 1997; Oh 
et al., 1995; Ozturk and Palsson, 1991b; Takagi et al., 2000]. Consequently, the specific 
production of lactate, CI -ilac, also increased. However, in contrast to the above observations, 
experiments carried out on hybridoma cells by Oyaas et al. [1994] on hybridoma cells reveal 
no changes in either qgin or CI Jac with increasing osmolarities, despite the increase in qAb. 
Glutamine metabolism  
For hybridoma cells, Oh et al. [1995] reported an increase in specific glutamine utilisation 
rate, qgin, with increasing osmolarity. Similar trends in qgin have been reported by Ozturk and 
Palsson [1991b] and Lin et al. [1999a]. Additionally, the specific ammonia production rate, 
CINH4, increased correspondingly with qgin [Lin et al., 1999a; Ozturk and Palsson, 1991b]. It 
was postulated that the increase in cell metabolic rates results in an increase in the amount of 
ATP produced, which was then channelled into the production of antibody [Lin et al., 
1999a]. Ozturk and Palsson [1991b] also proposed that the increase in cellular metabolism 
rates could be partially attributed to increase in cell volume resulting from hyperosmotic 
pressure. 
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Cell size 
It has been observed that the cell sizes in hyperosmotic cultures tend to be larger than those 
in standard osmotic medium [Ozturk and Palsson, 1991b]. In fact, in a study on KR12H-2 
transfectomas, Lee and Lee [2000] observed a 50% increase in cell volume and cell mass 
when the osmotic pressure was raised from 285 to 425 mOsm/kg. In addition, the dry cell 
weight and total cellular RNA also increased in hyperosmotic cultures [Lee and Lee, 2000; 
Oh et al., 1995]. These findings could have been a result of improved transport of nutrients, 
including amino acids, into the cell, due to the stimulation of Natamino acid symports 
during cell regulatory volume increase (RVI). The accumulation of nutrients would have 
caused cell volume to increase, while the increased amino acids uptake would increase the 
biosynthesis rate of protein in the cell [Oh et al., 1993]. In addition, the increase in total 
cellular RNA may also be partially responsible for the increase in antibody production rate. 
Cell cycle 
Introduction to the cell cycle  
The cell cycle refers to the process by which DNA is replicated and segregated in order to 
form two genetically identical daughter cells [Alberts et al., 1994]. The cycle can be divided 
into four distinct phases [Faraday et al., 2001]; 
(i) GO/GI (GAP 1): a period between cytokinesis and the beginning of DNA synthesis 
(ii) S: the DNA synthesis phase 
(iii) G2 (GAP 2): a period between the end of DNA synthesis and the start of mitosis 
(iv) M: the mitosis phase, where cell division occurs. 
The cycle can be viewed as a repetitive sequence of events in which each event has to be 
completed before the next event can occur. In order to ensure that a cell does not divide 
before the DNA has been replicated, the subcellular organelles have been duplicated and the 
cell has grown to a critical size [Fussenegger and Bailey, 1998] two main 'checkpoints' exist 
within the four cycle phases. These include: a commitment to chromosome replication in the 
G1 phase and a commitment to mitotic cell division at the end of G2 phase. However, for 
animal cell cultures, the latter (G2/M) control checkpoint is subsidiary compared to the 
former, as cells spend the longest part of their cycle in G1 [Lewin, 2000], therefore the focus 
here will be on the GI phase control checkpoint. 
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At the G1 phase checkpoint, the cells make a decision on whether to proceed past the 
G1 phase towards completion of the S phase and progression through the G2 phase. The 
decision is made based on two main criteria: firstly, the existence of a favourable 
extracellular environment in terms of nutrient supply, conditions such as temperature, pH 
and osmolarity, as well as the availability of growth factors and hormones in the extracellular 
medium. The second criterion is an assessment of whether the cell mass is sufficient to 
support a division cycle [Lewin, 2000]. Cells not meeting the above criteria due to, for 
instance, DNA damage as a result of extracellular conditions, will be arrested in the G1 
phase so as to allow time for DNA repair to occur [Nyberg, 2002]. 
Effects of osmotic culture conditions on cell cycle  
There is a significant difference in the cell cycle distribution when cultures are subjected to 
hyperosmotic culture conditions. Hyperosmolarity appears to induce cell cycle arrest in the 
G0/G1 phase [Ryu et al., 2001] for CHO cells — 84% of cells at an osmolarity of 502 
mOsm/kg were in the G0/G1 phase, compared to 45% of cells at the standard osmolarity of 
302 mOsm/kg. Cherlet and Marc [1999] also reported increasing proportion of cells in the 
G0/G1 phase with increasing osmolarity, up to 425 mOsm/kg, for OKT3 mouse hybridoma 
cells. However, there have also been contradicting observations; for instance, Sun [2000] 
reported that the proportion of cells in the GO/G1 phase decreased with increasing osmolarity 
in hybridoma cells (167.4G5.3), while the fraction of cells in the DNA synthesis (S) phase 
increased. 
In addition, there have been various attempts to link the cell cycle to antibody 
production rates. Hayter et al. [1992] stated that qAb was higher in the G0/G1 and G2 phases 
(preparation phases for cell division) as compared to the S and M (mitotic cell division 
phase) phases in a mouse hybridoma line. However, Lloyd et al. [2000] conducted a study on 
CHO cells and found contradictory results: qAb was reported to be lowest when the majority 
of cells were in the GO/G1 phase, intermediate when the majority of cells were in the S phase 
and greatest when the majority of cells were in the G2/M phases. Cherlet et al. [1995] also 
reported maximum qAb when cells were in the G2/M phases for a murine hybridoma cell line. 
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In the light of differing observations, no general consensus has been reached in 
relation to the optimal cell cycle phase for antibody production. It appears that cell cycle 
effects on qAb may be cell-line specific and the relationship between antibody production and 
cell cycle progression cannot be generalised at present [Zhou, 2002]. 
Intracellular mRNA and IgG heavy and light chain concentrations 
There have been few studies focusing on the intracellular concentrations of mRNA and IgG 
polypeptide species at hyperosmotic culture conditions, perhaps due to the difficulties in 
obtaining these values as compared to extracellular concentrations. The findings from two 
major studies currently available in literature today will be described in detail here. It should 
be noted that both studies are based on different hybridoma cell lines. In the first study on 
KR12H-2 transfectoma cells, Lee and Lee [2000] reported substantial increases in the levels 
of heavy (322% increase) and light chain (340% increase) mRNA as the culture osmolarity 
is increased from 285 mOsm/kg to 425 mOsm/kg during the mid-exponential phase. While 
the ratio of light (L) to heavy (H) chain mRNA remained relatively constant at 2.3, the half-
lives of H and L chain mRNA at 485 mOsm/kg (5 hrs for H mRNA, 5.6 hours for L mRNA) 
were lower than at 285 mOsm/kg (8 hrs for H mRNA, 8.7 hrs for L mRNA). These 
observations led to estimated specific transcription rate increases of 476% and 484% for H 
and L mRNA respectively. The authors also estimated that the specific translation rates for H 
and L chains increased by 172% and 240% respectively when the osmolarity of the culture 
was raised from 285 to 425 mOsm/kg. The authors hence concluded that the key reason for 
the increase in qAb at hyperosmotic culture conditions was the enhanced transcription rates of 
H and L mRNA. 
In the second study on the hybridoma cell line 167.4G5.3, Sun et.al. [2004] 
conducted osmotic shock experiments by changing the culture osmolarity from 290 to 400 
mOsm/kg at the mid-exponential phase of the culture. Measurements of the mRNA levels of 
both control and osmotic shock cultures showed that H and L mRNA levels per cell were 
higher in the latter cultures, particularly 72-84 hours after the induction of osmotic shock. 
However, the authors did not see a corresponding increase in antibody production rate, 
protein synthesis or antibody secretion rate. Conversely, they observed an increase in the 
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immunoglobulin translation rate for cultures subjected to osmotic shock, which was 
commensurate with an increase in antibody production. They therefore concluded that the 
increase in translation rate was likely to play a key role in improving antibody production 
rates. 
Based on the above observations, it could be noted that the H and L mRNA levels 
increased under hyperosmotic culture conditions for both studies. Similarly, immunoglobulin 
translation rates were reportedly higher for hyperosmotic cultures relative to normal osmotic 
cultures. However, both studies derived different conclusions with respect to the 
improvement of antibody production rates — the former study concluded that increased 
transcription rates were responsible for the increase in production while the latter postulated 
that transcription rates were not correlated to increased antibody production. Instead, 
increased translation rates were the main reason of antibody production increase. As such, 
there are still differing opinions regarding the mechanism through which hyperosmolarity 
improves antibody production. In the next section, a summary of the possible mechanisms 
proposed in literature will be presented and discussed. The effects of hyperosmotic culture 
conditions on the cell growth and antibody production aspects of a number of different cell 
culture systems can be found in Table 2.2. In addition, the general effects of osmotic 
pressure on the various aspects of cell physiology for mammalian cells that have been 
discussed are summarised in Table 2.3. 
40 
CHAPTER 2. LITERATURE REVIEW 
Cell line 	 Observations/findings 	 Reference 
CHO 	• Unspecified decrease in ja as osmolarity increases from 	[Ryu et al., 
(CS13-0.02 
	
305 to 537 mOsm/kg 	 2001] 
cell line) 	• qAb increased by approximately 400% over same 
increase in osmolarity 
• Final Ab titer decreased by approximately 60%. 
GS-NSO 	• Decrease in IA as osmolarity increases from 275 to 400 [Duncan et al., 
mOsm/kg. 	 1997] 
. 1.8-fold increase in qAb over same increase in 
osmolarity. 
• No mention of final Ab titer. 
Hybridoma 	• 2-fold decrease in }las osmolarity increases from 290 
	
[Ozturk and 
to 435 mOsm/kg. 	 Palsson, 
• qAb increased by more than 2-fold over same increase 
	1991b] 
in osmolarity. 
. Final Ab titer relatively unchanged. 
Hybridoma 	• p. decreased by 20% as osmolarity increases from 285 
	
[Lee and Lee, 
(KR12H-2 to 425 mOsm/kg. 	 2000] 
Transfectoma) • qAb increased by 376% over the same increase in 
osmolarity. 
• Final Ab titer increased by about 60% over same 
increase in osmolarity. 
Table 2.2. Summary of hyperosmotic effects on cell growth and antibody production in 
various cell systems. 
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Physiology aspect Response to hyperosmotic pressure 
Cell growth 
Specific antibody productivity 
Cell metabolism 
Cell size 
Cell cycle distribution 
Total cellular RNA levels 
H and L mRNA levels 
H and L translation rates 
Decrease 
Increase 
Increase 
Increase 
Cell line-dependent: 
G1 phase arrest or increase in S phase 
Increase 
Increase 
Increase 
Table 2.3. Summary of effects of hyperosmotic pressure on cell physiology 
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Hyperosmotic effects on antibody production — proposed mechanisms 
As the detailed mechanism of enhanced qAb as a consequence of hyperosmotic pressure is 
still not clearly understood at the basic cellular level, there have been a number of 
hypotheses proposed regarding this phenomenon [Ryu et al., 2001] in literature, including 
the following: 
Increase in transcription rates 
Hyperosmotic pressure induces the transcriptional activation because of the change of 
chromatin structure, as in the case of treatment with sodium butyrate, which is also known 
for enhancing the production of proteins while suppressing growth rates [Oh et al., 1993]. 
The chromatin becomes dispersed due to the unbinding of histones from DNA and made 
more accessible to RNA polymerase for transcription [Lee and Lee, 2000]. This leads 
subsequently to an increase in transcription rates and hence improved antibody production 
rates. 
Stimulation of assembly rates 
Hyperosmotic pressure may also stimulate the expression of assembly step catalysts and 
chaperone-like proteins in the ER, such as PDI or GRP78 and other similar molecular 
chaperones, which has been reported to increase the assembly rate of a single-chain antibody 
fragment in eukaryotic cells [Shusta et al., 1998]. However, it must be noted that 
overproduction of GRP78 may instead result in a decreased antibody assembly rate, as 
excessive binding of heavy and light chain to the chaperone occurs [Dorner et al., 1992; 
Gonzalez et al., 2001]. In a study on three chaperone-like ER proteins (GRP78, GRP94, 
ERp72) on batch cultures of GS-NSO cells, Downham et.al. [1996] observed an increase in 
the expressions of all three ER proteins as the culture progressed towards the stationary and 
decline phases, which corresponded to a halt in the uptake of glucose and glutamate by cells. 
However, the authors also found that increased productivity due to glutamate feeding during 
the batch culture did not relate to enhanced induction of the ER proteins and concluded that a 
more detailed study was required to discern any likely relationship between ER chaperone 
protein expression and antibody productivity. Based on the above contradictory observations 
43 
CHAPTER 2. LITERATURE REVIEW 
with regards to this hypothesis, it may be likely that the extent of stimulation of the above 
proteins is cell-line dependent. 
Increased amino acid uptake rates leading to enhanced antibody productivities 
Hyperosmotic pressure has been reported to enhance the transport of a number of amino 
acids into cells [Oh et al., 1995; Oh et al., 1993; Pastor-Anglada; et al., 1996]. The increase 
in amino acid uptake rates resulted in a larger available pool of amino acids for biosynthesis, 
thus leading to improved specific antibody productivities [Oh et al., 1995; Oh et al., 1993]. 
Increased energy levels due to enhanced uptake of nutrients 
Hyperosmotic pressure enhances the uptake of nutrients such as glucose, hence resulting in 
an increase in ATP production rates. This increase, coupled with the lower growth rate, 
implies that there is a larger amount of ATP being channelled into the antibody production 
process [Lin et al., 1999a]. As the antibody translation process is highly energy-dependent, 
this mechanism is likely to improve the translation rates of heavy and light IgG chains. 
Cell cycle phase-associated antibody production 
Hyperosmotic pressure induces G1 phase arrest. It has been observed in CHO cells that 
higher productivity is obtained when the majority of cells are in the G1 phase. It has been 
suggested that this is due to the fact that cells in that phase do not need to devote cellular 
resources to biomass production, hence enhancing qAb. However, this observation does not 
seem to be universal — a number of other studies found that antibody productivity is highest 
during the G2/M phase [Cherlet et al., 1995; Lloyd et al., 2000]. 
The aim of the combined modelling and experimental approach undertaken in this 
study is to ascertain the degree of applicability of some of the proposed mechanisms of 
hyperosmolarity to the GS-NSO cell line, as well as establish the possible rate-limiting 
step(s) in the GS-NSO antibody production process. 
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2.4 	Modelling and mathematical analysis of cell culture processes 
2.4.1 Importance of mathematical models 
Incomplete understanding of mammalian cell culture kinetics often hinders the design and 
development of control strategies for antibody production systems [DiMasi and Swartz, 
1995]. With the increasing demand for antibody products from mammalian cell lines, 
process optimisation has become a matter of extreme importance in the biopharmaceuticals 
industry [Mainwaring et al., 2002]. While the use of experiments to optimise the values of 
various culture parameters (such as nutrient feeding rates and environmental conditions) is 
the current preferred means of improving antibody production rates, this approach often 
results in large numbers of experiments that are expensive and time-consuming [Jacquez, 
1998]. An alternative approach to the above method is the use of mathematical models, 
which allows for the organization of preliminary experimental information in a logical and 
systematic manner, thereby facilitating the identification and quantification of key 
relationships between process parameters, variables and product output rates [Bailey, 1998]. 
Additionally, a thorough and systematic analysis of these models will help to identify key 
parameters affecting antibody production rates, which can then be studied in more detail 
experimentally. This approach is therefore likely to lead to a reduction in the required 
number of experiments for product optimisation, leading to savings both in terms of time and 
costs. 
2.4.2 Cell growth and metabolism models 
Cell growth and metabolism models constitute the largest proportion of mathematical models 
describing the mammalian antibody production process. One of the earliest cell growth 
models was developed by Monod, which relates bacterial growth rates to the availability of a 
substrate required for growth [Monod, 1949]. The kinetics in this model was based on the 
`Michaelis-Menten' kinetics equation, which has been used extensively in the current, more 
sophisticated models of cell growth and metabolism. 
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Structured and unstructured models 
Most cell culture models can be divided into two categories, namely unstructured and 
structured. Unstructured models are empirical and disregard intrinsic intracellular processes, 
while structured models aim to incorporate such features [Portner and Schafer, 1996]. Fully 
structured models are ideal for capturing the true nature of cellular functions; an example of 
an up-to-date structured model is the single-cell model developed by Sanderson [Sanderson, 
1997]. This model accounts for some 50 components in three distinct regions (medium, 
cytoplasm and mitochondria) and includes descriptions of major metabolic pathways, 
competitive trans-membrane transport, product formation, and cell growth and death. 
However, incorporation of biological detail has also contributed towards model complexity 
resulting in high computational costs and rendering model analysis particularly difficult 
[Sidoli et al., 2005]. In contrast, the simpler unstructured models utilise mainly extracellular 
data while treating intracellular processes as a "black box". Although this approach does not 
allow for the in-depth study of cellular processes, such models have been reported to be of 
great importance in aiding the design of monitoring and optimisation strategies [Provost and 
Bastin, 2004]. Additionally, they may be a good starting point for relatively new cell systems 
where data are limited. 
Unstructured models — a summary 
Many existing unstructured models are based on empirical correlations between the specific 
monoclonal antibody production rate, qAb and other variables, such as the specific growth 
rate [de Tremblay et al., 1992; Frame and Hu, 1991; Linardos et al., 1991] or the 
concentrations of nutrients like glucose and glutamine [Dalili et al., 1990; Jang and Barford, 
2000]. Suzuki and 011is [1989] also incorporated the characteristics of the cell cycle into a 
model by correlating the fraction of cells in each phase of the cell cycle to qAb. In general, 
these empirical correlations consisted of a growth-independent term and a growth-dependent 
term, which were determined experimentally. 
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The development of structured models 
One of the first structured models was developed by Batt and Kompala [1989], which 
consisted of defined 'metabolic pools' for amino acids, proteins, nucleotides and lipids. The 
antibodies produced were regarded as part of the protein pool and the interactions between 
different pools and the extracellular environment were described by Michaelis-Menten 
equations [Portner and Schafer, 1996]. Subsequently, Wu et al. [1992] derived a single-cell 
model for the growth and metabolism of Chinese Hamster Ovary (CHO) cells. In their 
model, glucose and glutamine were substitutable precursors of intracellular metabolites, and 
their respective contributions were determined by a 'dominance factor', which in turn was a 
function of their relative intracellular concentrations. 
In 1995, DiMasi and Swartz formulated an energetically structured (ES) model 
applicable to steady-state hybridoma cell growth in continuous culture. The model was based 
on the amount of energy (in the form of ATP) produced and consumed during catabolic and 
anabolic (biosynthesis) processes respectively. The predictions of specific nutrient utilisation 
rates, specific metabolite production rates with respect to specific growth rate were shown to 
agree well with the experimental results reported by Miller et al. [1987; 1988a; 1988b; 
1989a; 1989b] on hybridoma cells. 
As mentioned briefly in the previous subsection, the most recent structured model 
was developed by Sanderson et al. [1999], involving detailed descriptions of major 
metabolic pathways, competitive trans-membrane transport, product formation and cell 
growth and death. It has been applied to a variety of cell cultures, including hybridoma and 
baculovirus/insect cell systems. The rates of cell growth and antibody production in this 
model were represented by Michaelis-Menten type equations, which were in turn modulated 
by the availability of energy and the necessary precursor molecules, as well as the 
concentration of inhibitory products (such as lactate and ammonia) in the cell. Trans-
membrane transport was described by a modified version of the diffusion equation while the 
reactions in the major metabolic pathways were described using Michaelis-Menten kinetics. 
[Sanderson et al., 1999]. The combination of equations was able to provide a detailed 
description of intracellular metabolic events with respect to time. The model was 
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subsequently applied to a variety of cell culture systems, including two types of hybridoma 
cells and a baculovirus/insect cell system. 
The survey of the metabolism models in the literature seems to suggest that there is a 
trend towards the generalisation of models to various mammalian cell culture systems and 
beyond. While the models are extremely useful in the optimisation of antibody production 
based on metabolic factors (nutrient feeding), they do not consider the detailed steps in 
antibody production, and hence cannot be used to identify the rate-controlling step(s) in the 
antibody production pathway. The lack of detailed information leads to an incomplete 
understanding of the actual process of antibody production, which may hamper further 
improvements in antibody production rates. 
Antibody synthesis and secretion models 
There have been very few models that depict the antibody synthesis and secretion process as 
described in Section 2.2. The first key model describing this process was a basic structured 
kinetic model constructed by Bibila and Flickinger [1991a] for the description of antibody 
production in hybridoma cells. The model consisted of three main steps used to describe 
antibody synthesis: 
• Transcription of the heavy (H) and light (L) chain mRNAs 
• Translation of H and L mRNAs into H and L polypeptide chains 
• Assembly of the H and L polypeptide chains in the ER to form the antibody molecule 
This basic model was subsequently incorporated in a three-compartment model 
[Bibila and Flickinger, 1991b] describing the inter-organelle transport of the assembled 
antibody molecule. The three main steps in this larger model consisted of: 
• Transport of assembled antibody from the ER to the Golgi 
• Further processing of the molecule in the Golgi complex (glycosylation) and transport of 
the antibody from the Golgi to the extracellular medium (ECM) 
The model was structured with respect to the process of antibody synthesis and 
secretion alone, instead of at the whole cell level, in order to develop a modelling framework 
that was useful in identifying possibly rate-limiting steps in the antibody production process. 
Based on steady-state and transient model simulations carried out by Bibila and Flickinger 
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[1992a; 1992b] on the antibody secretory pathway in response to blocks in each key process 
step, the study concluded that the main rate-limiting steps were: the assembly rate of the 
antibody in the ER under fast growth conditions and the H and L chain translation rates 
under slow growth conditions. 
The second key model for monoclonal antibody synthesis was developed by 
Gonzalez et al. [2001] and consisted of the following key steps: 
• Production of nucleotides from a pool of precursors (consisting of amino acids used for 
biosynthesis) 
• Transcription 
• Translation and polypeptide translocation across the ER membrane 
• Primary glycosylation (catalysed by oligosaccharide transferase [OST] ) 
• Folding and assembly (including the involvement of protein disulphide isomerase [PDI], 
a catalyst for disulphide bond formation and GRP78, a molecular chaperone binding to 
incompletely assembled molecules) 
The model was analysed using metabolic control analysis, a technique which 
attempted to relate the overall properties of a metabolic system to the properties of its 
component parts [Gonzalez et al., 2001]. The technique used flux control coefficients, which 
gave an understanding of the control of each step on the pathway. It was found that the 
control structure of antibody synthesis was shared between transcription and post-
translational steps, including folding, glycosylation and the synthesis of nucleotides from 
precursors. The actual controlling step would depend on the concentration of the precursor 
pool, as well as the levels of OST, GRP78 and PDI. 
The conflicting point between the two models was the fact that while translation was 
considered to be a possible rate-limiting step in the first model, in the second model, it was 
stressed that translation was not a rate-controlling step 'under all conditions' [Gonzalez et 
al., 2001]. This might be due to differences in the approaches of the two models. The first 
model is based on mass balances for transcription and translation, with a number of 
empirical correlations derived from experimental data, as well as reaction kinetics for the 
assembly and interorganelle transport steps. In contrast, the second model is based purely on 
reaction kinetics. This resulted in the involvement of a large number of variables, including 
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the concentrations of DNA, various enzymes involved in each of the reaction steps, as well 
as the intermediate complexes formed (such as the mRNA-Ribosome complex). This latter 
approach requires a large amount of data relating to the kinetic parameters of each enzymes 
and the concentration of reaction intermediates with respect to time, which is not easily 
obtainable or available in literature. Many of the parameter values used in the model have 
therefore been derived for bacteria and yeast cell lines rather than mammalian cell lines, and 
this may lead to inaccuracies in the actual model. 
In addition to the two models above, there have also been a number of models that 
concentrated on certain steps in the antibody production pathway. Schroder et al. [1999] 
came up with a kinetic model for transcription and translation of recombinant protein in gene 
amplified CHO cells and used it to determine that neither of the two processes was rate-
limiting for recombinant protein production. Percy et al. [1975] devised a theoretical model 
for the covalent assembly of immunoglobulins which was based on the probabilities of the 
formation of a disulphide bond between two heavy chains, as well as, between a heavy and a 
light chain. The model successfully predicted the assembly rate for both IgG1 and IgG4 
molecules, based on the experimental results of Petersen and Dorrington [1974]. Robinson 
and Lauffenburger [1996] developed a model describing the interactions between the 
molecular chaperone GRP78 and foreign proteins in general in the folding process. Gonzalez 
et al. [2002] also derived a kinetic model for the folding and assembly of recombinant 
proteins in eukaryotic cells. This model incorporates the interactions of the chaperone 
GRP78, as well as PDI, which as mentioned above, is a catalyst for the formation of 
disulphide bonds. 
Umana and Bailey [1997] created a model that described the N-glycosylation 
process of recombinant glycoproteins passing through the Golgi complex, consisting of mass 
balances for 33 different oligosaccharide species which can be linked to the specific protein. 
Monica et al. [1997] also developed a model depicting sialylation of N-linked 
oligosaccharides in the trans-Golgi network. This model was based on Michaelis-Menten-
type dependency of reaction rates. The model was used to predict the heterogeneous 
outcome of a post-translational oligosaccharide biosynthesis step, which would lead to the 
production of proteins of varying quality. 
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The above models all contributed to the characterisation of the antibody production 
pathway. It is through such models that more insight into the intracellular mechanisms that 
govern antibody synthesis and secretion can be gained. 
Antibody production models and osmolarity effects 
At present, there appears to be no publication regarding an antibody production model that 
takes into account the effects of hyperosmotic culture conditions, although there have been a 
considerable number of experimental studies on osmotic effects on hybridoma and CHO cell 
lines (see Section 2.3.2). The closest resemblance of a model being used to describe the 
process is the study on transfectoma cells and their response to hyperosmotic pressure by 
Lee and Lee [2000], which has been described in Section 2.3.2. Based on their experimental 
results, the authors derived a correlation for the relative transcription rates at different 
osmotic pressures during exponential growth, which was subsequently used to quantify the 
relative mRNA transcription rates at different osmolarities. The correlation was derived from 
the H and L mRNA mass balances found in the model developed by Bibila and Flickinger 
[1991a]: 
S _ 	(k+ ,u)  1[[mRATAJ1 
So (ko +,uo ) [mRNAJ 0 (2.1) 
where S is the transcription rate, k is the decay rate constant, il represents the specific growth 
rate and [mRNA] is the intracellular mRNA concentration. The subscript 'o' refers to the 
original (control) osmolarity state. 
The lack of a model that is able to describe antibody production in hyperosmotic 
cultures may be another reason why hyperosmolarity is rarely used as a means of improving 
antibody production rates. As such, the construction of such a model will be beneficial in 
gaining an improved insight into hyperosmotic pressure mechanisms and contribute towards 
the developing of optimisation strategies for antibody production. 
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2.4.3 Mathematical analysis of cell culture models 
Having developed a mathematical model based on known experimental information, it is 
important to determine the robustness of the model structure and its validity under different 
environmental conditions. As such, an in-depth analysis of the model should be carried out 
to increase confidence in the model predictions [Saltelli, 2000], by evaluating existing 
relationships between model inputs (parameters) as well as how changes in the values of 
these inputs affect model outputs. 
Identifiability and sensitivity analysis mtehods 
Information on model parameters can be gathered through either a parameter identifiability 
or a sensitivity analysis approach [Kontoravdi et al., 2005]. An identifiability study is used to 
determine whether a unique solution can be derived for each parameter from measured 
experimental values [Sidoli et al., 2005]. While established methods have been derived for 
identifiability studies on simple models [Jacquez, 1998], carrying out such an analysis on 
highly non-linear and dynamic models has been reported to be extremely difficult 
computationally [Ljung and Glad, 1994; Sidoli et al., 2005]. In contrast, sensitivity analysis 
(SA) is defined as the study of how a variation in model output (antibody production) can be 
allocated among different sources of variation in the inputs (changes in parameter values) 
[Saltelli et al., 2004]. SA tends to have a lower computational cost as the derivation of 
unique solutions for each parameter is not required. As such, the SA approach tends to be 
more widely used in a variety of biological modelling applications, as summarised in the 
next subsection. 
Use of SA in various biological modelling applications 
Different sensitivity analysis techniques have been used to evaluate the structure and test the 
validity of mathematical models developed for a wide range of biological applications, 
including drug delivery [Rullmann et al., 2005; Tzafriri et al., 2005] tissue engineering 
[Malda et al., 2004; Radisic et al., 2005; Schiek and May, 2005] and signalling pathway 
modelling [Babu et al., 2004; Mutalik et al., 2004; Waters et al., 1990]. In the area of cell culture 
modelling, SA has been implemented in plant cell culture [Zhang and Su, 2002], insect/retrovirus 
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cell culture [Cruz et al., 2000; Enden et al., 2005] and hybridoma cell culture models [Dhir et al., 
2000; Kontoravdi et al., 2005; Lavric et al., 2005, 2006; Sidoli et al., 2004]. 
Types of Sensitivity Analysis 
Sensitivity analysis methods can be generally classified into three different groups: 
screening, local sensitivity analysis and global sensitivity analysis methods. Screening 
methods provide a qualitative measure of the relative importance of each model parameter 
and are particularly useful for the evaluation of large-scale models, which tend to have a 
high computational cost of analysis [Saltelli, 2000]. Local sensitivity analysis techniques 
involve the determination of changes in model output as parameter values are altered within 
the close vicinity of their nominal value. However, local sensitivity analysis data is by 
definition local as it is related only to a single point in the parameter space. Such data is not 
able to provide useful information on effects resulting from significant changes in parameter 
values, which might occur, for instance, in a cell culture model under different feeding 
regimes or environmental conditions [Turanyi and Rabitz, 2000]. In contrast, global 
sensitivity analysis (GSA) methods take into consideration the entire possible ranges of 
parameter values while apportioning the changes in the output to changes in input factors 
[Saltelli, 2000]. This characteristic is important in cell culture models as it allows for the 
analysis of how model parameters behave over their entire known physiological ranges. 
Additionally, in a GSA study, simultaneous changes in multiple parameter values are usually 
carried out, hence providing more information about both first- and higher- order 
sensitivities. 
In this study, GSA has been chosen to evaluate the relative impacts of model 
parameters on antibody production, as well as the possible interactive effects between 
different parameters. This decision is based on the fact that GSA provides the most detailed 
quantitative information on model parameters, which subsequently aids in the identification 
of key parameters crucial to the antibody production process which are then studied 
experimentally. 
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Development and Analysis of a 'Hybrid' Model 
3.1 	Introduction 
It has been mentioned briefly in Chapter 2 that while a fully structured cell culture model is 
ideal for capturing the true nature of intracellular processes, there are difficulties involved, 
both in the obtaining of the required experimental data for the determination of model 
parameters, as well as conducting a detailed analysis of such a model [Sidoli et al., 2005]. 
For example, in a highly structured model such as the single cell model developed by 
Sanderson [1997], there are over 350 parameters, many of which can only be determined 
accurately with intracellular metabolism data. As such data are still currently rather scarce 
(and non-dynamic), most of the parameters had to be estimated with existing extracellular 
metabolism data, utilising a set of heuristics and trial and error techniques [Sanderson, 
1997]. Additionally, the large number of equations and parameters involved in the single cell 
model poses a big challenge in terms of conducting an accurate analysis of the model. The 
problems faced in assessing the effects of individual parameter value changes for the single 
cell model are highlighted in a parameter estimability study conducted by Sidoli et.al. 
[2005]. Based on the above issues, the development of a fully structured model to describe 
antibody production in GS-NSO cells is likely to have limited model flexibility at present and 
therefore impractical as a first step. However, adopting a wholly unstructured model 
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approach will not allow for accurate representation of the intracellular antibody production 
process in GS-NSO cells, which is a main focus of this study. 
In view of these limitations, a combined unstructured and structured modelling 
approach has instead been undertaken for the development of the hybrid model presented in 
this chapter. As dynamic intracellular metabolic data for the GS-NSO cell system is not 
currently available in literature, to the best of the author's knowledge, an unstructured 
approach is used to describe cell growth, death and metabolic processes. The processes of 
antibody synthesis and transport are described through a structured model approach so as to 
gain greater insight into the individual production steps and aid identification of possible 
rate-limiting steps. The model thus allows for a detailed description of the antibody 
production process without the need for intracellular metabolic data. 
3.2 	Model structure 
As mentioned in Section 3.1, the model comprises of an unstructured description of cell 
growth and death kinetics, nutrient uptake and metabolite production, as well as a structured 
description of the intracellular antibody synthesis and secretion process. The unstructured 
elements of the model utilises Michaelis-Menten kinetic type expressions as the basis for 
description of cellular growth, death and metabolic processes. The structured element of the 
model is based on the antibody production pathway model developed by Bibila [1991] for 
hybridoma cells and consists of the following main steps: transcription of heavy (H) and 
light (L) mRNA molecules, translation of the H and L mRNA into H and L polypeptide 
chains, assembly of two H and L chains to form the H2L2 antibody structure, transport of the 
fully formed antibody molecule from the endoplasmic reticulum to the Golgi complex and 
subsequently to the extracellular medium. A graphic representation of the hybrid model is 
shown in Figure 3.1. 
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Figure 3.1. Schematic representation of hybrid model, showing both unstructured elements 
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3.2.1 Assumptions 
The proposed model operates under a number of assumptions: firstly, it is assumed that a 
well-mixed system exist in the shake flask cultures, hence any spatial variation in cell 
numbers and metabolite concentrations has been ignored. The cell culture is also assumed to 
be homogenous, as elements of the cell cycle has not been incorporated into the model. This 
implies that the nutrient uptake, metabolic production and antibody production behaviour of 
each cell is averaged over all viable cells in the whole culture. It should also be noted that the 
kinetic expressions have been developed for a batch culture. 
3.2.2 Mathematical formulation 
The unstructured part of the model comprises of the following expressions based on a 
combination of Michaelis-Menten kinetics and the mass conservation equations. 
Cell growth and death 
Equations (3.1) to (3.3) are continuity equations that describe the total (XT ), viable (X„) and 
non-viable (Xd ) cell numbers present in the shake flask culture. 
A" 
T  = 11X v — k iys X d 	 (3.1) dt 
djir " = (,I — k d )X „ 	 (3.2) 
dt 
dX 
dt
d = k
d
X
v 
 — k
'Ys
X
d 
(3.3) 
where p refers to the specific growth rate, kd is the specific death rate and kiy, represents the 
specific lysis rate of GS-NSO cells. 
The specific growth rate is assumed to be dependent on the concentration of glucose, 
as the main nutrient in the culture. The influence of lactate as the main inhibitor of cell 
growth in this expression was found to be negligible based on the experimental data obtained 
from our laboratory [personal communication, Wu, 2005]. Therefore, the specific growth 
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rate, p, can be represented by a Michaelis-Menten type expression dependent on the 
extracellular glucose concentration [GLC]: 
 
( 	[GLC]— [GLO„„„ 
  
P Pmax 
 
(3.4) 
\,K gic  + qGLC]—[GLC]min ) 
 
   
where An  is the maximum possible specific growth rate, [GLC]min is the minimum threshold 
glucose concentration and 4, is the Monod constant for glucose consumption. The [GLC]min 
term implies that the cells have an inability to absorb glucose once it falls below a certain 
minimum concentration. 
In addition, the specific death rate, kd, has been described using an expression 
adapted from de Tremblay et al. [1992]. This expression once again involves the 
accumulation of lactate, [LAC], as the main instigator of cell death: 
Kd,  
kd 	  
pmax — Kd,T [LAC] 
(3.5) 
where Kdl,u,nd, is equivalent to the minimum specific death rate (when no lactate is present in 
the medium) and KczT is a death rate constant associated with the toxicity of lactate in the 
medium. 
The specific lysis rate, kiy„ of cells has been linearly correlated with the specific 
death rate,kd, as shown in the following expression: 
ki„ = 	kd — k12 	 (3.6) 
where kid is the rate constant related to kd and k1,2 represents the threshold rate below which 
cell lysis is assumed to be negligible. 
Cell metabolism 
Cellular metabolism expressions have been derived to describe glucose uptake and lactate 
production. Expressions for glutamine and ammonia, which are found in most unstructured 
models, have been omitted since the GS-NSO cell line used in this study does not require 
exogenous glutamine. In addition, the accumulation of ammonia in the GS-NSO cultures has 
been shown to be less than 1 mM [Wu, 2006], and hence it is not expected to reach toxic 
58 
CHAPTER 3. DEVELOPMENT AND ANALYSIS OF A 'HYBRID' MODEL 
proportions based on the concentrations reported in the literature (approximately 2-3 mM, 
[Schneider et al., 1996]). The glucose uptake rate is described as follows: 
d[GLC]  —qgicX v dt 
where [GLC] is the glucose concentration and qgic refers to the specific glucose consumption 
rate of the cells. 
The specific glucose consumption rate, qgic, comprises of two terms: a "maintenance 
energy" term, mgk [Jang and Barford, 2000], which describes consumption at zero cell 
growth, as well as a Michaelis-Menten type term that is dependent on the glucose 
concentration in the extracellular medium: 
[GLC]— [GLC] 
qgic = mgleKgicK _ ([GLE]— [GLC] gic,l 	 min 
where Kgrc,max is the maximum uptake rate of glucose by the cells and Kgk , / is the Monod 
constant for glucose consumption. 
The accumulation of lactate in the extracellular medium, [LAC], is given by: 
d[LAC] 
dt = 
(3.9) 
where qia,  is the specific production rate of lactate by the cells. 
The specific production rate of lactate, 'Tao  includes a minimum lactate production 
term, miac, as well as a glucose uptake dependent term: 
q lac = ggicYlac,gic 	lac 
where Y - lac,g1c refers to the yield of lactate from glucose. 
(3.10) 
Antibody production 
This section describes the structured part of the hybrid model, which is based on the 
antibody synthesis and secretion pathway model proposed by Bibila [1991]. Expressions 
represent the intracellular mass balances for heavy and light chain mRNA species, heavy and 
light polypeptide chains, as well as the fully formed antibody molecule in a single cell. The 
59 
(3.7) 
(3.8) 
dt 
d[H] 
 = TH M H — ,u 171 H — RH  (3.14) 
dt 
4] 
 = TL mL - p mL -RL  (3.15) 
dt 
d[.1-1L] 
	= Rill,  — 2RAb — 11{11L] (3.16) 
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accumulation of heavy (H) and light (L) chain messenger RNA molecules, mH and mL, within 
a cell are represented by equations (3.11) and (3.12): 
dm
dtH = SH - kH inH —,u mH 
	 (3.11) 
dm L  
dt 
= Si, — kLmL mu mi, 	 (3.12) 
where SH and Si, are the transcription rates of H and L messenger RNA molecules 
respectively. The specific decay rates of the H and L messenger RNA molecules, kH and kL, 
are assumed to be equal and can be derived from the half-life of the molecules, tv2: 
kH = kL = 
In 2 
(3.13) 
1.1/2 
Similarly, continuity equations can be written for the H and L polypeptide chain 
concentrations, [H] and [L], as well as the concentration of the antibody assembly 
intermediate, the half-molecule, HL ([HL]): 
where TH and TL are the specific translation rates of the H and L polypeptide chains, RH and 
RL are the rate of consumption of the H and L chains in antibody assembly, RTH, is the rate of 
formation of the HL half-molecule and RAb is the rate of formation of the full H2L2 molecule. 
The cB72.3 antibody produced belongs to the IgG4 subclass and its main assembly 
pathway can be summarized by the following reaction scheme proposed by Percy et al. 
[1975]: 
km 
H - F L HL 
	
(3.17) 
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kHH 
HL + HL H 2 L2 	 (3.18) 
Assuming that mass action kinetics applies in the above reaction pathway, the reaction rates 
can therefore be represented by the following equations: 
RH = RL = RHL = kHL [H] [L] 	 (3.19) 
RAb = k HH [HL][HL] 	 (3.20) 
where kHL and kHH are the assembly rate constants for the reactions depicted by Equations 
3.17 and 3.18 respectively. 
The mass balance of the fully formed antibody molecule in the endoplasmic 
reticulum (ER), [H2L 2] ER is hence given by: 
— P[H 2L2kR 
d[H2L2]ER = 
dt 	
RAb - k ER [ H 2L2]ER (3.21) 
where kER is the rate constant for antibody transport from the ER to the Golgi complex and 
can be determined by the time required for transportation of half the number of total H2L2 
molecules from the ER to the Golgi complex, t I/2,ER: 
kER = , 
In 2 	
(3.22) 
i 1 I 2,ER 
A similar mass balance can be derived for the antibody molecule in the Golgi 
complex: 
d[H 2
dt
L 2]G  = k ER[H  2 L2 ]ER k GW 2 L2b 1-1 [H2L2 ]G 
	 (3.23) 
where kG is the rate constant for antibody transport from the Golgi complex to the 
extracellular medium (ECM) and can be determined by the time required for transportation 
of half the number of total H2L2 molecules from the Golgi complex to the ECM, ti/2,G: 
In 2 
kG = 
t1/2,G 
(3.24) 
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Finally, the accumulation of antibody in the medium, [H2L2]ECM  is derived from the 
following expression: 
d[H2 L2 litm _
x kG [H2 L2 .1G 	 (3.25) 
dt 
Initial parameter values for the hybrid model were determined using both existing 
literature data for the intracellular antibody production process, as well as currently available 
data on the GS-NSO cell system, based on a series of shake flask batch cultures carried out 
by Wu et al. [2004]. These parameter values can be found in Appendix A. 
3.2.3 Modelling environment 
The mathematical simulation of the proposed antibody production model has been carried 
out using a commercially available dynamic modelling software called gPROMS [Process 
Systems Enterprise Ltd., 2002]. gPROMS is a well established simulation and optimisation 
engine, originally developed for the design of chemical plants. The ability of the software to 
carry out dynamic simulations allows for the tracking of changes in the concentration of 
intracellular intermediates with time. In addition, the program has a parameter estimation 
module that can be used for the estimation of parameters from the experimental data 
generated. 
3.2.4 Adaptation of the single cell model (Sanderson) 
Description of the single cell model 
The single cell model (SCM) first developed for hybridoma cells by Sanderson [1997], has 
been adapted in this study to test the validity of the hybrid model and to provide a basis for 
comparison of the model outputs. The single cell model takes into consideration the major 
intracellular metabolic processes of glycolysis, tri-carboxylic acid (TCA) cycle, basic amino 
acid and fatty acid metabolism, as well as the external process of glutaminolysis. The types 
of mathematical expressions used in the model will be briefly described in this section. A 
complete description of these expressions can be found in [Sanderson, 1997]. 
62 
CHAPTER 3. DEVELOPMENT AND ANALYSIS OF A 'HYBRID' MODEL 
Firstly, the reaction rates for the intracellular metabolic processes are described 
using an adapted form of Michaelis-Menten kinetics, which takes into consideration the 
effects of multiple reactants as well as any feedback inhibition effects caused by products or 
other components. The adapted Michaelis-Menten kinetics has also been used to represent 
the incorporation of various media components into cells (specific growth rate) and antibody 
product (qAb). In this way, the antibody production rate is directly linked to the concentration 
of the individual amino acids and nutrients available in the cell. Additionally, the rate of cell 
death is presented as a function of the specific growth rate of the cells. Transport of 
components into and out of the cell is modelled using another form of the Michaelis-Menten 
expression, in which the difference in extracellular and intracellular concentrations of each 
component is the driving force for transport. Finally, each of the different nutrient or 
metabolite species present in the cell are represented by general mass conservation equations 
in the form: 
Accumulation 	Inflow Outflow Generation Consumption 
. . 	 _ 	+ 	 — 
Rate 	 Rate 	Rate 	 Rate 	Rate 
(3.26) 
Hence, the accumulation of the species inside the cell is given by the combination of 
the rates of reaction, the dilution rate caused by cell growth and the consumption of the 
species as it is incorporated into new cells or used in the production of antibody. 
Application of the SCM to GS-NSO cell system 
In the adaptation of the SCM for the GS-NSO cell system, a number of modifications had to 
be made in order to accommodate for differences in the characteristics of hybridoma and 
GS-NSO cells. A key change was in the removal of the extracellular description of 
glutaminolysis, based on the fact that GS-NSO cells do not require an exogenous glutamine 
supply. Additionally, some model parameters values were changed based on existing data for 
the GS-NSO cell system [Wu et al., 2004]. Firstly, parameters related to the glutamine to 
glutamate conversion pathway (VM,GLN and KLATP4) have been dampened due to the ability of 
GS-NSO cells to synthesise glutamine intracellularly. Alterations in parameter values relating 
to the specific growth, death and antibody production, as well as glucose and lactate 
metabolism, have been made to take into consideration differences between the metabolic 
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usage and growth behaviour of the GS-NSO and hybridoma cell lines. The parameters whose 
values have been changed are shown in Table 3.1. 
Parameter a 
VCELL 
VM,CELL 
Kr, LAC 
KsDR 
KD,XD 
MWAB 
VM, AB 
VM,GL 
KGL 
Vml,PY 
KLATP4 
VM,GLN 
VMI,SER  
Units 	 Values used b 
1.72 x 10-6 
umol L(cell)-1 	 0.045 
jamol L(cell)-1 1.8 x 104 
hr-I 	 1.5 x 10-3  
hr-I 5 x 10-4 
150 
L(ce1l)-1 hr-1 	 3 
L(cell)-1 hr-I 2 x 105 
L(cell)-1 	 3.5 x 103  
L(cell)"1 hil 	1.20 x 107 
[tmol L(cell)-1 2.25 x 103  
1=01 L(ce11)-1 	 7.65 x 102 
µmot L(cell)-1 hr-1 	5.00 x 103  
a For parameter descriptions, refer to [Sanderson, 1997] 
b Parameters are based on [Sanderson, 1997] and fitted to GS-NSO data from [Wu et.al., 2004]. 
Table 3.1. Summary of key parameter changes for the SCM. 
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3.3 	Global sensitivity analysis of the hybrid model 
The importance of carrying out a detailed analysis on a model after it has been developed has 
been discussed in Section 2.4.3. As mentioned previously, a global sensitivity analysis 
(GSA) has been conducted on the hybrid model as it is able to provide detailed quantitative 
information on each model parameter, thereby facilitating the identification of key 
parameters crucial to the antibody production process. 
There are a number of GSA techniques that can be used to evaluate the sensitivity of 
parameters in a model. These include correlation ratios, the Fourier amplitude sensitivity test 
(FAST) [Saltelli, 2000] and the Sobol' method [Sobol', 2001]. For this study, the Sobol' 
GSA method has been chosen as its number generator, known as a low discrepancy 
sequence, is able to sample the defined parameter space more uniformly than random 
number generators (for example, those used in Monte-Carlo methods), hence leading to more 
efficient coverage of the space [Sidoli et al., 2005]. The Sobol' GSA is a variance-based 
Monte-Carlo method which evaluates the effect of each parameter on model output by the 
computation of sensitivity indices (SI), whose values range from 0 to 1. Two SI values are 
calculated for each parameter - the individual SI (SIind), which represents the main effect of 
the parameter on model output and the total SI (Shot), which includes both the main effect of 
the parameter as well as the additional effects caused by interaction of the parameter with 
other parameters. Parameters with high SI values are considered to have a larger impact on 
the model output. 
3.3.1 Derivation of sensitivity indices 
Sobol' [2001] considers an integrable function, f(x), which is written in the form: 
n 	n 
f(x)= fo + E E 
s=1 i,<...<i, 
 
(3.27) 
where 1 	< ...< is < n. 
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The function represented by Equation 3.27 implies that f(x) can be broken down into 
terms of different orders: 
J  (x)= fo -FE f(x,)-FE f u (x,x j )+•••+ fi2 n(xi ,x2,••• ,;) 
	
(3.28) 
1' order 	2nd order 	 nth order 
term term term 
Equation 3.27 can then be defined as an Analysis of Variances (ANOVA)-
representation off(x) if 
0 
	f dxk = 0 	for 	k = 	. 	 (3.29) 
If f(x) is square integrable, the total variance, D, can then be calculated by squaring 
Equation 3.27 and integrating over n dimensions: 
then 
D= jf 2 (x)dx — fo2 = E E jf.2 dx. . 
s=1 
Therefore, if 
=142..;,  
D=E E s=1 
(3.30) 
(3.31) 
(3.32) 
where D 	represents the partial variances in the value off(x) as a result of simultaneous 
changes in the values of factors i1 to is. Equation 3.32 thus states that the sum of all partial 
variances associated with factors i1 to is is equal to the total variance of the function. The 
global sensitivity indices can therefore be defined as: 
(3.33) 
In this study, the function f(x) is equivalent to the extracellular antibody 
concentration, which is the key output from the hybrid model. In addition, the parameters in 
the model are represented by the factors i1 to is. The individual SI of each parameter is given 
by the first order indices 	 while the total SI of a parameter is given by the sum 
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of first order and all higher order indices associated with that parameter. For instance, the 
individual SI of parameter it is S, while its total SI, assuming there are n parameters in the 
model, is given by: 
Si tot = S +Is 	E s 1 +. ±s 
•• 
1< j 	1<j<k 
3.4 	Results and analyses 
3.4.1 Normal osmotic conditions — hybrid model and SCM outputs 
(3.34) 
In this section, the hybrid model and adapted SCM simulation outputs are compared to the 
experimental data obtained by Wu et al. [2004] for GS-NSO cells. Figures 3.2 a to 3.2 f show 
the experimental and predicted trends in cell number, growth and death rates, metabolism 
and antibody production for the hybrid and SCM. The viable cell number is well predicted 
by both the hybrid and SCM (Figure 3.2 a). In the case of the total cell number, while the 
hybrid model has a tendency to overestimate the total cell number at the stationary and early 
decline culture phases, it is able to capture the experimental trend more closely than the 
SCM (Figure 3.2 b). The agreement of both models with experimental data for the dead cell 
number appears quite satisfactory (Figure 3.2 b). Although both models are able to predict 
specific cell growth rates reasonably well, however, it can be seen that the SCM predicted 
cell death rate deviates from experimental data as the culture enters the decline phase (Figure 
3.2 c). The differences in trends at this late culture phase may be attributed to the different 
death rate expressions used in both models. Specifically, the hybrid model utilizes an 
expression that takes into account the maximum specific cell growth rate and the detrimental 
effects of lactate accumulation while the death rate expression in the SCM is a correlation 
based primarily on the specific cell growth rate. The results also indicate that the hybrid 
model simulations for glucose consumption (Figure 3.2 d) and lactate production (Figure 3.2 
e) are in better agreement than those produced by the SCM particularly beyond the mid-
exponential phase of the culture (>48 hrs). Finally, the antibody accumulation profile (Figure 
3.2 f) indicates that the predicted final antibody titer for both models is within 7% of the 
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experimental value, which is well within the proposed experimental error margin of 10% 
normally associated with cell culture data [Sanderson, 1997]. The above results confirm the 
predictive ability of the hybrid model for the GS-NSO system, which in certain cases 
performs better than the complex SCM. 
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Figure 3.2. Comparison of single-cell model (SCM) and hybrid model (Hybrid) simulation 
results with experimental data (Expt) for the GS-NSO system under normal culture 
conditions (290 mOsm/kg), as obtained from reference [Wu et al., 2004]: (a) viable cell 
number (X), (b) total (XT) and dead (Xd) cell numbers, (c) specific growth (p) and death (14 
rates, (d) glucose concentration in the medium ([Glc]), (e) lactate concentration in the 
medium ([Lac]), and (t) antibody concentration in the medium ([Ab]). 
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3.4.2 Results and analysis of GSA 
The Sobol' GSA method used here to analyse the hybrid model has been described in 
Section 3.3. The key advantage of the Sobol' method is that it provides detailed quantitative 
data regarding the relative importance of each parameter on the antibody production process 
by the computation of the sensitivity indices, SIind and SItot. In this study, GSA has been 
focused mainly on parameters specifically related to the antibody production mechanism, 
whose initial values have been largely obtained from literature. To capture possible dynamic 
variations in the impact of the parameters on antibody production at different culture phases, 
the analysis is conducted at 24-hour intervals from the mid-exponential phase (48 hrs) to the 
decline phase (192 hours). Parameter behaviour in the early exponential phase (24 hrs) has 
been omitted as the antibody produced during this time period was relatively insignificant in 
comparison to later culture phases. 
Figure 3.3 a shows the SI,nd and SItot for the model parameters averaged over all time 
points. It can be observed that the individual sensitivity indices for the specific heavy and 
light chain transcription (SH, SL) and translation (TH, TL) rates are significant. Figure 3.3 b, 
which presents Slind for all parameters under study at different time points, further reveals 
that the SI values of the specific transcription and translation rates remain consistently high 
throughout the entire culture. Differences in the individual impact of each parameter as the 
culture progresses are also highlighted by Figure 3.3 b, where it can be seen that a number of 
parameters increase while others decrease in importance with respect to their effects on 
antibody production. The GSA confirms the importance of transcriptional and translational 
processes within the antibody production mechanism. Furthermore, the sensitivity of certain 
parameters varies with culture time, which is in agreement with their biological function. 
Specifically, Figure 3.3 c shows that the initial intracellular amounts of heavy and light 
chains appear to be important at an early culture stage. Their impact on antibody production 
decline rapidly at later culture stages as reflected by the decrease in SI,„d and Sim. 
Conversely, the impact of the half-life of heavy and light mRNA molecules on the antibody 
production titer is predicted to be larger in the stationary and decline phases (Figure 3.3 d) 
based on the increasing SI,nd and Shot values. 
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Additionally, the interaction effects, given by the difference between Shot and SIind 
for the significant parameters have been assessed by further GSA, for which the key 
parameters, SH, SL, THO  and TL0, are grouped as a single parameter and the sensitivity indices 
recalculated. Consequently, the Kind of the grouped parameters is found to constitute more 
than 90% of the SItot, indicating that any key interactive effects are likely to be among the 
significant parameters, rather than with other less significant parameters. 
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Figure 3.3. (a) Average individual and total sensitivity indices of all parameters, (b) 
Individual sensitivity indices of parameters over all time points, (c) Individual and total 
sensitivity indices of initial heavy chain concentration, HO, over culture time, (d) Individual 
and total sensitivity indices of half-lives of mRNA, t1/2, over culture time. 
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GSA at hyperosmotic conditions 
In order to ascertain that the GSA results at normal osmotic conditions are still applicable 
with changes in the unstructured model parameters (particularly the cell growth, death and 
metabolism parameters) at hyperosmotic culture conditions, the GSA has been repeated for 
hyperosmotic culture simulations at 24-hour time points from the mid-exponential phase (72 
hrs) to the decline phase (288 hrs) of the culture. The SI,nd and SI,„, values averaged over all 
time points for both normal and hyperosmotic culture conditions are summarised in Table 
3.2. It can be observed that the SI values in both cases are relatively similar in terms of 
parameter importance and therefore verify that the results of the GSA are valid under both 
sets of culture conditions. 
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Parameter Av SIind (290) Av SIind (450) Av Ka  (290) Av SItot (450) 
SH 0.138 0.143 0.283 0.288 
SL 0.115 0.116 0.260 0.258 
THO 0.156 0.136 0.310 0.278 
TLO 0.121 0.102 0.270 0.237 
km., 
kHL/kHH 
0.006 
4.29E-04 
0.005 
3.20E-04 
0.008 
0.001 
0.006 
0.001 
ti/2,ER 0.006 0.007 0.009 0.010 
tI/2,G 0.002 0.003 0.004 0.004 
MHO 0.001 6.13E-05 0.003 1.63E-04 
MLO 0.001 3.88E-05 0.002 1.33E-04 
HO 0.023 0.051 0.036 0.074 
Lo 0.028 0.047 0.054 0.087 
m 0.022 0.005 0.040 0.010 
t1  0.078 0.088 0.123 0.138 
Table 3.2. Average parameter SI under normal (290) and hyperosmotic (450) conditions. 
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3.4.3 Hyperosmotic culture simulations 
Figure 3.4 compares the experimental data [Wu et al., 2004] for cell growth, death, 
metabolism and antibody production under hyperosmotic culture conditions with the 
simulation results generated by the hybrid model. It is observed that under normal conditions 
the lag phase is non-apparent, in contrast with the significant lag phase observed under 
hyperosmotic culture conditions (Figure 3.4 a). Consequently, as an initial approximation 
based on the presented experimental data, a simple 24-hour lag phase has been implemented 
for hyperosmotic culture simulations during which it is assumed that there is little cell 
growth or antibody production. This assumption is reflected in the behaviour of the specific 
growth rate (Figure 3.4 b) where there is a step increase in its value from 0 to 0.018 hf' at 24 
hours, the point at which significant cell growth and antibody production begins. Despite the 
basic nature of the above assumption, the simulated trends are in overall agreement with 
experimental data throughout the course of the culture. In addition, the specific death rate 
(Figure 3.4 b) and therefore the dead cell number, is well predicted by the hybrid model. The 
glucose consumption and lactate production (Figure 3.4 c) are also in good agreement with 
the experimental data. 
With the observations derived from GSA, the values of key parameters have been 
modified systematically based on their relative sensitivity to antibody production (as 
indicated by the sensitivity indices), as the hybrid model is applied to hyperosmotic culture 
conditions. A summary of all parameter values used in the simulation of hyperosmotic 
culture conditions can be found in Appendix A. Of these parameters, the most significant 
changes involve the heavy and light chain transcription rates (SH, SL) and the initial 
translation rates (TH,o, TL,o)•  It can be seen that higher values for these parameters are 
required in order to accurately describe antibody production at hyperosmotic conditions 
(Figure 3.4d). However, the selected parameter values still fall within the recommended 
physiological ranges (SH, SL) or are within reported parameter value increases observed 
under hyperosmotic pressure conditions (TH, TL, t112) [Lee and Lee, 2000]. Consequently, as 
demonstrated in Figure 3.4d the simulated antibody accumulation in the medium agrees well 
with the experimental values. The difference between simulated and experimental values at 
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each time point was less than 10%. These results indicate that the hybrid model predicts 
hyperosmotic culture behaviour relatively well. 
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Figure 3.4. Comparison of hybrid model simulation results (Predicted) and experimental 
data (Expt) for GS-NSO system under hyperosmotic pressure conditions (450 mOsm/kg) from 
reference [Wu et al., 2004]: (a) viable, total and dead cell numbers, (b) specific growth and 
death rates, (c) glucose and lactate concentrations in the medium and (d) antibody 
concentration in the medium. 
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3.5 	Discussion 
The key objective of this chapter was the development of a functional and tractable model 
that describes the antibody production process in GS-NSO cells under normal and 
hyperosmotic culture conditions to within accuracy off 30%. The proposed hybrid model is 
unique to the GS-NSO cell line and created a link between the metabolic processes in the cell 
and its antibody formation process. This represents an important advancement since previous 
models had either focused on the antibody production mechanism or cell metabolism. 
However, exclusion of cellular metabolism processes might result in the omission of 
potential effects of energy and precursor availability on the system [Sanderson et al., 1999], 
while a model based solely on cell metabolism tended to ignore the mechanistic details 
required to understand the antibody production process. The combination of an unstructured 
depiction of cell growth and metabolism with a structured representation of the intracellular 
antibody production mechanism allowed for relationships between metabolism, cell growth, 
death, and antibody formation to be described mathematically. 
Hybrid model and SCM comparisons 
Comparing the simulation results from the hybrid model with the results obtained from a 
complex, highly-detailed SCM indicate that both models predicted GS-NSO cellular 
behaviour reasonably well. Nonetheless, two key differences in the predicted trends became 
evident. The first key difference was the use of differing expressions for the specific death 
and lysis rates. These expressions were responsible for determining the dead cell number, 
and hence the number of total cells in the culture. The specific death rate was better 
described by the hybrid model in an expression that was governed by the maximum specific 
growth rate and the accumulation of lactate in the medium. In contrast, the specific death rate 
in the SCM was correlated only to the specific growth rate, which appeared to result in 
differences between simulated and experimental trends, particularly during the later stages of 
the culture. It has to be noted that there are numerous correlations available in the literature 
for the specific death rate, including Michaelis-Menten type expressions [Glacken et al., 
1989] and exponential type expressions [DiMasi and Swartz, 1995], some of which were 
correlated to specific growth rate and others that also involved waste metabolite 
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concentrations such as ammonia and lactate, or the concentration of rate-limiting substrates 
such as glutamine [Frahm et al., 2003; Portner and Schafer, 1996]. The wide variety of 
expressions, therefore, suggested that the specific death rate behaviour was likely to be cell 
line-specific, which in turn might explain the divergence in experimental and simulated 
values for the SCM that was originally derived for hybridoma cell cultures. In addition, the 
specific lysis rate was assumed to be constant in the SCM while it was correlated to the 
specific death rate in the hybrid model. The positive relationship in the hybrid model 
between the specific cell lysis rate and the specific death rate accounted for the effects of 
increasing toxicity of the medium. This led to a more accurate representation of the 
experimental data and was an improvement over the SCM. 
The second difference corresponds to the prediction of glucose consumption and 
lactate accumulation rates. The SCM tended to predict trends that deviate from experimental 
observations as the culture progresses, despite prior adjustments for its glucose and lactate 
parameters. This observation highlights one of the main difficulties in extending the SCM to 
accurately predict cellular behaviour in other cell lines since it involves more than 350 
parameters in order to describe the main intracellular metabolic processes as well as 
transmembrane transport of more than 50 components. As such, a vast amount of dynamic 
intracellular data, which at present is still difficult to obtain experimentally, would be 
required in order to allow for differences in the metabolic behaviour of different cell lines. In 
addition, it had been recently reported that just 37 out of the 350 parameters in the SCM 
were considered to be estimable from existing experimental data [Sidoli et al., 2005]. The 
practical difficulty involved in the accurate determination and analysis of parameter values 
for the SCM was an essential reason for the development of the simpler hybrid model, which 
focused particularly on the antibody production pathway. Unlike the SCM, the hybrid model 
had fewer than 30 parameters, half of which could be derived from existing experimental 
data. The remaining 13 parameters, which were involved in intracellular antibody formation 
and transport, could then be analysed in detail by performing GSA. The hybrid model could 
thus be seen as a successful compromise between the highly detailed structure of the SCM 
and the "black box" approach of unstructured models since it had the ability to correctly 
describe cellular and metabolic trends for GS-NSO cells. 
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Global sensitivity analysis 
GSA allows the incorporation of the entire parameter value ranges while providing 
quantitative results indicating the significance of each parameter [Saltelli et al., 2004]. This 
enables the compilation of a comprehensive overview of the individual parameter effects, as 
well as providing information regarding the existing degree of interaction between 
parameters. A time-dependent GSA can also identify any significant dynamic variations in 
Kind and Shot for model parameters. Previous research conducted [Kontoravdi et al., 2005; 
Sidoli et al., 2005] had shown that it was computationally inefficient to include a large 
number of model parameters in the GSA. In the former study for small size models, the less 
significant parameters were identified by GSA in the early exponential phase and grouped 
together in subsequent global sensitivity analyses at other time points. The latter study on the 
SCM by Sanderson [1997] involved carrying out a parameter perturbation study to determine 
the set of estimable and inestimable parameters before GSA was used to evaluate the two 
groups of parameters. Due to these considerations, the GSA in this study focused primarily 
on parameters within the structured antibody production mechanism, as actual experimental 
information on their values is scarce in comparison to the growth and metabolism parameters 
that have been experimentally determined for the GS-NSO cell line. 
The global sensitivity analysis identified parameters that appear to have a large 
impact on antibody production throughout the culture, as reflected by their consistently high 
sensitivity indices at all time points. These parameters included the heavy and light chain 
specific transcription and translation rates, which agreed with literature reports that stress the 
importance of the transcription [Fox et al., 2005; Lee and Lee, 2000; Yoon et al., 2003] and 
translation [Bibila, 1991; McKinney et al., 1995] steps in the production mechanism of 
recombinant proteins (including antibodies). This is in contrast to the time required for 
intracellular transport of the antibody molecule from the ER to the Golgi complex and 
subsequently to the extracellular medium, as reflected by the low sensitivity indices of t1/2,ER 
and tii2G. The differences in sensitivity indices might be explained by the fact that the 
accumulation of intracellular IgG chains was mainly dependent on their production rate, 
regulated through the processes of transcription and translation. Subsequently, an increase in 
the speed of intracellular transport would lead to a depletion of the intracellular IgG pool. 
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Thus, the increased transport rate could not be sustained without a corresponding increase in 
transcription or translation rates. As a result, the effects of t1/2,ER  and  t1/2,G  on increasing 
antibody production rates tended to be relatively small when compared to those of the 
transcription and translation parameters. In addition, certain parameters demonstrated a 
culture time-dependent behaviour following the sensitivity analysis. 	Specifically, a 
reduction in the sensitivity indices of the initial intracellular heavy and light chain values 
reflected their decreasing importance to antibody production as the culture progressed, which 
was biologically consistent. Early in the culture, the initial pools of heavy and light chains 
were the main intracellular source for antibody formation. However, as the culture 
progressed into the mid-exponential phase, the translational process became responsible for 
controlling the intracellular heavy and light chains concentrations; thus the importance of the 
initial heavy and light chains values decreased with culture time. Similarly, the half-life of 
heavy and light mRNA molecules is another example of parameters with a culture time-
dependent impact on antibody production. The half-life of the mRNA molecules determines 
the degradation rate of mRNA in the cell. As the culture progressed and nutrients were used 
up, the basic components required as "building blocks" for mRNA production also decrease, 
subsequently causing the accumulation of mRNA molecules in the cell to decline. Minute 
changes in the mRNA concentration would therefore have a larger effect on antibody 
production under these conditions. As such, the value of the mRNA half-life had a more 
significant impact on antibody production towards the stationary and decline phases of the 
culture. 
Extension of model to hyperosmotic conditions 
Initially, attempts to extend the model to hyperosmotic culture conditions by modifying the 
unstructured model parameters in order to reflect the lower cell growth rate and higher 
metabolic rates proved to be insufficient in providing an accurate depiction of experimental 
antibody production rates. However, global sensitivity analysis yielded useful information 
regarding important parameters involved in the antibody production mechanism in GS-NSO 
cells. These results were utilised in adapting the model parameters to hyperosmotic culture 
conditions. In Chapter 2, a number of hypotheses existing in literature regarding the possible 
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mechanisms of hyperosmolarity in improving antibody production were presented. Here, the 
changes in parameter values required to accurately reflect antibody production at 
hyperosmotic culture conditions are discussed in relation to these proposed hypotheses. 
Increasing the values of the specific transcription and translation rates under hyperosmotic 
pressure conditions was corroborated by the proposed theories of Oh et al. [1993] and Lin et 
al. [1999a]. Specifically, Oh and co-workers state that hyperosmotic pressure, together with 
butyrate treatment, induced transcriptional activation of mRNA due to the change of 
chromatin structure in the cell nucleus. This stimulation of transcription led to the increase 
in the amount of heavy and light mRNA chains, which in turn increased antibody 
productivity. Furthermore, the increase in specific translation rates is supported by the 
hypothesis proposed by Lin and co-workers [Lin et al., 1999a], which states that 
hyperosmotic pressure enhances the uptake of nutrients, such as glucose, resulting in an 
increase in ATP production rates. Translation is known to be an energy consuming process 
[Pestova and Hellen, 2000] and increases in ATP levels therefore resulted in higher heavy 
and light chain translation rates in the cells; thus the higher antibody productivity. 
Additionally, a study on hybridoma cells by Sun et al. also reported an overall increase in 
protein translation rates as a result of hyperosmotic culture conditions [Sun et al., 2004]. The 
simulation results under hyperosmotic pressure conditions also showed higher specific 
glucose consumption rates, as reflected in the higher maximum glucose consumption 
coefficient. This is consistent with Lin's hypothesis [Lin et al., 1999a]. In addition, the 
decrease in the value of the mRNA half-life under hyperosmotic culture conditions is 
supported by the findings of a study based on hybridoma cells [Lee and Lee, 2000]. The 
changes in key parameters, together with implementation of a lag phase, have enabled the 
hybrid model to capture the behaviour of extracellular antibody accumulation under 
hyperosmotic pressure conditions fairly accurately. 
3.6 	Conclusions 
In this chapter, a hybrid model was developed and its validity in describing the cellular and 
antibody production processes for the GS-NSO system successfully demonstrated. 
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Comparisons between the simulation trends of the SCM and hybrid models also highlighted 
the difficulties involved in the adaptation of a highly structured and complex model (SCM) 
for a different cell line, due primarily to the large number of inestimable model parameters 
involved. The GSA conducted on the hybrid model aided in the identification of parameters 
that heavily influence the antibody production process and established the time-dependent 
variation in the significance of certain parameters. The information gathered from the GSA 
was then used effectively to extend application of the hybrid model to hyperosmotic culture 
conditions. The GSA findings also highlighted the parameters in the model whose values 
significantly affect antibody production. Based on the proposed 10% error margin inherent in 
cell culture data [Sanderson, 1997], the key parameters involved in the antibody production 
process (as identified by average SI values greater than 0.1 from Table 3.2) are: the H and L 
mRNA transcription rates, SH and SL, the initial H and L chain translation rates, TH0 and 710, 
and the H and L mRNA half-lives, tp2. As a result, the subsequent experimental study on 
GS-NSO cells under normal and hyperosmotic culture conditions were focused on the 
transcription and translation processes in the antibody production pathway. The details of the 
experimental study and its findings will be further described and discussed in Chapters 4 and 
5. 
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Chapter 4 
Hyperosmotic Effects on GS-NSO Growth, Metabolism and 
Antibody Production 
4.1 	Introduction 
In Chapter 3, a hybrid model describing cell growth, metabolism and antibody production 
was developed using existing experimental data pertaining to the GS-NSO cell culture system 
under both normal and hyperosmotic culture conditions. Model analysis of the hybrid model 
using a global sensitivity analysis has indicated that parameters related to the transcription 
and translation processes in the antibody production pathway, in particular, have a 
significant impact on antibody production rates in GS-NSO cells. The experimental study 
has, therefore, focused on evaluating the behaviour of IgG mRNA and polypeptide chain 
concentrations at normal and hyperosmotic culture conditions. Additionally, in order to 
assess some of the proposed mechanisms of hyperosmolarity on antibody production 
mentioned in Section 2.3.2, the cell cycle and energy state of the GS-NSO cells under both 
normal and hyperosmotic conditions have also been studied. However, prior to investigating 
the intracellular aspects of mRNA and protein synthesis, the general characteristics of cell 
growth and death, basic metabolism and extracellular monoclonal antibody accumulation 
need to be addressed. The first part of this chapter includes a description of the above-
mentioned trends, as derived from the batch culture experiments. In the second part of this 
chapter, the effects of hyperosmolarity on the cell cycle and its significance in improving 
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specific antibody productivity in GS-NSO cells are discussed. Finally, the energy state of GS-
NSO cells under normal and hyperosmotic culture conditions is also assessed. Subsequently, 
Chapter 5 then focuses on evaluating the intracellular trends of IgG mRNA and polypeptide 
species with respect to culture phase, as well as assessing their contribution towards 
increasing antibody productivity at hyperosmotic conditions. Results regarding the stabilities 
of the heavy and light IgG mRNA molecules at the mid-exponential and early stationary 
phases, under both normal and hyperosmotic culture conditions are also discussed. 
4.1.1 Normal and hyperosmotic conditions — a summary of main characteristics 
Normal osmotic conditions in mammalian cell cultures range from 270 to 310 mOsm/kg in 
order to closely resemble the osmotic conditions in vivo [Bogner et al., 2004]. Increasing the 
osmolarity of the culture beyond this range has led to the improvement of specific antibody 
productivity in a number of cell lines, including hybridoma [Lee and Lee, 2000; Ozturk and 
Palsson, 1991b], CHO [Ryu et al., 2000; Ryu et al., 2001] and GS-NSO cells. In the 
experimental study conducted by Wu et al. [2004], an increase in the osmolarity of the 
culture from 290 mOsm/kg to 450 mOsm/kg resulted in a 30% increase in the accumulation 
of total antibody product in the extracellular medium. In addition, hyperosmotic culture 
conditions have been characterised by a slower rate of cell growth for various cell lines. For 
instance, in the GS-NSO study described above, a 35% decrease in maximum cell density 
and a shift in peak cell density from 96 hrs to about 150 hrs was observed. In an earlier study 
on the GS-NSO cell line, Duncan et al. [1997] had also reported an 1.8 fold increase in 
specific antibody productivity as the osmolarity of the culture was raised from 275 mOsm/kg 
to 400 mOsm/kg. The authors also observed that cell growth was suppressed and cell 
viability in the exponential growth phase was reduced under hyperosmotic culture 
conditions. Additionally, a 2-fold increase in the uptake of glucose and a 4-fold increase in 
lactate production occurred as a result of hyperosmolarity. 
Most studies on hyperosmotic culture conditions available in the literature, including 
the GS-NSO studies described above, have employed the use of sodium chloride as the 
means of increasing culture osmolarity, as it is relatively cost-effective and readily available 
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[Ryu et al., 2001] compared to other more expensive substances such as sorbitol and betaine. 
Similarly, in this study, sodium chloride is the substance chosen for increasing the 
osmolarity of the culture. Batch cultures of GS-NSO cells in 250 mL shake flasks have been 
grown at normal and hyperosmotic culture conditions of 290 and 450 mOsm/kg respectively 
and samples taken at different culture points for various analyses, as described in detail in 
Section 4.2. 
4.2 	Materials and methods 
4.2.1 Cell culture 
Cell line 
The cell line used in this study is a GS-NSO mouse myeloma designated 6A1 (100)-3, which 
has been kindly made available by Lonza Biologics (Slough, UK). The cell line was derived 
from a NSO mouse myeloma, which was transfected with the glutamine-synthetase (GS) 
selection marker, thus enabling it to grow in glutamine-free medium. A chimeric IgG4 
antibody, cB72.3, which recognises the Tag-72 tumour marker in colorectal cancer is 
produced by the GS-NSO cells. 
Culture medium and maintenance 
Culture medium used in the routine maintenance of GS-NSO cells consisted of the following 
components: 200 mg/L calcium chloride, 0.1 mg/L ferric nitrate, 400 mg/L potassium 
chloride, 97.7 mg/L magnesium sulphate, 3700 mg/L sodium bicarbonate, 125 mg/L sodium 
phosphate, 4500 mg/L D-glucose, 150 mg/L glutamic acid, 150 mg/L aspatagine, 220 mg/L 
pyruvic acid, 7 mg/L each of adenosine, guanosine, cytidine and uridine, 2.4 mg/L thymidine 
and 4.5 mg/L MSX (all from Sigma, UK). The medium was also supplemented with lx 
MEM amino acids solution, 2X MEM vitamins solution, 1000 mg/L pluronic acid solution 
1% (v/v) penicillin-streptomycin solution, and 2.5% (v/v) Foetal Bovine Serum (FBS) (all 
from Invitrogen, UK). The addition of different amounts of sodium chloride (NaC1) to the 
medium was used to vary the osmolarity of the medium, as required. 
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Cells were cultivated either in 250mL Erlenmeyer shake flasks (Corning 
Incorporated, Corning, US) with a 50-60 mL working volume or in 1 L shake flasks 
(Corning) with a 250 mL working volume. The shake flasks were incubated at 37°C and 
agitated using an orbital shaker at 125 revolutions per minute (rpm) (Stuart Scientific, UK). 
Cultures were gassed with 5% CO2 daily. Cells were routinely subcultured every 2 days with 
an inoculum density of 2 x 105 cells/mL. 
Freezing and recovery of GS-NSO cells in liquid nitrogen 
Prior to conducting batch culture experiments, a cell bank had to be created so as to 
minimise variations in the cell characteristics caused by a difference in cell generation. All 
experiments were therefore conducted with cells from the same generation number 
(approximately generation number 60). The freezing of GS-NSO cells was carried out as 
follows: cultures were first centrifuged for 5 minutes at 800 rpm to remove the supernatant. 
The cells were then resuspended in culture medium supplemented with 20% FBS and 10% 
dimethyl sulfoxide (DMSO, Sigma, UK) at a density of 1 x 107 cells/mL and aliquoted into 
1.5 mL cryovials (Corning). The vials were stored at —86 C overnight before being 
transferred to a liquid nitrogen dewar. Cells were recovered by thawing the cryovial in a 
water bath at 37 C. The contents of the cyrovial were added dropwise to 10m1 of culture 
medium at 37 C. The cell mixture was then centrifuged at 800 rpm for 5 minutes to remove 
the freezing agent, DMSO, from the cells. The cell pellet was then resuspended in culture 
medium at an inoculum density of 2 x 105 cells/mL. 
4.2.2 Cell culture experiments 
Normal and hyperosmotic batch culture experiments 
Batch culture experiments were carried out in triplicates using 1 L shake flasks with a 
working volume of 250 mL at either normal osmotic conditions (290 mOsm/kg) or 
hyperosmotic conditions (450 mOsm/kg). Samples of approximately 1-2 mL were taken 
daily for the measurements of extracellular metabolite and antibody concentrations, as well 
as cell number and viability determination. Additionally, 1 x 106 cells from each culture are 
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collected for cell cycle analysis and 1-2 x 106 cells were collected for the analysis of 
intracellular energy nucleotide levels on a daily basis until the late stationary — early decline 
culture phase. 
4.2.3 Extracellular analytical techniques 
Cell number and viability estimation 
Approximately 0.5 mL samples were removed from the shake flask cultures. Cell 
concentration was estimated using a haemocytometer and the dye exclusion assay employing 
0.4% trypan blue solution (Sigma). Each sample was counted at least in duplicate and if the 
values did not agree to within 10% of each other, additional counts were carried out. 
Metabolites analysis 
The analysis of glucose, lactate, glutamate and NH4+ ion concentrations was carried out 
using the BioProfile 200 Analyser (Nova Biomedical, UK). Approximately 0.5 mL of culture 
supernatant was required for each assay. 
Osmolarity measurement 
The osmolarity of the cell culture medium was measured using a freezing point osmometer 
(Camlab). 100 I.J.L of sample was required for each assay. The osmometer was calibrated at 0 
mOsm/kg using distilled water and at 300 mOsm/kg with a 300 mOsm/kg standard solution 
(Camlab). The response of the osmometer has been reported to be linear between 0 and 
25000 milliosmols and measurements to be accurate to within 0.5% [Bond, 2004]. 
Extracellular antibody concentration determination 
The extracellular antibody concentration was determined using a sandwich-based Enzyme-
Linked Immunosorbent Assay (ELISA). A 96-well microplate (Grenier BioOne, UK) was 
first coated with an anti-human gamma Fc antibody (Jackson immunoresearch, US) in a 
coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) at a concentration of 2 Kg/mL 
overnight in a 4 C refrigerator. The coating solution was then removed and the wells blocked 
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with a solution consisting of the coating buffer with 0.5% (w/v) casein hammerstein (VWR) 
for 1 hour at room temperature. Subsequently, the wells were rinsed 3 times with 300 .tL of 
washing solution (PBS with 0.05% Tween). 
Known standard concentrations of the cB72.3 IgG antibody (kindly provided by 
Lonza Biologics, UK) and cell free supernatant samples diluted in sample-conjugate buffer 
(12.1 g/L Tris, 5.84 g/L NaCI, 2.0 g/L Casein Hammerstein (VWR) and 0.2 mL Tween) 
were added next to the wells (100 pL/well) and incubated for 1.5 hours at room temperature 
on an orbital shaker. Sample-conjugate buffer was also added to at least two wells to serve as 
negative (background) controls. The standards, samples and sample-conjugate buffer were 
discarded and the wells washed 3 times with the washing solution described above. An anti-
human kappa chain Fab antibody fragment conjugated to horseradish peroxidase (Sigma) 
was then added at a dilution of 1:8000 (in sample-conjugate buffer) to each well (100 
1.1L/well) and incubated for a further 1 hour with shaking at room temperature. 
After the incubation period, wells were washed 4 times with the washing solution 
before substrate solution (100 pL/well) was added to the wells. The substrate solution 
consisted of a TMB tablet (lmg/tablet of 3,3',5,5'-Tetramethylbenzidine, Sigma), which was 
dissolved in 10 mL of 50 mM phosphate-citrate buffer (pH 5.0). Immediately prior to use, 2 
121, of 30% (w/v) hydrogen peroxide solution was added to the mixture. The reaction was 
allowed to proceed in the dark at room temperature for 15 to 30 minutes before being 
stopped by the addition of 50 pi, of 2.5 M H2SO4 solution to each well. The 0D450 of each 
well was measured using an ELISA microplate reader (BioTek, US). OD450 values for 
standards and samples were normalised by subtracting the average 0D450 reading of the 
negative control wells. A standard curve based on known concentrations of the IgG can then 
be plotted and used to derive the unknown concentrations in each supernatant sample. Each 
sample was assayed at least in quadruplicates. 
4.2.4 Cell cycle analysis 
A Beckman-Coulter Epics Altra (Beckman-Coulter, US) equipped with a 488 nm argon laser 
set at 15mW laser power was used to carry out cell cycle analysis for samples collected at 
normal and hyperomsotic culture conditions. 
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1 x 106 cells were collected daily from triplicate cultures under both normal and 
hyperosmotic conditions. The supernatant was aspirated after centrifugation at 800 rpm for 5 
minutes and cells were fixed by the addition of 1 mL of 70% ice-cold ethanol dropwise to 
the cell pellet with constant mixing using a vortex. The fixed cells were stored at —20 C for 
up to 1 month before being analysed by flow cytometry. Prior to flow cytometric analysis, 
the fixing solution was aspirated and the cell pellet rinsed with 1 mL of cold (4 C) PBS. The 
PBS was then aspirated after centrifugation at 800 rpm for 5 minutes and 1 mL of propidium 
iodide (PI) staining solution consisting of 50 pig/mL of PI, 0.1% (w/v) of Ribonuclease A 
(Sigma) and 0.1% bovine serum albumin (BSA) (Sigma) in PBS was added to the cell pellet. 
The mixture was then incubated at room temperature in the dark for at least 30 minutes to 
allow for cellular DNA staining. In addition, unstained cell samples were used as negative 
controls. 
Flow cytometric data was collected using an excitation wavelength of 488 nm and an 
emission wavelength of 610 nm (conditions suitable for analysis of DNA staining intensity 
by PI). A total of 20,000 events were collected for each sample. The dot plots generated were 
then gated to obtain histograms using the WinMDI Multicycler 2.8 software and further 
analysed using the Cylchred software, both available over the internet1. 
4.2.5 Intracellular energy nucleotides analysis — capillary electrophoresis 
Extraction of nucleotides from cell samples 
2 x 106 cells were collected from normal and hyperosmotic cultures in triplicate on a daily 
basis. The sample was centrifuged at 800 rpm for 5 minutes at room temperature and the 
culture supernatant aspirated. 950 ilL of ice-cold 0.3 M perchloric acid (60% (v/v), VWR) 
solution and 7.5 µL of 1.5 mM guanosine monophosphate (GMP, VWR) stock solution (to a 
final concentration of 10 1./M) as an extraction efficiency standard was added simultaneously 
to the cell pellet. The resulting mixture was then centrifuged for 5 minutes at 12,000 rpm and 
a temperature of 4 C. Subsequently, the supernatant containing the extracted nucleotides was 
I Analysis software downloaded from Cardiff University webpage. Web address: 
http://www.cardiffac.uk/medicine/haematology/cytonetulddocuments/software.htm 
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pipetted into a new microcentrifuge tube and 170 pL of 2 M potassium hydroxide solution 
(VWR) was added to neutralise the solution. The mixture was then centrifuged for 10 
minutes at 10,000 rpm and a temperature of 4 C to separate the precipitated potassium 
perchlorate salt (KC1O4) from the solution. The resulting supernatant was removed to a new 
microcentrifuge tube and stored at —20 C prior to analysis by capillary electrophoresis. 
Capillary electrophoresis system 
An analytical method based on capillary electrophoresis was developed for the quantification 
of the energy nucleotides ATP, ADP and AMP present in the cell extracts. The capillary 
electrophoresis system was a Hewlett Packard 3DCE (Hewlett Packard, UK) system with a 
fused silica capillary tube externally coated with polyimine (Composite Metal Services, UK) 
with an internal diameter of 100 i.im and a length of 64.5 cm. The internal surface of the 
capillary was coated with bind-silane (3-(Trimethoxysilyl)propyl methacrylate, Sigma) by 
flushing it with a solution containing 10% (w/v) bind-silane dissolved in acetone (VWR) for 
10 minutes at room temperature. 
The capillary tube was fixed into a cassette maintained at 25 C so as to allow for the 
precise alignment of the capillary with the capillary detection window. The ends of the 
capillary were dipped into two reservoirs containing 100 mM of MES ((2-(N-
Morpholino)ethanesulfonic Acid, VWR) containing 0.2% (w/v) of hydroxyethyl-cellulose 
(VWR). The distance from the cathode end of the capillary to the detection window is 56 cm 
and compounds passing through the capillary were detected as peaks in absorbance at a 
wavelength of 252 ± 10 nm. The peaks were then recorded as an electropherogram on the HP 
3DCE chemstation by the data handling software. 
Each sample was injected for 10 seconds using a vacuum injection pressure of 500 
mbars at the inlet side of the capillary. A voltage of —30 kV was then applied across both 
ends of the capillary, causing the nucleotides to migrate at different rates from one end of the 
capillary to the detection window according to their charge. Each sample was analysed for 
15-20 minutes and an electropherogram recording the absorbance peaks as each component 
passed through the detection window was generated. 
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Quantification of energy nucleotides through capillary electrophoresis 
Solutions containing known concentrations of ATP, ADP and AMP (all from Sigma), 
ranging from 0.5 to 20 µM, were prepared as calibration standards. 20 1.1..M of DNP-L-
glutamic acid (DNP) (Sigma) was added as an internal standard to account for minute 
differences that might be present in the volume of each sample loading. The peaks 
corresponding to ATP, ADP and AMP were identified firstly by the comparison of the 
retention time (RT) of each component as recorded on the electropherogram. The appropriate 
peaks were further confirmed by comparison between the electropherogram generated by a 
sample spiked with known concentrations (50 i..tM) of the 3 nucleotides and one that is 
generated by a sample that was not spiked. Additionally, a solution containing 20 1.1,M of the 
extraction efficiency standard, GMP mixed with 20 pM of DNP was also run in duplicate, 
and the resulting electropherogram used as a reference point (100% extraction efficiency). 
The integrated area under each peak on the electropherogram was then calculated for 
the different standard concentrations and calibration curves were plotted and fitted by linear 
regression for ATP, ADP and AMP. The areas were normalised according to the integrated 
area under the DNP peak for each sample. Subsequently, each unknown sample was run in 
duplicate and the concentrations of ATP, ADP and AMP determined by comparison to the 
standard curves, after the normalisation and adjustment for extraction efficiency of each 
integrated area was carried out. 
4.2.6 Statistical analysis 
The error bars in the figures refer to standard deviations of triplicate experiments unless 
otherwise stated. 95% confidence intervals have also been used to compare the similarities 
between the cell populations of normal and hyperosmotic cultures. Single-factor ANOVA at 
a significance level of p=0.05 have both been used to assess whether the mean values of any 
two samples can be considered to be significantly different from each other. 
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4.3 	Results and analyses 
4.3.1 Cell growth and death characteristics 
Hyperosmotic culture conditions are known to result in lower specific growth rates and 
decreased maximum cell densities when compared to normal culture conditions. In Figures 
4.1 a and 4.1 b, the number of viable, total and dead cells in normal and hyperosmotic 
culture conditions are shown. It is observed that the average maximum cell density was 
decreased by approximately 25%, from 9.7 x 105 cells/mL to 7.3 x 105 cells/mL in 
hyperosmotic cultures relative to normal condition cultures (Figure 4.1 a). Both average 
values were confirmed to be different statistically (p=0.027), based on a single-factor 
ANOVA test carried out at the 0.05 significance level. Additionally, the total cell number 
under hyperosmotic conditions reached a value that was approximately 33% lower than cells 
under normal conditions. Figure 4.1 b also indicates that the number of dead cells increased 
at a slower rate and was consistently lower for hyperosmotic cultures in comparison to 
normal osmotic cultures apart from during the hyperosmotic lag phase. The trends in Figure 
4.1 can be further analysed by examining the behaviours of the specific growth and death 
rates, as presented in Figures 4.2 a and 4.2 b respectively. From Figure 4.2 a, the average 
specific growth rate at the mid-exponential phase of hyperosmotic cultures was observed to 
be 0.014 hr-1, which represented a 33% decrease when compared to a growth rate of 0.021 
hr-1 achieved by cells under normal culture conditions. This behaviour was thus responsible 
for the lower viable cell numbers achieved by hyperosmotic cultures. Additionally, the 
specific growth rate under hyperosmotic conditions was also maintained at its exponential 
growth value over a longer time period, before decreasing at a slower rate than under normal 
osmotic conditions. These specific growth rate trends thus resulted in relatively longer 
exponential growth and stationary phases in hyperosmotic cultures (Figure 4.1 a). In Figure 
4.2 b, the specific death rates for hyperosmotic cultures were observed to remain at relatively 
low levels (< 0.010 hf l) over a longer time period (192 hrs) in comparison to the death rates 
of cells grown under normal culture conditions (kd started increasing at 144 hrs). This trend 
explains the comparatively lower number of dead cells in hyperosmotic cultures with respect 
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to normal osmotic cultures (Figure 4.1 b). In Figure 4.3, the percentage cell viability for both 
normal and hyperosmotic cultures are shown. It appears that there was an initial drop in the 
cell viability of hyperosmotic cultures during the lag phase, which implied that an adaptation 
period for the cells to adjust to higher osmolarity in the medium was required. The drop in 
cell viability was also reflected in the comparatively higher specific death rate (3.7 x 10-3 hr-
1) for hyperosmotic cultures relative to the normal cultures (1.7 x le hr-1). It was also 
observed that hyperosmotic cell viability averaged approximately 78% during the 
exponential growth phase, which was significantly lower than the 86% for normal cultures (p 
= 4 x 10-9 from single-factor ANOVA test conducted at a significance level of 0.05). Figure 
4.3 also shows clearly that the decrease in cell viabilities for hyperosmotic cultures was more 
gradual relative to normal cell cultures — in fact, the hyperosmotic cell viabilities were 
consistently higher than their corresponding normal osmotic values after 120 hours of culture 
time (normal and hyperosmotic cell viabilities were statistically analysed using single-factor 
ANOVA at all time points from 120 hours — all p values were less than 0.05). The above 
viability trend is in agreement with the aforementioned behaviour of both the specific growth 
rate (extended exponential growth and stationary phases) and the specific death rate (slower 
rate of increase), indicating that hyperosmotic conditions of 450 mOsm/kg resulted in an 
extended culture longevity for GS-NSO cells. 
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Figure 4.1. (a) Viable cell numbers and (b) total and dead cell numbers for normal osmotic 
(290 mOsm/kg) and hyperosmotic cultures (450 mOsm/kg). 
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4.3.2 Nutrient uptake and metabolite production 
Figures 4.4 a to 4.4 c show the normal and hyperosmotic glucose, lactate and ammonium ion 
profiles respectively. In Figure 4.4 a, it can be observed that the glucose uptake rate was 
higher at the exponential growth phase for both culture conditions (steeper gradient) and 
subsequently decreased (gentle gradient) as the culture progressed. This trend is more clearly 
observed in Figure 4.5 a, which presents the specific glucose uptake rate as a function of 
time under both osmotic conditions. These specific glucose uptake rates were derived by first 
fitting the data points with polynomial expressions, then differentiating the equations with 
respect to time and finally dividing by the viable cell number (analogous to the differential 
method of calculating specific antibody productivity from [Yang et al., 1996]). It can be seen 
that the specific glucose uptake rate was higher for hyperosmotic cultures than normal 
osmotic cultures at the mid-exponential growth phase. However, the specific rates for 
hyperosmotic cultures dropped below the rates for normal cultures at the late-exponential to 
stationary phase. Figure 4.4 b shows the variation of lactate concentration in the medium 
under both osmotic conditions. The lactate production in hyperosmotic cultures seems to be 
similar to the production in normal cultures, up to 120 hours, before levelling out around 23 
mM, which is slightly lower than the 26 mM produced under normal culture conditions. The 
relatively lower number of viable cells under hyperosmotic conditions suggests that lactate 
production rates are higher in hyperosmotic cultures. In order to substantiate this 
observation, the relationships between specific glucose uptake rate and the specific lactate 
production rate are presented in Figure 4.5 b; a linear relationship between both variables 
was approximated under both normal and hyperosmotic culture conditions. The specific 
yield of lactate from glucose can therefore be derived from the slopes of the curves. The 
calculated gradients indicate that that hyperosmotic cultures do indeed show a relatively 
higher specific yield (1.40) of lactate from glucose uptake, in comparison to the lactate yield 
at normal cultures (0.95). This behaviour suggests that there may have been a shift in glucose 
metabolism towards the lactate production pathway under hyperosmotic conditions. 
From Figure 4.4 c, the final ammonium ion (NI-14+) production appears to be slightly 
higher under hyperosmotic culture conditions. The variation in specific NH4+ production rate 
is more clearly seen in Figure 4.5 c. The specific NH4+ production rate increased to a 
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maximum at the mid-exponential phase before decreasing steadily in the stationary and 
decline phases under both osmotic culture conditions. While the normal condition-cultures 
had a higher maximum specific production rate during the mid-exponential phase, the 
specific rates were relatively lower than that of hyperosmotic cultures in the early stationary 
and decline phases. The observed trends for glucose uptake and lactate and NH4+ production 
are indications that hyperosmotic conditions lead to increased intracellular metabolic 
activity. However, the glutamate concentration, which has also been measured using the 
bioprofiler, do not show significant differences between normal and hyperosmotic cultures —
under both osmotic conditions, the concentration decreased from 0.80 to a relatively stable 
range of 0.30 — 0.40 mM within two days and no observable correlation between glutamate 
uptake and ammonium ion production was deduced. 
4.3.3 Antibody production in normal and hyperosmotic cultures 
Hyperosmotic culture conditions have resulted in an increase in specific antibody 
productivity for various cell lines, as briefly mentioned in Section 4.1, which may or may not 
lead to an increase in the final antibody titre obtained, depending on the extent of 
suppression of cell growth. In this study, the antibody accumulation trends are shown in 
Figure 4.6. The figure indicates that the final antibody titre increased from 88 .ig/mL to 157 
i.tg/mL as the osmolarity was raised from 290 to 450 mOsm/kg. This represents an 
approximate increase of 78% and highlights the potential use hyperosmotic culture 
conditions in antibody product optimisation strategies. 
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Figure 4.4. (a) Glucose, (b) lactate and (c) ammonium ion profiles under normal and 
hyperosmotic culture conditions. 
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4.3.4 Cell cycle distribution in normal and hyperosmotic cultures 
Having studied the general characteristics of GS-NSO cell behaviour under normal and 
hyperosmotic conditions, an analysis was then carried out on the cell cycle distribution in 
normal and hyperosmotic cultures. Flow cytometry was used to analyse fixed cell samples 
that had been stained with PI, which enabled the DNA content in each cell to be determined. 
A histogram displaying the frequency of cells with varying amounts of DNA (as measured 
by the staining intensities) was obtained for each sample, a typical example of which is 
shown in Figure 4.7. The figure illustrates how the proportion of cells in the GO/G1, S and 
G2/M phases were determined from the generated historgram. Cells in the G2/M phase have 
replicated their DNA and are poised to divide, hence they possess twice the amount of DNA 
as cells in the GO/G1 phase. The G2/M peak seen in the figure should therefore be 
approximately at twice the channel number (x-axis) as the GO/G1 phase. Cells in between the 
two peaks are considered to be in the process of synthesising DNA and thus belong to the S 
phase of the cell cycle. 
Hyperosmolarity, cell cycle arrest and effects on antibody productivity 
One of the main reasons proposed in literature for the increase in specific antibody 
productivity at hyperosmotic cultures is through the process of cell cycle arrest. It is 
postulated that cell cycle arrest at hyperosmotic conditions results in a re-allocation of 
resources towards antibody production, thereby leading to improved antibody production 
rates in CHO cells [Ryu et al., 2001]. The validity of this theory for the GS-NSO cell line will 
be tested by the results of this analysis. 
The comparison between the percentage of cells in each phase of the cell cycle is 
presented in Figures 4.8 a and 4.8 b. In Figure 4.8 a, it can be seen that hyperosmotic 
conditions resulted in a comparatively higher proportion of cells in the G0/G1 phase, hence 
confirming that partial cell cycle arrest at the G1 phase had indeed taken place. The 
proportion of cells in this phase increased as the culture progressed into the stationary and 
decline phases, which corresponded with the decrease in specific growth rate and increase in 
specific death rate (Figures 4.2 a and 4.2 b) under both osmotic conditions. It can be 
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observed from Figure 4.8 b that the hyperosmotic cultures had a lower proportion of cells in 
the S phase than the normal cultures, which agreed with the lower specific growth rates 
observed under hyperosmotic conditions. The G2/M trend however, was not as clear — the 
hyperosmotic cultures started out with a lower proportion of G2/M cells in the lag phase, 
however during the exponential growth phase, the proportion of G2/M cells increased until 
the late-exponential phase before declining at a slower rate than normal condition cultures. 
This slower rate of decrease corresponded to the relative longevity of hyperosmotic cultures 
when compared to normal cultures, as mentioned in Section 4.4.1. 
The results obtained confirm that hyperosmotic conditions partially induce cell cycle 
arrest, particularly in the GO/G1 checkpoint. The next step is therefore to evaluate whether 
the partial induction of cell cycle arrest actually leads to improved antibody production 
yields. In Figures 4.9 a and 4.9 b, the proportion of cells in the GO/G1 and S phases are 
shown with respect to the specific antibody productivities at various time points in the 
cultures. It is observed that two separate relationships between proportion of cells in the 
GO/G1 and S phases, and the specific antibody productivity, can be derived for normal and 
hyperosmotic cultures. A negative relationship was seen between the proportion of cells in 
the GO/G1 phase and specific antibody productivity, implying that a higher cell proportion in 
this phase resulted in a decrease in antibody productivity. Conversely, there was a direct 
relationship between the proportion of cells in the S phase and the antibody productivity for 
both normal and hyperosmotic cultures, indicating that antibody production was likely to be 
positively associated with growth in GS-NSO cells. This observation is further substantiated 
by the positive relationship existing between the specific growth rate and specific antibody 
productivity under both normal and hyperosmotic conditions, as presented in Figure 4.9 c. 
Based on these findings, it appears unlikely that partial arrest of the cell cycle is the reason 
for increase in antibody productivity at hyperosmotic culture conditions. 
109 
GO/G1 peak 
S phase 
G2/3/1 peak 
100 	200 
I 	I 	I 	I 	I 	I 
500 600 700 800 900 1000 300 400 
CHAPTER 4. HYPEROSMOTIC EFFECTS ON GROWTH, METABOLISM AND IgG PRODUCTION 
Figure 4.7. Example of a histogram (outlined in blue) displaying the frequency of cells with 
different staining intensities, as indicated by the channel number (x-axis). The histogram has 
been analysed using Cychlred software to determine the proportion of cells in the GO/G1 
(first peak outlined in red), S (outlined in green) and G2/M (second peak outlined in red) 
phases of the cell cycle. 
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4.3.5 Energy state of GS-NSO cells under normal and hyperosmotic conditions 
Energy state parameters 
The energy state of a cell can be assessed through the measurement of the energy nucleotide, 
adenosine tri-phosphate (ATP), as well as the derivation of the energy charge of the cell. The 
energy charge allows for a quantitative assessment of the energy levels in a cell and was first 
proposed by Atkinson [1968]. Based on the assumption that equilibrium of the adenine 
nucleotide pools is maintained, the energy charge can be defined as follows: 
([ATP] + 0.5 [ADP]) 
Energy Charge = 
([ATP]+[ADP]+[AMP]) 
(4.1) 
where [ATP], [ADP] and [AMP] refer to the concentrations of adenosine tri-phosphate 
(ATP), adenosine di-phosphate (ADP) and adenosine mono-phosphate (AMP) respectively. 
The value of the energy charge ranges from 0 to 1, where 0 represents a cellular state 
in which only AMP is present and 1 indicates that only ATP is present in the cell. A larger 
energy charge value is indicative of higher energy levels in the cell [Bibila, 1991]. In 
addition, the concentration of ATP in cells under normal conditions is reported to be in the 
range of 2-10 mM [Szewczyk and Pikula, 1998]; for example, in the hamster pancreatic cell 
line HIT-T1 (3, the intracellular ATP concentration was reported to be 5.2 mM [Niki et al., 
1989]. 
Use of capillary electrophoresis in nucleotide measurements 
Capillary electrophoresis has been chosen for the measurement of intracellular ATP, ADP 
and AMP concentrations due a number of reasons — firstly, the amount of sample required 
for analysis is relatively small compared to other methods such as high performance liquid 
chromatography (HPLC) (the amount of detected compound required in the sample is 100 
times less in capillary electrophoresis [Ng et al., 1992]). Capillary electrophoresis methods 
also lead to reduced buffer consumption [Ji et al., 1999] and can result in shorter analysis 
times with the appropriate capillary and running conditions [Hsu et al., 1995; Kaulich et al., 
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2003; Ng et al., 1992]. In addition, it is able to analyse the concentrations of all three 
nucleotides in a single run, unlike the use of fluorescent assays, in which each nucleotide has 
to be detected individually. Each electrophoresis run produces an electropherogram, an 
example of which can be seen in Figure 4.10. The ATP, ADP and AMP peaks are indicated 
in the figure, together with the extraction efficiency standard, GMP as well as the inverted 
peak which is representative of the internal loading standard, DNP-L-glutamic acid (DNP). 
The results obtained in this analysis were normalised to DNP and adjusted according to the 
extraction efficiency obtained in each sample run. The concentration of each nucleotide in 
unknown samples was then determined by comparing the area under the peak (AUP) to the 
respective standard curves constructed with known nucleotide concentrations. An example of 
the standard curves obtained for each data set is given in Figure 4.11. 
Behaviour of energy parameters with specific growth rate and antibody productivity 
Another key hypothesis regarding the mechanism of hyperosmolarity proposes that the 
increase in nutrient uptake leads to increased cellular energy levels and subsequently 
enhances IgG translation rates and specific antibody productivity [Lin et al., 1999a]. In order 
to test this hypothesis, the behaviour of ATP concentration and energy charge under normal 
and hyperosmotic conditions with respect to both specific growth rate and antibody 
productivity is presented in Figures 4.12 and 4.13. Firstly, as expected, the ATP 
concentrations under both osmotic conditions were positively correlated to the specific 
growth rates. The trends in Figure 4.12 a also indicate that the mid-exponential ATP 
concentration was in excess, hence, the decrease in specific growth rate in response to a fall 
in ATP concentration was comparatively smaller than in the stationary and decline culture 
stages. For instance, in hyperosmotic cultures — a drop in ATP concentration resulted in a 
less than proportionate decrease in specific growth rate initially, however, once the 
experimentally observed "threshold" ATP concentration (approximately 3 mM) was reached, 
the growth rate became very sensitive to slight decreases in the amount of ATP present. The 
same trend, although to a lesser extent, was also observed under normal culture conditions. 
To determine whether the ATP concentrations for normal and hyperosmotic culture 
conditions were significantly different with respect to growth, a single factor ANOVA and 
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two-tailed t-test were performed on both ATP data sets. Results of both tests indicate that the 
ATP values in both groups were not significantly different, implying that there was 
insufficient evidence to show that ATP concentrations were enhanced at hyperosmotic 
conditions. Figure 4.12 b shows the relationship between energy charge and the specific 
growth rate under both sets of osmotic conditions. In this graph, a distinct difference can be 
seen in the energy charge trends between normal and hyperosmotic cultures — at the same 
energy charge level, hyperosmotic cultures had a distinctly lower specific growth rate, which 
suggested that cells under hyperosmotic stress require a larger amount of energy to attain the 
same level of growth present under normal culture conditions. 
From Figures 4.13 a and 4.13 b, the relationships between the energy parameters and 
specific antibody productivity can be determined. Figure 4.13 a indicates that a positive 
relationship existed between ATP concentration and specific productivity. However, two 
distinct positive relationships were derived for normal and hyperosmotic cultures, implying 
that specific productivities at hyperosmotic conditions were comparatively higher than those 
at normal culture conditions for any given ATP concentration. These trends also indicated 
that the increase in specific productivity at hyperosmotic culture conditions was probably not 
a direct result of increased energy levels in the cell. In Figure 4.13 b, a positive relationship 
between the energy charge and specific productivity was also apparent. Once again, the 
specific productivity at hyperosmotic conditions appeared to be relatively higher in 
comparison to normal culture conditions at the same energy charge level. 
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Figure 4.10. Example of an electropherogram obtained from the capillary electrophoresis 
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Figure 4.11. Example of standard curves derived for ATP, ADP and AMP with known 
nucleotide concentrations ranging from 0.5 to 20 mM. The standard curves were then used 
to determine ATP, ADP and AMP concentrations in cell sample extracts. 
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Figure 4.12. (a) ATP concentrations and (b) energy charge values with respect to specific 
growth rates under normal (290 mOsm/kg) and hyperosmotic (450 mOsm/kg) conditions. 
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Figure 4.13. Behaviour of (a) ATP and (b) energy charge trends with respect to specific 
antibody productivity under normal (290 mOsm/kg) and hyperosmotic (450 mOsm/kg) 
culture conditions. 
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4.4 	Discussion 
In this chapter, the effects of hyperosmotic culture conditions on the aspects of growth, 
metabolism and extracellular antibody production for GS-NSO cells have been studied. The 
resulting observations in terms of growth suppression and enhanced antibody production due 
to increased osmolarity are in agreement with previous studies conducted on the cell line 
[Duncan et al., 1997; Wu et al., 2004]. 
Extended culture longevity under hyperosmotic conditions 
One of the key characteristics of GS-NSO cells cultivated under hyperosmotic conditions is 
that of extended culture longevity. The relatively longer duration of hyperosmotic cultures 
can be attributed to longer mid-exponential and stationary phases due to a combination of a 
slower decrease in specific growth rates and a slower increase in specific death rate. The 
extension of culture longevity as a consequence of hyperosmotic conditions has been 
observed in previous studies on CHO [Ryu et al., 2001] and GS-NSO cells [Wu et al., 2004]. 
The culture longevity is important at hyperosmotic conditions as it increases the duration of 
time available for the accumulation of antibody product in the medium and may partially 
compensate for the cell suppression effects caused by hyperosmolarity. In this study, the 
total antibody titre at hyperosmotic conditions (450 mOsm/kg) was substantially higher than 
under normal culture conditions. Antibody production trends indicated that the increase in 
final antibody titre could be attributed in large to the longer duration of the hyperosmotic 
culture. This is due to the fact that up until the 168-hour time point (towards the end of the 
normal condition culture), the total amount of antibody accumulated for both normal and 
hyperosmotic cultures were approximately the same; it was only after this time point that the 
main difference in total accumulated antibody concentration between the two osmotic 
conditions could be clearly discerned. 
Relationships between hyperosmolarity, cell cycle arrest and growth suppression 
The suppression of cellular growth under hyperosmotic culture conditions has frequently 
been attributed to the induction of cell cycle arrest in a number of mammalian cell lines, 
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including CHO [Ryu et al., 2001], hybridoma [Cherlet and Marc, 1999] and mIMCD-3 cells 
(murine inner medullary cell line) [Santos et al., 2003]. Hyperosmolarity induced by high 
concentrations of sodium chloride has been reported to induce DNA breaks, as well as 
prevent the repair of DNA damage in cells [Dimitrieva and Burg, 2005], thereby resulting in 
cell cycle arrest of damaged cells in the GO/G1 phase. In this study, a similar trend was 
observed in GS-NSO cells under hyperosmotic culture conditions - the proportion of cells in 
the GO/G1 phase was significantly higher than in cultures under normal osmotic conditions, 
which supported the link between hyperosmolarity and the partial arrest of the cell cycle. 
Indeed, it appears that the proportion of cells in the G0/G1 phase under both osmotic 
conditions showed a negative correlation to the specific growth rate. For instance, the initial 
increase in specific growth rate as hyperosmotic cultures progressed from the lag to the mid-
exponential phase was reflected in the slight decrease in the proportion of cells in the GO/G1 
phase. The GO/G1 cell proportion then increased steadily as the cultures progressed from the 
mid-exponential to the stationary phase, reflecting the decrease in specific growth rates 
under both osmotic conditions, which further illustrated the inverse relationship between 
hyperosmotically- induced cell cycle arrest and cell growth rates. 
It is also observed that the proportion of cells in the G2/M phase is consistently 
higher for hyperosmotic cultures when compared to normal osmotic cultures at time points 
beyond 72 hours into the culture. This phenomenon may have been due to a an arrest of a 
proportion of cells in the G2/M phase (in addition to GO/G1 cycle arrest), which had been 
previously observed in murine kidney cells after hyperosmotic induction by the addition of 
sodium chloride [Kultz et al., 1998]. 
Cell cycle arrest and enhancement of specific antibody productivity 
In order to evaluate the hypothesis that the partial cell cycle arrest results in a redistribution 
of resources towards enhancing antibody productivity, the relationship between cell cycle 
behaviour and antibody productivity trends has also been analysed. Two key observations 
can be derived from the trends in the figures and will be discussed in detail in this section. 
The first important observation is concerned with determining the type of producers that GS-
NSO cells belong to. In a previous study conducted on hybridoma cell lines, Dutton et al. 
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[1998] had stated that cells could be classified according to four different types of producers 
based on the correlations between their specific productivity and specific growth rates. These 
four types include: (i) non-growth-associated producers, whose specific productivities 
remain unaffected by growth rates, (ii) growth-associated producers, whose productivities 
show a positive relationship with specific growth rates, (iii) negatively growth-associated 
producers, for which specific productivities increase when growth rates decrease and (iv) 
partially growth-associated producers, which show the characteristics of the first three 
producer types at different growth intervals. 
Apart from the correlations between specific productivities and specific growth 
rates, the type of producer can also be inferred from relationships between specific 
productivities and the proportion of cells in different phases of the cell cycle. For instance, 
Fox et al. [2005] studied the effects of hypothermia on CHO cells and established that a 
positive relationship existed between the proportion of cells in the S phase and the specific 
antibody productivity values. As cells in the S phase were actively growing cells, the authors 
subsequently deduced that the cells were growth-associated producers. In our study, an 
increase in the proportion of cells in the S phase resulted in increased antibody productivity. 
Conversely, the antibody productivity had an inverse relationship with the proportion of cells 
in the GO/G1 phase (cell repair and "resting" phase), indicating that an increase in the 
proportion of arrested cells actually resulted in lower antibody productivity. In addition, a 
positive relationship was seen between the specific antibody productivity and the specific 
growth rate, further implying that antibody production in GS-NSO cells was indeed growth-
associated. It must be mentioned here that there had been suggestions that the increase in 
specific productivity could be attributed solely to an increase in cell size under hyperosmotic 
conditions [Lloyd et al., 2000], rather than being associated with growth charaacteristics. 
However, previous information related to the GS-NSO cell size calculated at the mid-
exponential phase [Wu, unpublished data] indicated that the percentage increase in cell 
volume was substantially less than the increase in antibody productivity at the mid-
exponential phase (<30% increase in cell size compared to > 90% increase in qAb). 
Therefore, the increase in cell size is not likely to be the sole reason for the increase in 
specific productivities at hyperosmotic conditions. 
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The second point to note from the cell cycle and specific antibody productivities data 
is the fact that two separate correlations existed between the proportion of cells in each cycle 
phase and the specific antibody productivity under normal and hyperosmotic culture 
conditions. This implies that there was a shift in the cell cycle-specific antibody productivity 
relationship under hyperosmotic conditions, hence indicating that the increase in productivity 
is likely to be attributed to some other mechanism, rather than associated with changes in the 
cell cycle characteristics of hyperosmotic cultures. These deductions suggest that partial cell 
cycle arrest is unlikely to be a key reason for the improvement of antibody production rates 
under hyperosmotic conditions. Instead, the positive relationship between specific growth 
rate and antibody productivity seemed to imply that at hyperosmotic conditions, a reduction 
in cell growth suppression leading to improvements in the specific growth rates might 
actually lead to higher specific productivities. In the upcoming sections and the next chapter, 
other possible mechanisms through which hyperosmolarity may act will be further 
investigated so as to ascertain the cause of the increase in specific antibody productivities. 
Hyperosmolarity effects on cellular metabolism and energy production processes 
The trends of specific glucose, lactate and ammonium ion (NH4+) rates indicate that 
increases in metabolic rates were observed under hyperosmotic conditions. This increase is 
further corroborated by the gene expression analysis conducted by Wu [2006], who found an 
up-regulation in genes related to carbohydrate, nitrogen and energy metabolism, and glucose 
uptake under hyperosmotic culture conditions. In particular, the increase in specific glucose 
consumption at heightened osmolarity had been similarly observed in several previous 
studies on CHO [Takagi et al., 2000], hybridoma [Oh et al., 1995; Ozturk and Palsson, 
1991b] and GS-NSO cells [Duncan et al., 1997]. In addition, it was found that the lactate 
yield from glucose increased under hyperosmotic conditions, suggesting that a shift in 
glucose metabolism towards the production of more lactate from pyruvate was likely to have 
occurred. The shift could possibly reduced the proportion of pyruvate entering the TCA 
cycle and led to less efficient energy producing pathways — the theoretical yield of energy for 
the glucose to lactate pathway is only 8 moles of ATP per mole of glucose compared to the 
maximum theoretical yield of 36 moles ATP per mole glucose that can be produced by the 
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complete oxidation of glucose through oxidative phosphorylation. This metabolic shift 
towards less efficient energy pathways by hyperosmotic cultures had likely resulted in the 
similar cellular ATP concentrations being observed under both osmotic conditions. The 
observations are in agreement with results reported by Devin et al. [1996], who found a 
reduction in the oxidative phosphorylation efficiency (as given by [ATP]/[O] where [0] is 
the oxygen concentration) occurred under hyperosmotic conditions in the mitochondria of rat 
liver cells. Due to the reduced energy yield per mole of glucose, cells under hyperosmotic 
conditions at the exponential culture phase had to compensate by increasing the glucose 
consumption rate in order to generate the same amount of energy as cells under normal 
culture conditions. Duncan et al. [1997] also suggested that hyperosmotic cells might 
require comparatively higher maintenance energies, which agreed with our findings that a 
larger amount of energy had to be expended in hyperosmotic cultures so that the same 
growth rate present in normal cultures could be reached. The implications of the 
aforementioned metabolic and energy trends with respect to specific antibody productivities 
will be further discussed in the next section. 
Energy metabolism and antibody productivity 
In literature, the protein synthesis process is often affected by the availability of energy-
providing substrates (in the form of nutrients) in the cell [Bibila, 1991]. The depletion of 
nutrients such as glucose and glutamine generally resulted in a decrease in protein translation 
rates [Dahn et al., 1993; Duncan and Hershey, 1987; Jorgensen and Tyers, 2004]. These 
reports signify that cellular energy levels may be a key factor in the determination of heavy 
and light IgG polypeptide chain synthesis rates. Additionally, it had been proposed by Lin et 
al. [1999a] that hyperosmotic conditions led to an increase in specific ATP production rates, 
which in turn resulted in heightened translation rates, hence improving specific antibody 
productivities. In this study, a positive relationship was derived between the energy levels in 
GS-NSO cells and the specific antibody productivity, indicating that the availability of 
energy did indeed play an important role in the determination of antibody production rates, 
particularly at lower ATP concentrations (experimentally observed to be less than 
3mM/cell). However, as discussed in the previous section, hyperosmotic conditions did not 
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lead to a significant increase in cellular ATP concentration due to the shift in metabolic 
processes towards less efficient energy producing pathways. Additionally, separate 
correlations had been obtained between ATP concentration and specific productivity for 
normal and hyperosmotic cultures. This implies that for any given ATP concentration, the 
specific productivities derived under normal and hyperosmotic conditions were different, 
suggesting that another determining factor was responsible for improving GS-NSO antibody 
productivity under hyperosmotic conditions. Nevertheless, the positive correlation between 
specific productivity and ATP concentration highlights the possibility of further improving 
antibody productivities by increasing energy levels in the cell under hyperosmotic 
conditions. This may be achieved by firstly, the identification of the less efficient energy-
producing pathways, and subsequently attempting to shift cellular metabolisms back towards 
the more efficient pathways; for instance, using a basal medium [Ryu and Lee, 1997] best 
suited to hyperosmotic conditions, as well as using a suitable nutrient feeding strategy may 
lead to more effective nutrient utilisation and an increase in cellular energy levels. 
4.5 	Conclusions 
This chapter had focused on evaluating how the characteristics of growth and metabolism 
under normal and hyperosmotic conditions relate to antibody production rates in GS-NSO 
cells. It was observed that hyperosmotic conditions lead to cell cycle arrest, which in turn 
reduced the specific growth rate of the cultures. However, GS-NSO specific antibody 
productivity was found to be growth-associated, indicating that cell cycle arrest was unlikely 
to be the reason for the increased antibody productivity under hyperosmotic conditions. 
Additionally, relatively higher specific metabolic rates in hyperosmotic cultures did not 
result in a substantial increase in ATP concentration. Instead, a higher lactate yield from 
glucose indicated that there was a possible shift in metabolism towards less efficient energy 
production pathways at hyperosmotic conditions. As a result, the increase in glucose uptake 
rate was necessary to produce sufficient energy in hyperosmotically stressed cells to sustain 
growth and other cellular processes. Consequently, it was deduced that an increase in ATP 
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levels was not the key reason for the improvement of specific antibody productivity at 
hyperosmotic culture conditions. 
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Behaviour of mRNA and Intracellular IgG Trends in GS-
NSO Batch Cultures 
5.1 	Introduction 
In Chapter 4, two proposed hypotheses regarding the mechanism through which 
hyperosmotic conditions lead to improved specific antibody productivity were investigated —
experimental results obtained subsequently indicated that neither cell cycle arrest induced by 
hyperosmolarity, nor an increase in cellular energy (ATP) levels, was likely to be responsible 
for increasing antibody productivity under hyperosmotic conditions in GS-NSO cells. This 
chapter will focus on two key points: firstly, in order to identify the main reasons for 
hyperosmotic stimulation of antibody productivities and evaluate other existing 
hyperosmotic hypotheses associated with intracellular IgG synthesis, the behaviour of IgG 
mRNA, polypeptide chains and IgG mRNA degradation rates with respect to time and 
osmolarity are studied experimentally. The second key issue involves the experimental 
estimation of the key parameters (specific transcription and translation rates, as well as 
mRNA degradation rates) previously identified by global sensitivity analysis of the hybrid 
model (see Chapter 3). 
The experimental study involves the use of two main experimental techniques for 
the analyses of intracellular mRNA and polypeptide chain concentrations. Northern blotting 
is utilised in the determination of relative mRNA levels at different culture time points while 
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a Western blotting procedure involving SDS-PAGE gel electrophoresis under reducing 
conditions is used for the evaluation of total intracellular heavy and light IgG polypeptide 
species. A more detailed description of these techniques will be given in Section 5.2. 
In Sections 5.1.1 to 5.1.3, currently known information obtained from various 
literature studies regarding the behaviour of total RNA, heavy and light IgG mRNA and 
polypeptide chain concentrations with respect to time and osmolarity are summarised. 
5.1.1 Behaviour of RNA and mRNA concentrations with respect to culture time 
In previous studies on the variation of total RNA with culture time for hybridoma cells, 
Ozturk and Palsson [Ozturk and Palsson, 1991a], Bibila [1991], and Sun et al. [2004] 
reported that RNA concentration decreases steadily as the culture progresses from the 
exponential to the stationary and decline phases. However, Leno et al. [1992] observed that 
the total RNA concentration initially increased until it reached a peak at the end of the 
exponential phase before decreasing to 34% of the maximum RNA concentration in the 
decline phase. The trends for heavy and light mRNA concentrations on a per cell basis have 
also been studied. Relatively constant concentrations of heavy and light mRNA molecules 
were detected throughout the exponential phase before decreasing in the later culture phases 
[Bibila, 1991]. In contrast, both mRNA species were reported to increase to a maximum 
towards the end of the exponential phase before declining in the stationary and decline 
phases by Leno et al. [1992]. Another study on hybridoma cells carried out by Zhou [2002] 
appears to agree with the above trends - heavy and light mRNA concentrations were shown 
to increase until near the end of the exponential phase, before declining in the stationary 
phase. 
5.1.2 RNA and mRNA trends under hyperosmotic culture conditions 
At present, there are relatively few studies that have evaluated RNA and mRNA trends under 
hyperosmotic culture conditions. Two major studies have been mentioned in Section 2.3.2: 
the study on KR12H-2 transfectomas conducted by Lee and Lee [2000], which analysed 
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differences in RNA and mRNA values for different osmotic culture conditions solely at the 
mid-exponential phase, as well as the study carried out by Sun et al. [2004], which focused 
on how inducing osmotic shock in cultures affect RNA and mRNA values. The first study 
found a 56% increase in the amount of total RNA when the osmolarity of the culture was 
increased from 285 to 425 mOsm/kg while heavy and light mRNA concentrations were 
increased by 322% and 340% respectively. In the second study, a slower rate of decline for 
total RNA was observed when the osmolarity of the culture was increased from 290 to 400 
mOsm/kg in the mid-exponential phase (36 hours). As the osmotically stressed cells enter 
the stationary phase of the culture, the RNA content was 20% higher than in normal, 
unstressed cells at 72 hours and 50% higher at 84 hours into the culture. Additionally, the 
heavy and light mRNA concentrations for osmotically stressed cells were approximately 4 
times higher than in normal cells during the stationary phase of the culture. From the above 
observations, it can be concluded that higher RNA and mRNA concentrations are expected 
in hyperosmotic cultures. 
5.1.3 Intracellular heavy and light polypeptide trends under normal and 
hyperosmotic culture conditions 
Total cellular protein levels have been observed to increase in the exponential growth phase 
before declining as the culture progresses into the stationary and decline phases [Tang and 
Barford, 2000]. This behaviour may be explained by the fact that the depletion of nutrients 
present in the medium tends to occur at the later cell culture stages, hence resulting in a 
reduction of intracellular amino acid pools available for protein synthesis. Additionally, 
hyperosmotic culture conditions have been reported to result in an increase in total cellular 
protein levels [Lee and Lee, 2000; Oh et al., 1995; Sun, 2000]. However, in a study on 
mouse plasmacytoma cells, Nuss and Koch [1976] found a drastic decrease in total protein 
levels as translation initiation was inhibited under hyperosmotic conditions. 
The intracellular heavy and light polypeptide chain concentrations with respect to 
normal and hyperosmotic conditions have been studied by Sun et al. [2004]. The authors 
deduced that the heavy and light chain concentrations remained the same in hyperosmotic 
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cultures on a per i_tg protein basis, and suggested that any increase in polypeptide chain 
concentrations could be fully attributed to the overall increase in protein synthesis. On the 
other hand, Nuss and Koch [1976] reported that the translation of IgG polypeptide chains 
were preferentially enhanced at hyperosmotic conditions relative to the translation of other 
proteins, as seen from the following observations - while the addition of low levels of 
sodium chloride increased osmolarity and led to a 10-15% inhibition of protein synthesis, a 
2-12% increase in the absolute amount of light polypeptide chains in comparison to normal 
culture conditions was measured. The authors also stated that light polypeptide chains appear 
to be more resistant to the inhibition of translation initiation by sodium chloride than heavy 
polypeptide chains, resulting in a higher light to heavy polypeptide chain ratio at increased 
osmotic conditions. 
The aim of this chapter is to evaluate the behaviour of total RNA and cellular 
protein, as well as heavy and light mRNA and polypeptide chains with respect to both 
culture time and hyperosmotic culture conditions. In addition, the mRNA degradation rates 
for normal and hyperosmotic cultures are also studied at the mid-exponential and early-
stationary culture phases. 
5.2 	Materials and methods 
5.2.1 Normal and hyperosmotic batch culture experiments 
For the purposes of RNA and intracellular IgG polypeptide chains analyses, duplicate batch 
shake flask cultures were grown under normal (290 mOsm/kg) and hyperosmotic (450 
mOsm/kg) culture conditions. 1 x 106 cells were collected for IgG polypeptide analysis by 
gel electrophoresis and Western blotting. For RNA analysis, 7.5 x 106 cells were collected at 
48, 96, 120 and 144 hours after the start of the culture, corresponding to the mid-exponential, 
stationary and decline phases in normal osmotic cultures. In cultures under hyperosmotic 
conditions, 5 x 106 cells were collected at 96 (mid-exponential phase), 144 (late-exponential/ 
early-stationary) and 216 hours (decline phase) from the beginning of the culture. 
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5.2.2 Determination of heavy and light chain mRNA half-lives 
In order to estimate the half-lives of the heavy and light IgG chain mRNA molecules, 
duplicate shake flask experiments were carried out at normal and hyperosmotic culture 
conditions. At the mid-exponential and early stationary phases of each culture, cell 
transcription was blocked by the addition of 65 1,1,M of the transcription inhibitor DRB (5,6 
dichloro-113-D-ribofuranosyl benzimidazole; Sigma) dissolved in 100% ethanol (VWR). The 
concentration was chosen as it had previously been reported to ensure near maximal 
inhibition of transcription [Bibila, 1991]. Subsequently, 5 x 106 cells were collected from 
each culture at various time intervals following the addition of DRB. To ensure that ethanol 
does not affect the mRNA degradation process, the same volume of ethanol was added to 
control cultures at the mid-exponential phase under both normal and hyperosmotic 
conditions. Samples consisting of 5 x 106 cells were then collected at 0, 4, 8 and 12 hours 
after ethanol addition. All RNA samples collected were subsequently analysed by agarose 
gel electrophoresis and Northern blotting (procedure described in Section 5.2.3). 
5.2.3 Intracellular heavy and light chain mRNA analysis — Northern blotting 
Preparation of total cellular RNA from GS-NSO cells 
The cell samples collected at different culture phases from normal and hyperosmotic cultures 
were centrifuged at 800 rpm for 5 minutes in order to aspirate the supernatant. The cells were 
then washed once with PBS and centrifuged again (same conditions as above) to remove the 
PBS solution. 600 µL of cell lysis solution (buffer RLT) from the Qiagen RNeasy mini kit 
for total RNA extraction (Qiagen, UK), supplemented with 6 pL of fl-mercaptoethanol 
(Sigma), was added to each cellular sample and mixed thoroughly by pipetting vigorously 
and vortexing continuously for 1 minute. The samples were then stored at -86°C prior to 
RNA extraction. 
RNA extraction from the lysed cell samples prepared above was carried out just 
before analysis by agarose gel electrophoresis. The samples were first thawed by immersing 
them in a 37°C water bath for 10 minutes to ensure that all salts within the samples were 
131 
CHAPTER 5. HYPEROSMOTIC EFFECTS ON GROWTH, METABOLISM AND IgG PRODUCTION 
dissolved. 600 pL of 70% ethanol (prepared in RNase-free water) was then added to the 
samples and mixed thoroughly by pipetting. 700 pL aliquots of each sample were applied 
successively to the RNeasy mini spin column supplied in the kit and centrifuged at 10,000 
rpm for 15 seconds. The flow-through was discarded after each centrifugation step. 
Subsequently, the silica-gel membrane in the RNeasy column was washed by 700 pL of 
buffer RW1 and two successive washes of 500 pL of buffer RPE each. The columns were 
centrifuged at 10,000 rpm for 15 seconds and the flow-through discarded after each washing 
step. After the final washing step, the column is centrifuged at 10,000 rpm for 2 minutes to 
dry the RNeasy membrane. The RNeasy column was transferred to a new 1.5 mL 
microcentrifuge tube and 35 pL of RNase-free water (both tube and water supplied by 
RNeasy kit) was pipetted directly onto the silica-gel membrane. The tube was centrifuged for 
1 minute at 10,000 rpm to elute the RNA collected by the membrane. The above elution step 
was repeated with 30 pL of RNase-free water to ensure all RNA on the membrane has been 
collected. 
Total RNA quantification 
5 pL of the RNA eluent collected in the previous section was diluted in 245 pL of RNase-
free water and vortexed to ensure equal mixing. The absorbance of the 1:50 diluted sample 
was then measured using a UV spectrophotometer (CaryWin UV, Varian Inc, USA) at 
wavelengths of 260 nm (A260) and 280 nm (A280). The concentration of RNA is given by the 
following formula: 
RNA concentration 	= 	40 x A260 x 50 
200 x A260 pg/mL 
The A260/ A280 ratio provides an estimate of the purity of RNA with respect to 
contaminants that absorb in the UV and all sample ratios were determined to be > 1.8. 
Sample preparation for agarose gel electrophoresis 
10 pg of sample was mixed with 5 x RNA sample buffer in a 4:1 volume ratio, vortexed and 
heated at 65 C for 15 minutes. The samples were transferred immediately onto ice for 5 
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minutes before being loaded onto the gel. For 10 mL of 5 x RNA sample buffer, the 
composition was as follows: 80 pL 0.5 M sodium EDTA at pH 8.0, 750 pL of 37% 
formaldehyde (Sigma), 3.084 mL of formamide (VWR), 4 mL of 10 x MOPS ((3-(N-
Morpholino)propanesulfonic acid) buffer (0.4 M MOPS (VWR), 0.1 sodium acetate (Sigma) 
and 0.01 M di-sodium EDTA (VWR)), 25 mg bromophenol blue (Sigma), 25 mg xylene 
cyanol (Sigma) and 2 mL of glycerol. 
Agarose gel electrophoresis of RNA and transfer to nylon membrane 
A 1.5% agarose-formaldehyde based gel was used to separate the RNA molecules according 
to their molecular weight. The composition of the gel was as follows: 1.5 g agarose 
(Invitrogen), 10 mL of 10 x MOPS buffer, 1.8 mL formaldehyde (Sigma) made up to 100 
mL with DEPC-treated water (1 mL diethyl pyrocarbonate, (Sigma) in 1 L deionised water). 
The gel was allowed to cool for 1 hour at room temperature before being submersed in 
approximately 500 mL of 1 x MOPS buffer composed of the following components in 
DEPC-treated water: 10% (v/v) of 10 x MOPS buffer and 2% (v/v) of 37% formaldehyde 
solution (Sigma). The gel was allowed to equilibrate with the buffer for at least 30 minutes 
prior to sample loading. 5 pg of RNA per sample was loaded into each well and the gel was 
run at a constant voltage of 75 V for 2.5 hours. 
After RNA separation was completed, the gel was rinsed in large quantities of 
nanopure water (Nanopure Diamond unit, Barnstead Thermolyne, USA) in order to remove 
formaldehyde, which inhibits RNA transfer to membrane, from the gel. The gel was then 
soaked for 40 minutes in 20 x SSC transfer buffer (3 M sodium chloride, 0.3 M sodium 
citrate tribasic dehydrate, both chemicals from Sigma) before the RNA was transferred to a 
nylon membrane (Nytran membrane, Schleicher and Schuell, USA) by downward capillary 
action for 1 hour and 15 minutes. The membrane was then rinsed with 2 x SSC and air-dried 
for 1 hour before being UV irradiated for 3 minutes to allow cross-linking to take place. 
Subsequently, the membrane was wrapped in Saran wrap and kept in a cool, dark place for 
further analysis by Northern blotting. 
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Membrane staining and Northern blotting of heavy and light chain mRNA 
The membrane was first stained for 3-5 minutes in methylene blue solution consisting of 
0.02%(w/v) methylene blue (Sigma) and 0.3 M sodium acetate. This allowed for the 
visualisation of the 18S ribosomal RNA band, which was then used as an equal loading 
standard. The membrane was photographed using an Olympus C-5060 camera (Olympus, 
UK) and the band intensities quantified by densitometry methods using the AlphaEaseFC 
software (Alpha Innotech Corp, USA). Subsequently, the membrane was destained in a 
solution comprising of 0.2 x SSC and 1% (w/v) SDS for 15 minutes. 
Prior to prehybridisation, the membrane was rinsed briefly in 6 x SSC. The 
prehybridsation solution recipe was as follows: 5 x SSPE (0.75 M sodium chloride, 50 mM 
sodium phosphate monobasic (Sigma), 4 mM di-sodium EDTA), 5 x Denhardt's solution 
(50 x concentrate from VWR), 50% (v/v) formamide, 0.5% (w/v) SDS and 100 pg/mL 
denatured salmon sperm DNA (Sigma). 1 mL of prehybridisation solution was used for 
every 10 cm3 of membrane. The prehybridisation solution was pre-warmed to 42 C before 
being added to the membrane. The membrane was then placed in an orbital shaking 
incubator at 42 C for 1 hour. Subsequently, heavy and light chain mRNA-specific biotin-
labelled oligonucleotide probes (Operon, Germany) were added to the prehybridisation 
solution at a concentration of 25 ng/mL and the membrane incubated overnight at 42 C on an 
orbital shaker. The oligonucleotide probe sequences were kindly provided by Dr Mark 
Smales (Univ. of Kent, UK) and are as follows: 
Heavy chain mRNA probe — 5' GGCAGTGCTGGAGGATTT 3' and 
Light chain mRNA probe — 5' TGTGTGCCCGATCCACTGCCA 3' 
After hybridisation, the membrane was washed twice in 2 x SSC solution with 0.1% 
SDS for 5 minutes each. It was then washed once in 0.2 x SSC with 0.1% SDS for an 
additional 5 minutes at 42 C. The membrane was then processed with the Nucleic Acid 
Chemiluminescent kit (Perbio, UK) following manufacturer's instructions. Briefly, the 
membrane was blocked for 15 minutes with the supplied blocking solution at room 
temperature before the streptavidin-HRP conjugated solution was added (66.7 pL per 20 mL 
blocking solution). The membrane was incubated with this solution for a further 15 minutes 
at room temperature. Next, the membrane was transferred to a new container, rinsed briefly 
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with the supplied washing buffer before being washed 4 times with the same washing buffer 
for 5 minutes each. The membrane was then equilibrated for 5 minutes in the equilibration 
buffer before excess solution was blotted off and the membrane placed on a piece of Saran 
wrap. The luminal substrate was mixed with the stable peroxide solution in equal volumes 
and the mixture poured evenly onto the surface of the membrane. The substrate was allowed 
to react with the HRP-conjugated molecules for 5 minutes before the membrane was 
wrapped in Saran wrap and exposed to Kodak BioMax Light film (Kodak, UK) for a time 
period ranging from 1 second to 1 minute. The relative intensities of the bands were once 
again quantified using the densitometry function available in AlphaEaseFC software and 
normalised using the 18S rRNA relative intensities. 
5.2.4 Intracellular cB72.3 antibody analysis — SDS-PAGE and Western blotting 
Separation of viable and non-viable cells from sample 
1-2 x 106 cells were harvested daily by centrifugation at 800 rpm for 5 minutes and washed 
in ice-cold PBS. The PBS was aspirated and the viable cells separated from non-viable cells 
using the MACS® dead cell removal kit (Miltenyi Biotec, UK), according to manufacturer's 
instructions. Briefly, the cell pellet was resuspended in 100 !AL of dead cell removal 
microbeads for 15 minutes at room temperature. A positive selection column of type MS was 
set up in the magnetic field of a MiniMACS® Separator and rinsed with 500 1..IL of the 
supplied binding buffer. The cell-microbead mixture was subsequently mixed with 500 p.L 
of binding buffer and allowed to pass through the MS column. The effluent from the column 
was then collected as the live cell fraction. The column was further rinsed with 4 x 5004 of 
binding buffer and the additional effluent collected to ensure all viable cells are selected. 
Finally, the effluent was centrifuged at 800 rpm for 5 minutes so that the binding buffer can 
be aspirated and the resulting cell pellet was stored at —20 C for further analysis. 
Preparation of GS-NSO cell lysates 
Cell samples were retrieved from —20 C and resuspended in 125 i_tL of CelLyticTM M 
solution supplemented by 1% (v/v) protease inhibitor cocktail (both products from Sigma). 
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The solution is then incubated at room temperature on an orbital shaker for 15 minutes. 
Subsequently, the lysed cells are centrifuged at 18,000 x g for 15 minutes to pellet the cell 
debris. The protein-containing supernatant is then removed to a chilled microcentrifuge tube 
and stored at —86 C prior to gel electrophoresis and Western blot analysis. 
Total protein quantification 
The total amount of protein in each cell sample was determined using the BCATM Protein 
Assay Kit (Perbio). The quantification method was based on the reduction of the Cu2+ ion to 
Cul+ by protein in an alkaline medium. The Cul+ ion was then detected via a colorimetric 
reaction with a reagent containing BCA. The resulting intensity of the colour change (from 
pale green to purple) could then be used to determine the amount of protein present in the 
sample. Bovine serum albumin (BSA) was utilised as the known protein standard in a series 
of 8 dilutions to create a calibration curve against which the protein concentration in the 
unknown cell samples was determined. The quantification procedure is briefly described as 
follows: the protein-containing supernatant derived in the previous section was first diluted 
1:10 with deionised water. 8 dilutions of the BSA standard was then prepared in deionised 
water with concentrations ranging from 0 µg,/mL to 500 i..tg/mL. 25 µI, of each standard and 
unknown sample was pipetted into a microplate well in duplicate. 200 µL of the supplied 
working reagent (consisting of Cu2+ ions and BCA) was then added to each well, the plate 
was covered and incubated in an orbital shaking incubator at 37 C for 30 minutes. Following 
incubation, the plate was cooled to room temperature and the absorbance of each well 
measured on a microplate reader at a wavelength of 560 nm. 
Sample preparation for SDS-PAGE 
20 µg of each cellular sample as determined by the BCA protein assay, in addition to known 
concentrations of the purified cB72.3 antibody standard kindly provided by Lonza Biologics 
(UK) (ranging from 100 lig to 1000 µg) were prepared for loading onto each lane for SDS-
PAGE. The samples and standards are topped up to 20 pL with deionised water and mixed 
with 20 µL of 2 x SDS-PAGE reducing sample buffer comprising of the following: 0.125 M 
Tris-HCI, 5% SDS, 20% (v/v) glycerol, 0.2 M DTT (Dithiothreitol from VWR, UK) , 
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0.02% bromophenol blue at pH 6.8. The mixture was then heated at 100 C for 10 minutes to 
ensure that the proteins were denatured. Subsequently, the mixture was placed on ice prior to 
gel loading. 
SDS-PAGE and transfer to nitrocellulose membrane 
One-dimensional SDS-PAGE (based on the method of Laemmli, 1970) was carried out in a 
vertical mini-gel electrophoresis unit (Thermo Electron, US) at a constant voltage of 150 V 
for 65 minutes or until the bromophenol blue dye has migrated to the bottom of the gel. The 
separating gel acrylamide concentration was 10% and the size of each gel was approximately 
9 cm width x 8 cm height x 0.75 mm thick. The following solutions were used in the 
separation and stacking gels: 10% separation gel — 7.25 mL of Protogel acrylamide mixture 
(National Diagnostics, USA), 3.8 mL of 2M Tris-HC1 at pH 8.8, 0.4 mL of 10%(w/v) SDS, 
topped up to 20 mL with deionised water, stacking gel — 1.7 mL of Protogel acrylamide 
mixture, 625 ❑L of 2M Tris-HC1 at pH 6.8, 100 1.1.L of 10%(w/v) SDS, topped up to 10 mL 
with deionised water. The separation gel solution was mixed with 200 1AL of ammonium 
persulfate (APS) and 40 µL of TEMED (N, N, N', N' tetramethyl-ethylenediamine) (both 
chemicals from VWR, UK) and immediately introduced between the glass plates and 
allowed to polymerise for about 20-30 minutes. 40 JAL of APS and 30 pi of TEMED were 
then added to the stacking gel mixture prior to the solution being introduced on top of the 
polymerised separation gel. A tris-glycine based solution was used as the SDS-PAGE 
running buffer ( 14.4 g/L glycine, 3.0 g/L tris, 1.0 g/L SDS). 
Following gel electrophoresis, the gel was carefully removed from the glass plates 
and soaked in 1 x transfer buffer (14.4 g/L glycine, 3.0 g/L tris, 1.0 g/L SDS, 10% (v/v) 
methanol) for 30 minutes to allow for equilibration of the gel. The proteins on the gel were 
then transferred onto a nitrocellulose membrane (Protran, 0.45 pm pore size, Schleicher and 
Schuell, USA) following the method of Towbin et al. (1979) using the C140 Mini Blot 
Module (Thermo Electron, USA). The electro-blotter was assembled based on the 
manufacturer's instructions and filled with ice-cold 1 x transfer buffer. It was set to run at a 
constant current of 70 mA for 40 minutes. Subsequently, the blotted membrane was air-dried 
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for half a day at room temperature before being wrapped in Saran wrap and stored in a cool, 
dry place prior to Western blot analysis. 
Western blotting of heavy and light IgG polypeptide chains 
The dried nitrocellulose membrane was firstly blocked for 10 minutes in a blocking solution 
containing 10% (w/v) non-fat milk powder (Marvel non-fat milk powder, Premier 
International Foods Ltd, UK) in PBS. The blot was then allowed to react with a horseradish 
peroxidase (HRP)-conjugated goat anti-human IgG(H+L) antibody (Jackson 
Immunoresearch, USA) at a dilution of 1:4000 for 2 hours at room temperature on an orbital 
shaker. Following the incubation period, the blot was rinsed once with PBS for 5 minutes, 
washed 3 times with PBS containing 0.1% Tween for 5 minutes each and rinsed once again 
with PBS for a further 5 minutes. Excess solution was carefully blotted off using 3 MM 
chromatography paper (Whatman, UK) before the ECL chemiluminescent substrate solution, 
which reacted with the HRP molecule (Amersham Biosciences, UK), was added to the 
membrane and further incubated for 1 minute with gentle shaking. The membrane was then 
blotted dry, wrapped in Saran wrap and exposed to Kodak BioMax Light film for a period of 
time ranging from 2.5 to 30 minutes. The heavy and light polypeptide chains targeted by the 
HRP-conjugated antibody would appear as dark bands on the film. The resulting intensity of 
each band was quantified using AlphaEase FC densitometry-scanning software. 
In order to check for equal loading of protein in each lane, the blot was then stripped 
by rinsing it twice in large quantities of PBS solution containing 0.1% Tween for 15 minutes 
each . Subsequently, the blot was blocked with 10% (w/v) non-fat milk powder in PBS for 
10 minutes and re-probed with a HRP-conjugated anti-GAPDH antibody (Santa Cruz, CA, 
US) at a dilution of 1:500 for 2 hours. The blot was then washed with PBS and PBS-0.1% 
Tween solution and detected using the ECL substrate solution and Kodak BioMax film as 
described above. 
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5.2.5 Statistical analysis 
The error bars in all graphs refer to standard deviations of duplicate measurements from two 
individual experiments unless otherwise stated. Single-factor ANOVA and two-sample t-
tests (assuming unequal variance) at a significance level of p=0.05 have both been used to 
assess whether the mean values of any two samples can be considered to be significantly 
different from each other. 
5.3 	Results and analyses 
5.3.1 Total RNA behaviour with respect to time and hyperosmotic conditions 
The total RNA behaviours with respect to culture time for normal and hyperosmotic cultures 
are presented in Figure 5.1. Under both culture conditions, the total RNA appeared to be 
relatively constant during the mid-exponential phase and subsequently decreased as the 
culture progressed towards the stationary and decline phases. Hyperosmotic culture 
conditions seemed to result in a slower rate of decrease of total RNA concentration with 
respect to time. In particular, at the interface of the exponential and stationary phases, an 8% 
decrease in total RNA concentration was observed in hyperosmotic cultures, as compared to 
the 19% drop in RNA concentration observed in normal cultures. 
The total RNA concentration has also been shown as a function of specific growth 
rate in Figure 5.2. The trends in the figure indicate that a positive relationship exists between 
cell growth and the amount of intracellular RNA under both normal and hyperosmotic 
conditions. It is observed that with respect to specific growth rates, total RNA concentrations 
were relatively higher in hyperosmotic cultures than in normal cultures. This trend is similar 
to the experimental observations of Zhou [2002], whose results have been derived from 
literature and displayed in the same figure. Once again, heightened levels of RNA were seen 
under hyperosmotic culture conditions at a given specific growth rate. 
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Figure 5.1. Variation of total RNA concentration at different culture time points for normal 
and hyperosmotic condition cultures. 
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Figure 5.2. Relationships between total RNA concentrations and specific growth rates for 
both GS-NSO cultures and hybridoma (HB) cells from experimental data derived from Zhou 
[2000J. Dotted lines represent the lines of best fit for each data set. 
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5.3.2 Heavy and light mRNA trends under normal and hyperosmotic conditions 
Linearity of integrated intensity values 
It is essential to first establish a relationship between the hybridisation signals of the heavy 
and light chain probes obtained from densitometry analysis and the amount of mRNA 
present on the blot before the densitometric value of each band on the blot can be compared. 
This relationship was determined by loading different known amounts of total RNA from a 
single sample onto a gel, and subsequently hybridising the membrane onto which the RNA 
was transferred. The bands on the membrane were then probed with the specific probe for 
either the heavy mRNA species or the light mRNA species and subsequently quantified 
using densitometry scanning, which calculated the integrated density value (IDV). Figures 
5.3 a (heavy mRNA probe used) and 5.4 a (light mRNA probe used) show examples of the 
bands present on the Northern blots onto which total RNA amounts ranging from 1 to 12.5 
j.tg, extracted from cells in the mid-exponential phase of a culture under normal conditions, 
were loaded. From Figures 5.3 b and 5.4 b, it can be observed that in both cases, within the 
range of intensity values, a linear relationship existed between the IDV and the total amount 
of RNA loaded for both the heavy and light mRNA probes. It is therefore possible to use the 
IDVs to determine and compare the relative amounts of mRNA present in each band, 
provided the IDV fall within the linear range studied. 
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Figure 5.3. (a) Examples of two separate Northern blots probed with the specific heavy 
mRNA probe for total RNA concentrations ranging from 1 to 12.5 pg and (b) the linear 
relationships between the integrated density values obtained from densitornetry scanning 
and total RNA (in pg) loaded on each lane of the gel using specific heavy mRNA probe. 
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Figure 5.4. (a) Examples of two separate Northern blots probed with the specific light mRNA 
probe for total RNA concentrations ranging from 1 to 12.5 deg and (b) the linear 
relationships between the integrated density values obtained from densitometry scanning 
and total RNA (in jig) loaded on each lane of the gel using specific light mRNA probe. 
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Heavy and light mRNA behaviour under different osmotic conditions 
The variations in heavy and light mRNA concentrations under normal and hyperosmotic 
conditions as a function of culture time are shown in Figures 5.5 and 5.6. Figures 5.5 a to 5.5 
d represent the mRNA trends per i.tg of total RNA. It can be observed that in all four cases, 
the relative heavy and light mRNA concentrations per Hz of RNA increased with respect to 
time until the decline phase of the culture, at which point the relative mRNA concentrations 
decreased. This indicated that the proportion of heavy and light mRNA in total RNA 
increased as the culture progressed, which in turn suggested that the heavy and light mRNA 
molecules were more stable compared to other mRNA species in the cell up till the 
stationary phase of the culture. 
In Figures 5.6 a and 5.6 b, the mRNA values were determined on a per cell basis 
relative to the heavy or light mRNA concentration in the mid-exponential phase. In this 
representation, the decline in the amount of total RNA as the culture progressed 
counterbalanced the increases in the proportions of heavy and light mRNA molecules, 
resulting in fairly constant mRNA values until marked decreases of approximately 25 to 35% 
were observed in the early decline phase of the cultures. The trends are similar in both 
normal and hyperosmotic cultures. 
Figures 5.7 a and 5.7 b show a comparison between the values for heavy and light 
mRNA species on a per cell basis for normal and hyperosmotic conditions at different 
culture phases. The mRNA values shown were relative to the heavy and light mRNA 
amounts at mid-exponential phase for normal osmotic cultures. It can be seen that there were 
comparatively higher concentrations of both heavy and light mRNA molecules in 
hyperosmotic cultures. Both the single-factor ANOVA and t-test analyses conducted at a 
significance level of 0.05 indicated that the relative mean heavy and light mRNA values for 
hyperosmotic cultures were significantly different from the mean mRNA values under 
normal culture conditions (with p<0.05). The ratio of mRNA values in hyperosmotic 
cultures and mRNA concentration in normal osmotic cultures remained relatively constant 
throughout the different culture phases, fluctuating between values of 1.5 and 1.7 for both 
heavy and light species. 
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Figure 5.5. Relative mRNA amounts per jig of total RNA with respect to culture time 
(duplicate measurements from duplicate cultures) for (a) heavy mRNA species at normal 
osmotic and (b) hyperosmotic culture conditions as well as (c) light mRNA species at normal 
osmotic and (d) hyperosmotic conditions. Dotted lines represent the curves of best fit, with 
the R2 value giving an indication of how good the fit is (R2 values range from 0 to 1, with a 
larger value indicating a better fit). 
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Figure 5.6. Relative mRNA amounts per cell with respect to culture time (from duplicate 
cultures) for (a) heavy mRNA species at normal osmotic and hyperosmotic culture 
conditions as well as (b) light mRNA species at normal osmotic and hyperosmotic 
conditions. Dotted lines represent the curves of best fit. 
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Culture phase 
Figure 5.7. Relative mRNA amounts per cell with respect to culture time (from duplicate 
cultures) normalised by the mRNA concentration at mid-exponential phase (290 mOsm/kg 
cultures) for (a) heavy and (b) light mRNA species at different osmotic conditions. 
(* denotes values of p < 0.05 for both single-factor ANOVA and t-test analysis, indicating 
that the differences in the normal and hyperosmotic values are likely to be significant .) 
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Heavy and light mRNA behaviour with respect to growth and antibody productivity 
The relationships between heavy and light mRNA concentrations and the specific growth 
and antibody productivity are presented in Figures 5.8 and 5.9 respectively. In Figures 5.8 a 
and 5.8 b, a positive relationship was discerned between mRNA concentrations and cell 
growth. The figures also indicate almost parallel mRNA-cell growth relationships existed 
under normal and hyperosmotic conditions — for a given specific growth rate, the mRNA 
levels were found to be comparatively higher in hyperosmotic cultures. The heightened 
mRNA levels may be attributed to either a rise in mRNA transcription rates or an 
improvement in the stability of mRNA species at hyperosmotic conditions. 
In Figures 5.9 a and 5.9 b, the relationships between heavy and light mRNA levels 
and the antibody productivity are analysed. It was found that mRNA levels show a positive 
correlation with the specific antibody productivity, reinforcing the findings from the global 
sensitivity analysis (GSA) conducted in Chapter 3, which identified both the transcription 
rates and mRNA half-lives as key influences on antibody production rates. Additionally, the 
relative mRNA levels at normal and hyperosmotic conditions appear to lie on the same 
curve, suggesting that the improved specific antibody productivities due to hyperosmolarity 
might be attributed to increases in mRNA levels. 
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Figure 5.8. Relationships between the relative (a) heavy and (b) light mRNA concentration 
per cell with specific growth rates under normal and hyperosmotic culture conditions. 
Dotted lines represent the approximated linear relationships between the variables. 
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5.3.3 Degradation rates of heavy and light mRNA at different culture phases 
Control ethanol cultures 
The anti-transcription agent DRB, dissolved in ethanol, is used to inhibit transcriptional 
processes in the cell cultures. Prior to evaluation of the heavy and light mRNA degradation 
rates, ethanol was added to control cultures under normal and hyperosmotic culture 
conditions at the mid-exponential phase. Theses control cultures allowed us to ascertain that 
ethanol did not affect the degradation of mRNA molecules in any way. Samples were 
extracted from these control cultures at 0, 4, 8 and 12 hours after the addition of ethanol for 
cell number and mRNA levels analysis. Figure 5.10 a shows the viable cell concentrations of 
the control cultures, while the heavy and light mRNA integral intensity values, which were 
normalised to the intensities of the 18 S gene, as a function of time is presented in Figures 
5.10 b and 5.10 c. It can be observed that no sudden drop in viable cell number was visible; 
although the number of viable cells in the hyperosmotic control cultures decreased slightly at 
12 hours from 2.6 x 105 cells/mL to approximately 2.2 x 105 cells/mL. Similarly, the integral 
intensity values remained relatively constant for all cultures; however, at 12 hours after 
ethanol addition, apart from the heavy mRNA levels at 290 mOsm/kg, distinct decreases in 
the intensity values can be seen in the mRNA levels under both osmotic conditions (Figures 
5.10 b and 5.10c). These results suggest that the effects of ethanol on heavy and light mRNA 
degradation were negligible up to a time point between 8 to 12 hours and indicate that the 
half-lives experiments should be completed in less than 12 hours after the addition of DRB 
dissolved in ethanol. 
Half-lives determination of heavy and light IgG mRNA molecules 
The half-lives of heavy and light IgG mRNA molecules were determined by conducting 
duplicate shake flask experiments at normal and hyperosmotic culture conditions. At the 
mid-exponential and stationary phases, 65 1.1,M of DRB dissolved in ethanol was added to 
each culture to inhibit the transcription process. Samples were then collected at different 
time points to capture the degradation behaviour of the heavy and light mRNA molecules. 
For both normal and hyperosmotic cultures disrupted at the mid-exponential phase, cell 
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samples were collected at 0, 3, 7 and 10 hours following the addition of DRB. At the 
stationary phase, the cells were collected at 0, 3, 6 and 9 hours after the addition of DRB for 
normal osmotic cultures while for hyperosmotic cultures, cells were collected at 0, 2, 5 and 8 
hours. All samples were run in duplicate on Northern blots and the IDV obtained were 
normalised according to the 18 S gene staining intensity. The intensity values in each case 
are presented in Figures 5.11 a and 5.11 b (mid-exponential phase) and 5.12 a and 5.12 b 
(stationary phase). As observed from the figures, a linear relationship could be approximated 
for each case and the half-lives were subsequently estimated using these linear relationships. 
The half-lives of heavy and light mRNA molecules at mid-exponential phase were 
determined as 13.1 ± 2.1 hrs and 12.1 ± 1.5 hrs respectively for normal osmotic cultures. 
Hyperosmotic cultures appear to show faster mRNA degradation rates, with the half-lives of 
heavy and light mRNA species estimated at 9.0 ± 1.1 hrs and 9.0 ± 0.5 hrs respectively at the 
mid-exponential phase. In the stationary culture phase, the stability of the mRNA molecules 
is observed to have decreased for both normal and hyperosmotic cultures. Heavy and light 
mRNA molecules half-lives were derived as 8.5 ± 0.9 hrs and 8.2 ± 0.9 hrs respectively for 
normal osmotic cultures and determined as 6.6 ± 0.7 hrs and 5.9 ± 0.6 hrs respectively for 
hyperosmotic cultures. These values were compared using the both the single-factor 
ANOVA and unpaired two-tailed t-test at a significance level of 0.05, in order to identify any 
significant differences in the half-lives values with respect to mRNA species and culture 
conditions. A significance level of 0.05 was used to indicate how similar two sets of values 
are to each other. Table 5.1 summarises the p values for the various test sets carried out. 
From the table, the differences between heavy and light mRNA half-lives at the same culture 
phase and similar osmotic conditions were relatively insignificant (p > 0.05). However, the 
half-life values of both heavy and light mRNA at normal osmotic conditions were 
significantly different from the heavy and light mRNA half-lives at hyperosmotic cultures. 
Similarly, between culture phases, heavy and light mRNA half-lives were determined to be 
significantly different. These observations imply that hyperosmotic culture conditions did 
not lead to improved stabilities of the heavy and light mRNA species; instead, 
hyperosmolarity resulted in a higher rate of degradation of IgG mRNA species. 
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Similarity of means between different ANOVA t-test 
species/culture phases p value p value 
Mid-exponential Phase 
H and L mRNA (290) 0.50 0.50 
H and L mRNA (450) 0.88 0.88 
H mRNA (290 and 450) 7.0x10-3  0.02 
L mRNA (290 and 450) 0.02 0.02 
Stationary Phase 
H and L mRNA (290) 0.62 0.62 
H and L mRNA (450) 0.22 0.22 
H mRNA (290 and 450) 7.0x10-3  0.01 
L mRNA (290 and 450) 0.01 0.01 
Comparison Between Phases 
H mRNA (290) 4.3x10-3  6.6x10-3  
L mRNA (290) 7.5x10-3  0.02 
H mRNA (450) 3.7x10-4 4.0x 104  
L mRNA (450) 9.9x10-3  0.01 
Table 5.1. Summary of p values for single-factor ANOVA and two-tailed t-tests for 
comparison of the similarity between means from various pairs of half-life data. (p < 0.05 
indicate that the means of both species under analysis are significantly different.) 
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5.3.4 Total protein behaviour with respect to culture time and hyperosmolarity 
In Figure 5.13 a and 5.13 b, total cellular protein trends at normal and hyperosmotic 
conditions with respect to time and specific growth rate are presented. While some 
variability exist in the experimental data obtained, a general decrease in total protein 
concentration as the culture progressed to the stationary and early decline phases could be 
deduced (Figure 5.13 a). This observation is corroborated by the trend shown in Figure 5.13 
b, where total protein concentration declined following a decrease in the specific growth rate. 
The differences in total protein concentration with respect to hyperosmotic conditions were 
not particularly distinguishable — in Figure 5.13 a, there was a significant difference in total 
protein concentration between normal and hyperosmotic cultures only at 3 time-points. In 
Figure 5.13 b, particularly at specific growth rates less than 0.015 hf', the total protein 
concentration at both osmotic conditions appear to overlap, suggesting that for GS-NSO 
cells, hyperosmotic conditions did not result in a significant increase in overall protein 
synthesis. 
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Time (hrs) 
Figure 5.13. Total cellular protein concentration at normal and hyperosmotic conditions 
with respect to (a) culture time and (b) specific growth rates. (* denotes p<0.05, indicating 
that the difference in normal and hyperosmotic protein concentration is statistically 
significant) Dotted line represents curve of best fit for the experimental data. 
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5.3.5 Heavy and light polypeptide chains behaviour in GS-NSO cells 
Linearity of integrated intensity values 
Prior to the quantitative analysis of IgG polypeptide chain concentrations, a relationship had 
to be established between the integrated density value (IDV) and known concentrations of 
heavy and light chains. Known amounts of the cB72.3 antibody ranging from 100 to 800 
ng/lane were processed through gel electrophoresis under reducing conditions and blotted 
with the HRP-conjugated anti-IgG (H+L) antibody capable of both heavy and light chain 
detection. Examples of the standard curves for heavy and light IgG polypeptides, together 
with the bands detected through Western blotting are shown in Figure 5.14 a and 5.14 b. The 
heavy and light chain amounts in Figure 5.14 b were calculated based on the following 
formula: 
2 x Amt H2 L2 (g)xMW,(daltons)  
Amt i chains (g)= 
MWH2L2 (daltons) 
(5.1) 
where i = heavy (H) or light (L) chain species, H2L2 refers to the number of 
completely assembled IgG molecule and MW is the molecular weight of each species in 
daltons. The above formula is based on the fact that two heavy and two light polypeptide 
chain molecules are used in the assembly of a complete IgG molecule. 
The standard curves in Figure 5.14 b indicate that linear relationships between the 
IDV and heavy and light chain amounts could be approximated over the given range of 
density values. The amount of heavy and light chains in an unknown sample (obtained from 
the mid-exponential phase of a normal-condition culture) processed on the same blot could 
therefore be quantified by comparing the IDVs of the unknown sample to the standard 
curves. A standard curve for the equal loading standard, GAPDH, was also derived by 
loading 10 to 60 ng of total protein onto individual lanes and subsequently blotting with an 
HRP-conjugated anti-GAPDH antibody (Figure 5.14 c). The linear relationship between 
GAPDH IDV and sample concentration in Figure 5.14 d shows that GAPDH density values 
could be used to normalise the IDVs obtained from heavy and light chain bands. 
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Figure 5.14. (a) Western blot bands depicting known concentrations of heavy and light 
polypeptide chains in each lane (equivalent to 100 ng — 800 ng cB72.3 antibody standard) 
and (b) the corresponding standard curves obtained by quantifying the bands using 
densitometric methods. (c) Western blot bands depicting 10 to 60 ,ag of the same cell sample 
and (d) the corresponding curve relating the IDV to the amount of sample loaded onto each 
lane. Dotted lines represent the approximate linear relationships between the IDV and 
amount of polypeptide chains or loaded sample. Note that reducing conditions were used for 
all Western blots obtained. 
161 
CHAPTER 5. HYPEROSMOTIC EFFECTS ON GROWTH, METABOLISM AND IgG PRODUCTION 
Heavy and light chain behaviour with respect to culture time and hyperosmolarity 
The total intracellular heavy and light polypeptide chain concentrations were analysed on a 
daily basis for both normal and hyperosmotic culture conditions until the early decline phase 
of the culture. The resulting trends are displayed in Figures 5.15 a and 5.15 b. A couple of 
key points can be inferred from these figures: firstly, there seemed to be a higher 
concentration of light chains in comparison to heavy chains throughout the culture under 
both osmotic conditions. Secondly, the heavy and light chain trends with respect to time 
appeared to mirror the specific antibody productivity trends for both normal and 
hyperosmotic conditions. This implies that antibody productivity was likely to be dependent 
on the IgG polypeptide concentrations in the cell. The relationship between specific 
productivity and polypeptide chain concentrations will be further analysed in the next 
section. 
The variation in heavy and light chains with respect to normal and hyperosmotic 
conditions is presented in Figures 5.16 a and 5.16 b. At 24 hours, the heavy polypeptide 
chain concentration appeared to be slightly higher in normal cultures compared to 
hyperosmotic cultures while the light chain concentrations seemed to be comparable. 
Beyond 24 hours, however, the heavy and light chains quantities under hyperosmotic 
conditions became larger in comparison to normal culture conditions. The trends can be 
explained by the fact that the hyperosmotic cultures were in the lag phase at 24 hours, during 
which there was comparatively little antibody production, while cells under normal culture 
conditions were already in the exponential growth phase and actively producing the antibody 
product. Subsequently, the hyperosmotic culture entered the exponential growth phase, 
thereby stimulating the antibody synthesis process and resulting in the increase of heavy and 
light chain concentrations. Another key observation was that the light chain concentrations 
appeared to show a relatively larger increase at hyperosmotic conditions as compared to the 
heavy chain concentrations, suggesting that light chain synthesis could have been more 
preferentially enhanced than heavy chain synthesis with respect to total protein synthesis 
rates. This possibility will be further discussed in Section 5.4. 
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Figure 5.15. Heavy and light chain polypeptide trends with the corresponding time-
dependent specific antibody productivity behaviour at (a) normal and (b) hyperosmotic 
culture conditions. 
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Figure 5.16. Relative concentrations of (a) heavy and (b) light polypeptide chains at normal 
and hyperosmotic conditions normalised to the polypeptide chain concentrations at 24 hours 
in normal osmotic cultures.(* denotes p<0.05, based on both ANOVA and t-tests, indicating 
that the polypeptide chain concentrations for normal and hyperosmotic cultures at a 
particular time point are significantly different from each other.) 
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Heavy and light chain behaviour with respect to growth and antibody productivity 
The heavy and light chain trends with respect to specific growth rate and specific 
productivity has been ascertained in Figures 5.17 and 5.18. In Figures 5.17 a and 5.17 b, 
positive relationships are seen between polypeptide chain concentrations and the specific 
growth rate. While the heavy chain concentrations were only slightly elevated at 
hyperosmotic conditions with respect to specific growth rate, the increase in light chain 
concentrations as more distinct, once again suggesting that overall synthesis of light chains 
was more elevated under hyperosmotic conditions than heavy chains. Figures 5.18 a and 
5.18 b indicate that a positive relationship existed between polypeptide chain concentrations 
and specific antibody productivity, confirming the observations made in the previous section 
regarding the similarity between the polypeptide chain trends and the specific antibody 
productivity trends. The positive association between these two variables implies that IgG 
translation rates are likely to be a key determinant of antibody production rates throughout 
the culture duration. In addition, it is observed that the polypeptide concentrations derived 
from normal and hyperosmotic cells appeared to lie on the same curve, indicating that the 
same correlation can be used to describe the heavy and light chain behaviour with specific 
productivity under both osmotic conditions. 
165 
N
o.
  o
f H
 p
ol
yp
ep
ti
de
  c
ha
in
s  
/ c
el
l 
CHAPTER 5. HYPEROSMOTIC EFFECTS ON GROWTH, METABOLISM AND IgG PRODUCTION 
I 	 I 	 1 
0.000 	0.005 0.010 0.015 
specific growth rate, µ (he) 
$ 	I 	I 	I 
0.000 0.005 0.010 0.015 
specific growth rate, g (hr') 
(b) 1.2x10°  
toxioe 
• 8.0x107 - 
.0 
O 
6.0x107 - 
0. 
a 4.0x107 - 
"a 
6 2.0x10' - 
Z 
0.0 
0.020 
0.020 
Figure 5.17. Relationships between (a) heavy and (b) light polypeptide chain concentrations 
and the specific growth rate under normal and hyperosmotic conditions. Dotted lines refer to 
best fit curves for each data set. 
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Figure 5.18. Relationships between (a) heavy and (b) light polypeptide chain concentrations 
and the specific antibody productivity under normal and hyperosmotic conditions. Dotted 
lines refer to best fit curves for each data set. 
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5.3.6 Estimation of parameters from experimental study 
One of the key aims of the intracellular study of mRNA and polypeptide chains trends under 
normal and hyperosmotic conditions is to derive estimates for the key parameters identified 
by the global sensitivity analysis (GSA), as described in Chapter 3. The key parameters 
included the specific transcription and translation rates for heavy and light chain species, as 
well as the half-lives of heavy and light mRNA molecules. The half-life values already have 
been derived by Northern blot analysis in Section 5.3.3 previously. In this section, the 
estimation of the specific transcription and translation rates will be discussed. 
Determination of specific transcription rates 
The accumulation of heavy and light mRNA molecules in the cell is dependent on three key 
factors: the specific transcription rate, the mRNA degradation rate, as well as the dilution by 
growth term, as shown by Equations (3.11) and (3.12) from Chapter 3. The general form of 
the equation is shown below: 
dm, 
= S,-k,m,-,u m, 	 (5.1) 
where i refers to heavy or light mRNA species, m, represents the mRNA concentration, S, is 
the specific transcription rate of mRNA and k, refers to the mRNA degradation rate. 
The mRNA degradation rates (k) are derived from the mRNA half-lives (tyz ,) using 
the following expression: 
k
ln 2 = 
t1/2,1 
By rearranging equation (5.1), an expression for the specific transcription rate can be 
obtained: 
dm.  
S 	k m + ,u m 
dt " 
(5.3) 
In a previous study on hybridoma cells conducted by Lee and Lee [2000], the 
authors had estimated the specific transcription rates for heavy and light mRNA species, 
based on the assumption that mRNA concentrations remain relatively constant during the 
mid-exponential culture phase. This assumption appeared to be valid for GS-NSO cells, 
dt 
(5.2) 
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based on the experimental mRNA trends shown in Figures 5.6 a and 5.6 b. As a result, the 
accumulation term, 
dm , could therefore be ignored at the mid-exponential culture phase. 
dt 
Estimates of the specific transcription rates (S1 ) of mRNA molecules under normal and 
hyperosmotic conditions were thus determined by the simplified version of Equation 5.3: 
S, = k,m, +,u m, 	 (5.4) 
As only the relative amounts of mRNA molecules was determined in the 
experimental study, typical values for actual heavy and light mRNA concentrations during 
the mid-exponential phase were obtained from a study on myeloma cells conducted by 
Wallach and Laskov [1980]. Heavy mRNA concentration was assumed to be 2.0 x 104 
molecules per cell while light mRNA concentration was 3.0 x 104 molecules per cell. The 
relative mRNA values at normal and hyperosmotic conditions were derived from Figures 5.7 
a and 5.7 b, while the mRNA degradation rates were calculated from the half-life values 
reported in Section 5.3.3. The resulting estimated specific transcription rates are shown in 
Table 5.2, where it can be deduced that hyperosmotic conditions of 450 mOsm/kg resulted in 
approximately a one-fold increase in both heavy and light mRNA transcription rates. 
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Transcription rates 	 Heavy mRNA 	Light mRNA 
Normal (290 mOsm/kg) 	 1450 	 2300 
Hyperosmotic (450 mOsm/kg) 	 3000 	 4360 
Ratio [(450 mOsm/kg)/(290 mOsm/kg)] 	2.07 	 1.89 
Table 5.2. Estimated specific transcription rates for heavy and light mRNA molecules at 
normal and hyperosmotic culture conditions (3 significant figures). 
Culture phase TH (290) TH (450) 
Ratio TH 
(450/290) 
TL (290) TL (450) 
Ratio TL 
(450/290) 
Mid-exponential 491 575 1.17 320 421 1.31 
Stationary 364 392 1.08 234 263 1.13 
Early decline 338 337 1.00 212 229 1.08 
Table 5.3. Estimated specific translation rates for heavy and light polypeptide molecules at 
normal and hyperosmotic culture conditions (3 significant figures). 
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A rearrangement of equation 5.6 results in the following: 
d[H]total THmH = 
dt 
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Estimation of specific translation rates 
The estimation of specific translation rates is not as straightforward as the specific 
transcription rates derivation, due to the fact that specific translation rates do not remain 
constant throughout the culture. Consequently, these rates had to be calculated at each time 
point. In the experimental study, the measurement of total heavy and light polypeptide chains 
included not just the free heavy and light chains, but also the heavy and light chains found in 
the partially formed ([HL]) and fully formed intracellular antibody ([H2L2]) molecules. As a 
result, an intracellular mass balance for the total amount of heavy chains can be written as 
follows: 
d[H]total d[1-1] + 4.1-1L1 + 2 d[H2 L2 ]ER + 2 d [112.LdG 
	
dt 	dt 	dt 	dt 	 dt 
(1) 	(2) 	(3) (4) (5) 
Briefly, the above equation states that rate of accumulation of total intracellular 
heavy polypeptide chains (1), is given by the summation of the accumulation rates of free 
heavy chains (2), the intermediate HL (3), and the fully formed H2L2 molecules in the 
endoplasmic reticulum (ER) (4) and the Golgi complex (G) (5). The coefficient '2' is applied 
to the H2L2 concentration terms as each H2L2 molecule contains two heavy chains. 
By combining equations (3.14), (3.16), (3.21), (3.23) and (3.25) from Chapter 3, and 
subsequently substituting unknown variables with measured quantities (the full derivation is 
given in Appendix B), the following expression is then obtained: 
d[H]total  = TH mH — p[H]lotal 2qAb dt 
(5.5) 
(5.6) 
where TH refers to the heavy chain specific translation rate, ,u is the specific growth rate and 
qAb represents the specific antibody productivity; where qAb has units of 
[molecules/(cell.hr)]. A similar mass balance can be derived for describing the variation of 
the light polypeptide chain concentrations with time. 
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From equation 5.7, it can be noted that the translation rate term (TN mH ) actually 
consists of two factors: the heavy chain specific translation rate and the heavy mRNA 
concentration. Using the mRNA values obtained in the study, the specific translation rates at 
various culture phases were estimated for normal and hyperosmotic conditions. A summary 
of these rates can be found in Table 5.3. It is observed that the specific translation rates for 
both heavy and light chains were higher at the mid-exponential phase of hyperosmotic 
cultures in comparison to normal osmotic cultures. However, the difference between normal 
and hyperosmotic specific translation rates was not sustained as the cultures approached the 
late-exponential and stationary culture phases. Another key observation from Table 5.3 to be 
noted is that the heavy chain specific translation rates were actually higher than the light 
chain specific translation rates, despite the larger intracellular pool of light chains under both 
normal and hyperosmotic conditions. It appears that the relatively higher light chain 
concentration compared to the concentration of heavy chains could be mainly attributed to 
the larger number of light mRNA molecules present in the cell. 
5.4 	Discussion 
The aim of this chapter was two-fold: firstly, to study the behaviour of intracellular mRNA 
and polypeptide chain concentrations with respect to time under normal and hyperosmotic 
culture conditions, as well as to evaluate their relevance to antibody production rates. 
Secondly, the experimental results obtained have enabled estimates of the key parameters, 
previously identified through a GSA of the hybrid antibody production model, to be derived. 
Based on the experimental results, it was determined that hyperosmotic cells possessed 
higher levels of heavy and light mRNA molecules due to elevated specific transcription 
rates, which subsequently led to improved specific antibody productivities. A more detailed 
discussion on the findings is provided in the next few sub-sections. 
Total RNA trends under normal and hyperosmotic conditions 
The variation of total RNA concentration with respect to medium osmolarity had been 
studied in the past, with the general observation that hyperosmotic conditions tended to lead 
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to an increase the total cellular RNA content [Lee and Lee, 2000; Oh et al., 1995; Sun et al., 
2004]. The results obtained from this study were in agreement with this trend, suggesting 
that an increase in RNA synthesis appeared to have occurred under hyperosmotic conditions. 
A possible reason for the higher RNA concentrations at hyperosmotic conditions had been 
proposed by Oh et al. [1995; 1993], who suggested that an increase in the available pool of 
"RNA building blocks" occurred under hyperosmotic conditions, thereby leading to higher 
RNA synthesis rates. The larger available pool of "building blocks", in turn, might have been 
a result of the increased uptake rates of nutrients observed under hyperosmotic conditions. 
Influence of mRNA stability on IgG mRNA behaviour over culture time 
The variation of IgG mRNA levels with respect to time could either be expressed per ❑  g of 
total RNA or per cell. In particular, the former approach gave an indication of the relative 
proportions of heavy and light mRNA molecules in total RNA with respect to culture time. 
Using this approach, the proportions of heavy and light mRNA levels in total RNA were 
observed to increase as the culture progressed until the stationary culture phase, indicating 
that IgG mRNA molecules might be relatively more stable than other mRNA species over 
this culture period, despite the observed decrease in their half-lives under both normal (from 
12.6 hrs to 8.4 hours) and hyperosmotic (9.0 hrs to 6.3 hrs) conditions. These findings agree 
with the mRNA trends reported by Bibila [1991], who also suggested that there might be a 
"preferential destabilisation" of non-IgG mRNA species as cultures progressed towards the 
stationary phase. In a study on MPC-11 cells, Schibler et al. [1978] also deduced that the 
heavy and light immunoglobulin mRNA species had relatively lower turnover rates when 
compared to other mRNA species. However, beyond the stationary phase, it appears that 
further decreases in the IgG mRNA half-lives must have occurred, eventually resulting in 
reductions of IgG mRNA proportions in total RNA in the decline phase. These observations 
highlight the importance of the heavy and light mRNA degradation rates in governing the 
variations in mRNA levels with respect to culture time, particularly in the stationary and 
decline phases. They also suggest that IgG mRNA degradation rates might exert an indirect 
influence on antibody production rates, through changes in the IgG mRNA levels. The next 
sub-section will thus focus on the major role that IgG mRNA levels play in the determination 
of specific antibody productivities throughout the duration of the culture. 
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Relationship between IgG mRNA levels and specific antibody productivity 
The relationship between heavy and light mRNA levels with respect to specific antibody 
productivity has been a source of interest in previous studies, mainly conducted on 
hybridoma cells. However, there appears to be no general consensus regarding this 
relationship. Leno et al. [1992] noted that specific antibody productivity began to decrease 
during the mid-exponential phase despite increasing mRNA levels. The study found no real 
correlation between mRNA levels and productivity and it was conjectured that the regulation 
of specific antibody productivity occurred at a post-transcriptional stage of the production 
process. Sun et al. [2004] also mentioned that the changes in IgG mRNA levels did not 
match the changes in antibody production rates under both normal and hyperosmotic 
conditions. However, Lee and Lee [2000] found that the increase in specific productivity due 
to hyperosomlarity was likely to be a result of an increase in specific IgG transcripton rates, 
which had directly increased the heavy and light mRNA levels. In this study, a direct 
relationship was observed between mRNA levels and antibody productivity over the entire 
course of the culture, indicating that the factors influencing mRNA concentrations, including 
the specific transcription and mRNA degradation rates, played key roles in the determination 
of antibody production rates at all times. These observations are in agreement with the 
findings of the global sensitivity analysis (GSA) previously described in Chapter 3, which 
had shown that both the individual and total sensitivity indices (SI) of the specific 
transcription rates remain high throughout the culture, highlighting its perennial importance 
to antibody production. Additionally, the total SI values for IgG mRNA half-lives 
approximately doubled as the culture progresses from the mid-exponential to the stationary 
phase, which was a reflection of its growing influence on the antibody production process. 
Furthermore, the experimental study results showed that the same linear correlation between 
specific antibody productivity and mRNA levels could be applied for both normal and 
hyperosmotic conditions, thereby suggesting that the higher specific antibody productivities 
at hyperosmotic conditions could be attributed, at least in part, to the observed increases in 
heavy and light mRNA levels resulting from elevated transcription rates. This hypothesis is 
further discussed in the next sub-section, which considers the two factors governing 
intracellular mRNA levels under varying osmotic conditions. 
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Evidence of elevated transcription rates at hyperosmotic conditions 
Based on the mass balance expressions describing the rate of accumulation of heavy and 
light mRNA molecules in the cell, it can be deduced that the two main determinants of 
mRNA levels are: (i) the specific mRNA transcription rate and (ii) the mRNA degradation 
rate. An increase in mRNA levels, therefore, can be attributed to either an increase in the 
specific transcription rate, or a decrease in the mRNA degradation rate, as reflected by a 
longer mRNA half-life. 
However, results from the mRNA degradation experiments conducted in this study 
have shown that the half-lives of heavy and light mRNA molecules were distinctly shorter 
for cells cultured under hyperosmotic conditions (— 9.0 hrs at mid-exponential and 6.2 hrs at 
stationary phase) when compared to normal-condition cells (-12.6 hrs at mid-exponential 
and 8.4 hrs at stationary phase). These findings imply that hyperosmotic conditions actually 
resulted in a destabilisation of mRNA molecules, making them more susceptible to mRNA 
degradation in comparison to normal osmotic conditions. Consequently, it is highly likely 
that the specific transcription rates of heavy and light mRNA molecules were elevated due to 
hyperosmolarity. The subsequent parameter estimation conducted in Section 5.3.4 showed 
that there was indeed an approximate one-fold increase in the specific transcription rates of 
both heavy and light mRNA molecules under hyperosmotic culture conditions. Similar 
observations had been made by Lee and Lee [2000], who reported a 37% decrease in half-
lives of heavy and light mRNA molecules when osmolarity was increased from 285 to 425 
mOsm/kg. The authors subsequently deduced that the transcription rates of heavy and light 
mRNA were significantly increased (by more than 400%) due to the rise in medium 
osmolarity. 
It should also be noted that the estimated heavy (1450 molecules/(cell.hr)) and light 
mRNA (2300 molecules/(cell.hr)) transcription rates for normal osmotic cultures were 
comparable to values previously reported in literature. In a study using a myeloma cell line 
[Wallach and Laskov, 1980], the heavy and light mRNA transcription rates were determined 
to be 1020 molecules/(cell.hr) and 1440 molecules/(cell.hr) respectively. Schibler et al. 
[1978] also reported that the immunoglobulin mRNA transcription rates ranged from 20 to 
60 molecules/min (1200 to 3600 molecules/(cell.hr)) for MPC-11 cells. The 2-fold increase 
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in IgG mRNA transcription rates under hyperosmotic conditions was less than the 400% 
increase reported by Lee and Lee [2000] in hybridoma cells, suggesting that the extent of 
transcription rates enhancement was probably cell-line specific. However, the hyperosmotic 
trancription rates estimated from this study were still within the physiological range derived 
from previous literature studies [Bibila, 1991; Schibler et al., 1978; Wallach and Laskov, 
1980]. 
Total protein behaviour and cellular energy levels 
Total protein concentration has been shown to vary positively with specific growth rates in 
cultures operating under both normal and hyperosmotic conditions. However, no distinct 
differences in the protein concentration could be discernable between normal and 
hyperosmotic cultures with respect to specific growth rates. This behaviour may be 
explained by the fact that protein synthesis is known to be an energy-intensive process 
[Bolster et al., 2002; Hucul et al., 1985]. As such, the total protein concentration is likely to 
be dependent on the availability of ATP in the cell. However, in this study, ATP levels had 
not been significantly elevated by hyperosmotic conditions, despite an increase in glucose 
uptake rates throughout the exponential phase. Although hyperosmotic conditions tend to 
increase the intracellular accumulation of amino acids and thus providing additional 
"building blocks" for protein synthesis [Oh et al., 1993, 1995], the relatively similar energy 
levels available in the cell under both osmotic conditions could have limited any possible 
increase in total protein levels. 
Behaviour of heavy and light polypeptide chains in normal and hyperosmotic cultures 
Having deduced that total protein concentrations are not elevated at hyperosmotic culture 
conditions, the behaviour of heavy and light polypeptide chain trends under normal and 
hyperosmotic conditions is subsequently analysed. Experimental results indicated that the 
concentrations of the IgG polypeptide chains were relatively higher at hyperosmotic 
conditions. Additionally, an abundance of light polypeptide chains in comparison to heavy 
polypeptide chains could be found in GS-NSO cells under both osmotic conditions. This 
observation is in agreement with other studies on immunoglobulin production in mammalian 
cells [Laskov and Scharff, 1974; Whicher et al., 1987], which all reported an excess of IgG 
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light chain production in animal cells. A reason for this trend had been proposed by Schlatter 
et al. [Schlatter et al., 2005], who noted that excess light chains were required to minimise 
the accumulation of unfolded heavy chain polypeptides and increase the rate of antibody 
folding in the endoplasmic reticulum. This hypothesis is supported by findings from previous 
studies, which stated that light chains were necessary for the release of unfolded heavy 
chains from the immunoglobulin binding protein (BiP) and subsequently for facilitation of 
its folding process [Kaloff and Haas, 1995; Lee et al., 1999; Leitzgen et al., 1997]. 
Another important point to note is that positive relationships exist between the IgG 
polypeptide chain concentrations and the specific antibody productivities for both normal 
and hyperosmotic cultures. The fact that the same correlation could be deduced between the 
two variables under both osmotic conditions imply that the increase in polypeptide chain 
concentrations was likely to be responsible, at least in part, for the increase in antibody 
productivity at hyperosmotic conditions. Subsequently, estimates of the heavy and light 
chain specific translation rates were derived experimentally. The values were then used to 
determine whether the increase in antibody productivity could be attributed to improved 
specific translation rates. The resulting analysis reveals two interesting points: firstly, it is 
found that the heavy chain specific translation rates were generally higher than the light 
chain specific translation rates, despite the fact that the light polypeptide chains were present 
in larger amounts than the heavy polypeptide chains in the cell throughout the culture. This 
trait had also been seen in the study carried out by Bibila [1991], who derived higher specific 
translation rates for heavy polypeptide chains in comparison to light polypeptide chains, as 
more ribosomes were found to be present on the heavy chains. The observations imply that 
the elevated light chain concentrations were a result of the larger pool of light mRNA 
molecules present in the cell in comparison to heavy mRNA molecules rather than due to 
higher light chain specific translation rates. In addition, the estimated specific translation 
rates were also in general agreement with the range of values obtained from various 
literature sources — Shapiro et al. [1966] stated that the light immunoglobulin chain required 
approximately 30 seconds to synthesise (120 light chain molecules/(mRNA.hr)), while the 
heavy chain required 60 seconds (60 heavy chain molecules/(mRNA.hr)). Conversely, de 
Petris et al. [1970] calculated that each heavy mRNA molecule had 11-16 polyribosomes 
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while there were 4-5 polyribosomes present on each light mRNA molecule. Based on an 
average ribosome translation velocity of 7.2 x 104 ribonucleotides/(ribosome.hr) [Bibila, 
1991], the specific translation rates of a 1.4kb heavy mRNA and a 0.7 kb light mRNA 
molecule was estimated to range from 580 to 850 molecules/(mRNA.hr) and from 400 to 
510 molecules/(mRNA.hr) respectively. From the two examples above, it appears that there 
is a relatively large range of specific translation rates for immunoglobulin heavy and light 
chains in murine cells, which encompasses the estimated values obtained in this study. 
The second interesting observation derived from this analysis concerns the relative 
specific translation rates of IgG polypeptide chains in normal and hyperosmotic cultures. It 
appears that in the mid-exponential phase, the specific rates were on average approximately 
24% higher at hyperosmotic culture conditions, indicating that elevated specific translation 
rates did play a role in the improvement of antibody productivity levels. However, the extent 
of increase in the specific translation rates appeared to be relatively small in comparison to 
the approximate 100% increase seen in the specific transcription rate under hyperosmotic 
conditions. Furthermore, the differences between normal and hyperosmotic specific 
translation rates became smaller with culture progression. In fact, the ratio of hyperosmotic 
to normal spsecific translation rates (given by TH(450)/TH(290) and TL(450)/TL(290)) 
decreased to almost 1.0 as the cultures entered the stationary and decline phases. These 
trends indicate that as the culture progresses, the positive effects that hyperosmotic 
conditions exerted on specific translation rates were not sustained. Instead, larger IgG 
mRNA concentrations at hyperosmotic conditions became the main reason for the increase 
in IgG polypeptide chain concentrations. Consequently, it can be deduced that the increase in 
specific antibody productivity under hyperosmotic conditions could be attributed mainly to 
an increase in specific transcription rates. The reduction in the ratios of specific translation 
rates [TH(450)/TH(290) and TL(450)/TL(290)] to a value of 1 also implies that translation may 
become rate-limiting at the stationary and decline phases of cultures that are exposed to 
hyperosmotic culture conditions. 
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5.5 	Conclusions 
The two key goals of this chapter included both the evaluation of possible mechanisms 
through which hyperosmolarity improves specific antibody productivity, as well as the 
estimation of key parameters for the hybrid antibody production model. Both goals were met 
based on the analysis of the intracellular behaviour of IgG mRNA and polypeptide chains 
under normal and hyperosmotic conditions obtained from the experimental study. It was 
found that heavy and light mRNA levels under hyperosmotic conditions were relatively 
higher at all culture phases. This increase could be mainly attributed to an approximate 100% 
rise in the mRNA transcription rates in hyperosmotic cells, as the stabilities of mRNA 
molecules were not improved; indeed, mRNA molecules were less stable under 
hyperosmotic conditions, as shown by the lower mRNA half-life values obtained 
experimentally. The higher mRNA levels were also largely responsible for the increases in 
heavy and light polypeptide chain concentrations under hyperosmotic conditions. The 
estimated specific translation rates showed an average increase of only 24% during the mid-
exponential phase for hyperosmotic cultures, based on the calculated heavy and light 
translation rate ratios [TH(450)/TH(290) and TL(450)/TL(290)]. The ratios decreased in value 
as the culture progressed until a relatively similar translation rate was obtained in the 
stationary and early decline phases, indicating that IgG translation process might have 
become a rate-limiting step in hyperosmotic cultures beyond the mid-exponential phase. 
Finally, it was also determined that the increase in specific antibody productivities at 
hyperosmotic conditions was attributed mainly to the improvements in the specific 
transcription rates at a medium osmolarity of 450 mOsm/kg. 
179 
Chapter 6 
Model Validation and Hyperosmotic Strategy 
6.1 	Introduction 
In this chapter, the estimated parameter values for transcription, translation and mRNA 
degradation rates, first described in Chapter 5, are incorporated into the hybrid model. The 
validity of the updated model is verified and subsequently utilised to support a strategy to 
optimise GS-NSO antibody production. This involves the induction of hyperosmotic 
conditions at different time points in the culture. The optimal hyperosmotic induction culture 
time is then derived based on simulation results of the hybrid model, described in further 
details in Section 6.3.2. 
6.1.1 Product optimisation strategies involving hyperosmotic conditions 
Hyperosmotic culture conditions have not been used widely in product optimisation 
strategies, as the trade-off between the induction of high specific antibody productivities and 
the suppression of cell growth often leads to a similar total antibody titre as normal 
conditions. However, there have been a number of studies conducted on overcoming the 
inhibitory cell growth effects caused by hyperosmolarity in literature. Cherlet and Merc 
[1999] reported that increasing the medium osmolarity in successive steps for a continuous 
culture allowed hybridoma cells to adapt to the increased osmolarity and resulted in 100% 
increases in total antibody titres at 370 and 400 mOsm/kg, in comparison to normal osmotic 
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conditions (335 mOsm/kg). A similar strategy was proposed by Lin et al. [1999b], who 
found that a gradual increase in osmolarity enabled hybridoma cells to recover from the 
osmotic shock. This led to total antibody titres that were higher than a culture grown solely 
under normal or hyperosmotic culture conditions. 
The use of osmoprotectants in overcoming growth suppression under hyperosmotic 
conditions is one of the most well-studied in literature, with glycine betaine the most 
commonly used osmoprotective substance [Berg et al., 1991; Kim et al., 2000; Ryu et al., 
2000]. However, all three studies, which were conducted on both hybridoma and CHO cells, 
concluded that while glycine betaine reduced the effects of growth inhibition at 
hyperosmotic conditions, its presence also eroded the increase in specific antibody 
productivity due to hyperosmolarity. The extent to which the specific productivity decreased 
was cell line dependent and could result in antibody titres that were not significantly 
enhanced. Other proposed strategies involving the alleviation of growth suppression 
included: the adaptation of cells to hyperosmotic conditions through successive subcultures 
[Oh et al., 1993], as well as the genetic modification of cells to over-express the anti-
apoptotic family of Bcl-2 proteins [Kim and Lee, 2002]. The latter study found that 
overexpression of Bcl-2 proteins delayed the apoptotic effects of hyperosmolarity and 
resulted in a 200% increase in final antibody concentration at 522 mOsm/kg compared to 
values obtained under normal osmotic conditions and a 50% increase compared to a control 
culture (without Bcl-2 overexpression) conducted at 522 mOsm/kg. 
More recently, a biphasic culture strategy for CHO cells was proposed [Kim et al., 
2002]. The two phases in the culture involved initially culturing cells under normal osmotic 
conditions to allow for cell proliferation up to a certain cell density in the "growth phase" 
before increasing the medium osmolarity to enhance the specific antibody productivity in the 
"production phase" of the culture. This strategy had resulted in a 161% increase in final 
antibody titre when medium osmolarity was increased to 522 mOsm/kg from 294 mOsm/kg 
after 72 hours. However, an increase in medium osmolarity after 48 hrs did not result in a 
substantial increase in total antibody production relative to normal osmotic conditions. The 
varying results suggested that the time point at which hyperosmolarity was induced had an 
important effect on the final antibody titre. Subsequently, the hybrid model developed in 
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Chapter 3 has been used in an attempt to predict the optimal time point for the increase in 
media osmolarity. The simulation results attained are presented in the latter sections of this 
chapter. 
	
6.2 	Materials and methods 
6.2.1 Hyperosmotic induction experiments 
GS-NSO cells (Lonza Biologics) were grown in 50 mL shake flask cultures at normal culture 
osmolarity with an inoculum density of 2 x 105 cells/mL. At 48, 72, 96 and 120 hours after 
inoculation, the osmolarities of duplicate cultures were increased to 450 mOsm/kg by the 
addition of 4 M sodium chloride (Sigma) solution prepared in standard medium in two 3-
hour steps (290 mOsm/kg to 370 mOsm/kg, then to 450 mOsm/kg). Cell growth and 
viability was monitored daily, as previously described in Section 4.3.3, while the supernatant 
samples were collected and stored at -20 C for the determination of extracellular antibody 
concentrations. 
6.2.2 Statistical analysis 
In this chapter, the error bars in graphs represent the standard deviation of replicate 
experiments. 
6.3 	Results and analyses 
6.3.1 Hybrid model validation 
Based on the experimental results discussed in Chapters 4 and 5, estimates for the key 
parameters, as identified by the global sensitivity analysis (GSA), have been obtained and 
incorporated into the hybrid model. The key intracellular parameters estimated include the 
specific transcription rates, the mRNA degradation rates and the specific translation rates. 
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The resulting simulation trends for a number of variables under both normal and 
hyperosmotic conditions were then compared to the experimental results obtained (Figures 
6.1 to 6.7). 
Behaviour of heavy and light mRNA species 
Figures 6.1 a and 6.1 b show the variation of experimental and predicted mRNA 
concentrations with respect to culture time. It is evident that the model was able to describe 
the behaviour of heavy and light mRNA species fairly well, indicating that the estimates of 
specific transcription rates and mRNA degradation rates were relatively accurate for both 
normal and hyperosmotic culture conditions. The mild increase in the initial mRNA 
concentrations observed under hyperosmotic culture conditions is due to the step increase in 
specific growth rate after the lag phase of 24 hours implemented in the model. In addition, 
the results also reflect the relatively higher mRNA concentrations observed under 
hyperosmotic conditions in comparison to normal conditions. 
Specific translation rates and polypeptide chain concentrations 
The previous model developed for antibody production by Bibila [1991] assumed that 
specific translation rates were a linear function of the total RNA content present in the cells. 
This correlation was based on the observations that specific translation rates were dependent 
on the number of polyribosomes present on each mRNA transcript. Since ribosomal RNA 
constituted 80-85% of total cellular RNA [Bibila, 1991], the specific translation rates were 
therefore assumed to vary proportionally with total RNA content. In the present model 
(hybrid), the same correlation has been adopted given the experimental results demonstrate 
that a positive relationship does exist between specific translation rates and total RNA levels. 
The simulated and experimentally derived heavy and light specific translation rate trends 
under both normal and hyperosmotic conditions can be observed in Figures 6.2 a and 6.2 b, 
plotted with respect to specific growth rate. The specific growth rate was chosen as a basis 
for comparison as it was also positively related to total RNA levels (see Chapter 5, Figure 
5.2). The results indicate that there is a reasonably good agreement between predicted and 
experimentally derived values for the specific translation rates. Figures 6.3 a and b shows the 
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variation of total heavy and light polypeptide chain concentrations with respect to specific 
growth rate. For total heavy polypeptide chain concentrations, the predicted trends are in 
general agreement with experimental trends. However, a discrepancy can be seen in the total 
light polypeptide chain trends, especially under hyperosmotic conditions — the predicted 
trend appears to increase initially during the mid-exponential phase before remaining 
relatively constant while the experimental total light chain concentrations decreased with a 
decline in growth rates. However, it can subsequently be noted that the differences in the 
intracellular total light chain pool do not have a large impact on specific antibody 
productivity or total antibody produced (Figures 6.6 and 6.7). 
Specific glucose and lactate metabolic rates 
Figures 6.4 and 6.5 illustrate that the hybrid model is able to predict glucose uptake and 
lactate production rates relatively well under both normal and hyperosmotic conditions. As 
seen from these results, the specific glucose uptake rates are generally higher for 
hyperosmotic cultures in the exponential phase but decrease during the stationary and 
decline phases with respect to cultures under normal osmotic conditions. The glucose uptake 
trends are mirrored in the lactate production rates — the specific rates are higher for 
hyperosmotic cultures relative to normal osmotic cultures during the exponential phase but 
fall below normal-condition production rates during the stationary and decline phases. 
Antibody production trends 
The specific antibody productivity and total antibody concentration are shown in Figures 6.6 
and 6.7. From Figure 6.6, it is observed that the experimental antibody productivity values 
are in relatively good agreement with values the predicted values, indicating that the hybrid 
model has succeeded in describing the intracellular antibody production process with some 
accuracy. The predicted antibody production trends shown in Figure 6.7 are in general 
agreement with experimental values, further supporting the validity of the hybrid model. 
In addition, a summary of the parameter values used in the hybrid model under 
normal and hyperosmotic conditions have been provided in Table 6.1. A key point to note 
from the table is that, apart from the intracellular parameter values estimated in Chapter 5, 
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other intracellular parameters have all been maintained at their normal culture condition 
values. 
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Figure 6.1. Hybrid model predictions with experimental results for (a) heavy and (b) light 
mRNA concentration profiles under normal (290 mOsm/kg) and hyperosmotic (450 
mOsm/kg) culture conditions. 
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Figure 6.2. Hybrid model predictions with experimental results for (a) heavy and (b) light 
specific translation rates with respect to specific growth rates under normal (290 mOsm/kg) 
and hyperosmotic (450 mOsm/kg) culture conditions. 
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Figure 6.3. Hybrid model predictions with experimental results for (a) heavy and (b) light 
polypeptide chain concentrations with respect to specific growth rates under normal (290 
mOsm/kg) and hyperosmotic (450 mOsm/kg) culture conditions. 
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Figure 6.4. Experimental and predicted specific glucose uptake rates under normal (290 
mOsm/kg) and hyperosmotic (450 mOsm/kg) culture conditions. 
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Figure 6.5. Hybrid model predictions with experimental results for specific lactate 
production rates under normal (290 mOsm/kg) and hyperosmotic (450 mOsm/kg) culture 
conditions. 
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Figure 6.7. Hybrid model predictions with experimental results for antibody production 
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Growth kinetics and metabolism parameters 
Parameter Values used (normal condition) 
Values used 
(hyperosmotic 
condition) 
References 
i-tmax 	 0.33 	 0.023 
[GLC]. 6.5 	 8.3 
Ico 	 5.0 x 104 	 1.4 x 10'5  
1(d,T 	 1.2 x 10-2 	 9.7 x 10 4 
	 This study 
k,,1 0.030 0.025 
1(1,2 8.4 x 10-3  2.2 x 10-3  
Kgic 240 7.1 
Kgic,max 2.7 x 10-7 1.3 x 10-5  
Kgic,i 9.6 4.81 x 102 
Mglc 1.0 X 10-7 3.0 x 10.8  
Mlac 4.6 x 10-8 1.1 x 10-8 
Ylac,g1c 0.95 1.4 
Antibody formation and transport parameters 
Parameter Reference values Values used (normal) 
Values used 
(hyperosmotic) References 
SH 
SL 
TH,0 
11,0 
IcHL, 
kin/kiln 
t1/2,ER 
tu2,0 
ti/2 
MH,0 
mL,o 
[H]o 
[L]o 
1200-3600 
1800-5400 
60-850 
120-510 
11.5 
0.5-1 
0.083-0.5 
2-14 
2 x 104-4 x 104 
3 x 104-6 x 104 
2 x 107 - 4 x 109 
2 x 107 - 6 x 109 
1450 
2300 
449 
293 
1.5 x 10 6 
11.5 
0.7 
0.333 
12.6 
2 x 104 
3 x 104 
2 x 107 
2 x 107 
3000 
4360 
544 
386 
1.5 x 10 6 
11.5 
0.7 
0.333 
9.0 
2 x 104 
3 x 104 
2 x 107 
2 x 107 
[Schibler et al., 1978; Wallach 
and Laskov, 1980] 
[Bibila, 1991] 
[de Petris, 1970; Shapiro et al., 
1966] 
[de Petris, 1970; Shapiro et al., 
1966] 
[Percy et al., 1975] 
[Choi et al., 1971] 
[Fries et al., 1984; Lodish, 
1988] 
[Wallach and Laskov, 1980] 
[Potter, 1972; Wallach and 
 Laskov, 1980] 
[Bibila, 1991] 
[Bibila, 1991] 
[Bibila, 1991] 
Table 6.1. Final parameter values for the hybrid model under both normal and hyperosmotic 
condition cultures. 
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6.3.2 Biphasic antibody production strategy with hyperosmotic induction 
As described in Section 6.1, one of the proposed optimisation strategies involving the use of 
hyperosmotic culture conditions is the biphasic culture — during which cells are first allowed 
to proliferate until a certain cell density level is attained, before hyperosmotic conditions are 
induced so as to achieve the higher specific productivities associated with high osmolarity 
for the remaining culture period. Here, a strategy based on a trade-off between obtaining a 
high cell density at normal conditions and high specific antibody productivity at 
hyperosmotic conditions is proposed, in order to maximise the total antibody titre in the 
culture. The balance between both variables indicates that the optimal time point for 
hyperosmotic induction must be identified to achieve the highest increase in total antibody 
produced. In this study, the hybrid model is used to derive an estimate of the optimal 
hyperosmotic induction culture period, via a simple "switching" mechanism, in which the 
parameters are switched from their normal values to their values under hyperosmotic 
condition at different time points in the culture, ranging from 48 to 120 hours. The model 
predictions of total antibody produced at the end of each culture provides an indication of the 
best time point in the culture to switch to hyperosmotic culture conditions. Simulation results 
from the hybrid model suggests that the accumulation of total antibody product is maximum 
(182 mg/L) at approximately 72 hours into the culture, which represents an increase of 
approximately 100% from the antibody concentration derived under normal osmotic 
conditions and a 12% increase from total antibody produced under hyperosmotic (450 
mOsm/kg) conditions. In comparison to the hyperosmotic conditions, the increase in the total 
antibody titre in the biphasic process appears to be less significant, however, this extra 
antibody titre required 25% less culture time. 
To support the simulation study, further experimental work was undertaken. In brief, 
the procedure was as follows: duplicate cultures cultivated at normal osmotic conditions 
were hyperosmotically induced by the addition of sodium chloride to the culture medium at 
48, 72, 96 and 120 hours into the culture. The resulting comparisons between experimental 
and predicted trends can be observed in Figures 6.8 and 6.9. Figure 6.8 shows the trends for 
final antibody titre achievable at different hyperosmotic induction time points. The optimal 
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hyperosmotic induction time point as predicted by the model appears to be consistent with 
experimental data — both trends demonstrate that the peak total antibody titre is achieved 
when hyperosmolarity is induced 72 hours into the culture. The experimental study appears 
to support the simulation work fairly closely, though there are variations at specific points; in 
particular at t = 72 hours. 
Figure 6.9 shows the variations in the viable cell numbers (6.9 a and 6.9 b) and in 
the antibody concentration (6.9 c and 6.9 d). These results were obtained from the 
hyperosmotic shift points of 72 and 96 hours. From Figures 6.9 a and 6.9 b, it appears that 
the model does over predict the number of viable cells after the induction of hyperosmotic 
conditions. Here it is evident that the actual viable cell concentrations reach a lower 
maximum peak density and also show a steeper gradient during the decline phase than it is 
predicted by the hybrid model. Table 6.2 shows the predicted and experimental maximum 
cell densities obtained at the various hyperosmotic induction time points. The data suggests 
that the number of viable cells is consistently being overestimated by the model. In contrast, 
the simulated antibody accumulation profiles (figures 6.9 c and 6.9 d), which are dependent 
on the viable cell number, are in good agreement with the actual profiles attained from 
experimental methods, instead of being overestimated. Therefore, the data seems to imply 
that that the specific productivities of these hyperosmotically induced cultures are in fact 
higher than the values achieved under constant hyperosmotic conditions (solely 
hyperosmotic cultures inoculated at 450 mOsm/kg). 
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I 	 I 	 1 	 I 	 I 	 i 
450 culture 	48 hr shift 	72 hr shift 	96 hr shift 	120 hr shift 290 culture 
Hyperosmotic induction cultures 
Figure 6.8. Predicted and experimental values of the final antibody titre achievable at each 
hyperosmotic induction time point. 
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Figure 6.9. Predicted and experimental values of the viable cell concentration at (a) 72 
hours and (b) 96 hours hyperosmotic induction time points, and predicted and experimental 
values of the antibody production profiles at (c) 72 hours and (d) 96 hours hyperosmotic 
induction time points. 
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Hyperosmotic 
induction time (hrs) 
Max Xv (Predicted) 
(Cells/mL) 
Max Xv (Experimental) 
(Cells/mL) 
48 8.6 x 105 7.3 x 105 
72 9.4 x 105 7.6 x 105 
96 9.7 x 105 8.5 x 105 
120 9.8 x 105 8.8 x 105 
Table 6.2. Summary of predicted and experimental maximum cell densities for different 
hyperosmotic induction time points. 
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6.4 	Discussion 
Hybrid model validation 
The ability of the hybrid model to predict growth, metabolism, intracellular and extracellular 
antibody production trends was assessed in Section 6.3.1. Based on the comparisons between 
experimental and predicted trends, it can be concluded that the model was relatively accurate 
in the depiction of the intracellular antibody production process, after key parameter values 
were estimated from the experimental study described in Chapters 4 and 5. It has also been 
noted that the only differences in intracellular parameter values were of the key parameters 
identified by the GSA conducted on the hybrid model (described in Section 3.4.2) while all 
other intracellular parameter values remained unchanged relative to normal culture 
conditions. This implies that the estimation of a small number of key parameters would be 
sufficient to accurately describe the intracellular antibody process and illustrates the 
effectiveness of the GSA in identifying the most influential parameters involved in the 
determination of antibody production rates and demonstrates how it has successfully guided 
the design of the subsequent experimental study. 
Biphasic culture strategy 
The hybrid model, under a simple "parameter switchover" strategy, was able to correctly 
predict the optimal hyperosmotic induction time point for a biphasic culture strategy. 
However, as identified previously, the model did consistently overestimate the number of 
viable cells present in the culture in comparison to the experimental data. The initial 
hypothesis of the biphasic culture resulting in an extended culture longevity due to 
hyperosmotic induction remained unconfirmed. The number of viable cells in biphasic 
culture experiments declined at approximately the same rate, or slightly even faster, than 
cultures solely grown under in either normal or hyperosmotic media. Similar trends were 
observed for the CHO cell line in biphasic culture experiments conducted by Kim et al. 
[2002]. In their study, the viable cell concentrations after the induction of hyperosmolarity 
(ranging from 370 to 522 mOsm/kg from a control osmolarity of 294 mOsm/kg) by the 
addition of sodium chloride after 3 and 4 days into the cultures were seen to decline at more 
rapid rates than the control cultures at normal osmolarities. 
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The variations in the viable cell number behaviour for hyperosmotically induced 
cultures in comparison to cultures grown solely under hyperosmotic conditions appear to 
imply that there are inherent differences in the growth characteristics of both culture types. 
For a newly inoculated culture in a hyperosmotic medium, a lag phase was initially 
observed, during which cells adjust to the increased osmolarity before proliferating actively 
(see Section 4.4.1). However, in cultures that had been hyperosmotically induced at a certain 
point during its progression, the sudden increase in medium osmolarity might have added to 
the stress caused by the accumulation of toxic metabolites and the reduction in nutrient 
levels. This might have resulted in a larger proportion of necrotic and apoptotic cell deaths 
compared to a culture originally inoculated at hyperosmotic conditions. G0/G1 cell cycle 
arrest was also likely to have been induced when the medium osmolarity was increased, 
further reducing the proportion of actively proliferating cells. In addition, the sharp decrease 
in the experimental viable cell numbers after hyperosmotic induction was particularly 
apparent for the 96- and 120-hour time-shift cultures, in comparison to the time-shift cultures 
at 48 and 72 hours, for which the viable cell numbers continued to increase for 1 to 2 days 
before declining. These observations suggest that hyperosmotic induction at a later culture 
stage was more likely to cause cell lysis through necrotic cell deaths, while induction at an 
earlier culture stage may cause cell apoptosis to occur. In general, the effects of apoptosis are 
not instantaneously visible and only become apparent after a period of time, which could 
explain the relatively rapid decrease in viable cell number after 1 to 2 days in the 48- and 72-
hour time shift cultures. As the present model adopted a parameter "switchover" mechanism, 
it was not able to take into consideration the initial osmotic shock effects on normal osmotic 
cultures that were already in progression. Therefore, a possible modification to the hybrid 
model is the inclusion of an "osmotic shock" term, which takes into account the apoptotic 
and necrotic cellular effects of hyperosmotic induction. The use of an "osmotic shock" term 
is further discussed in Section 7.2.1. 
The similarity in predicted and experimental antibody production results suggests 
that higher than expected specific antibody productivities might have been achieved after the 
induction of hyperosmolarity. The combined stress of hyperosmotic shock, the reduction in 
nutrient levels and the build up of toxic metabolites could have possibly led to further 
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overexpression of certain genes related to the antibody production pathway of the cells and 
subsequently caused the specific antibody productivity to increase by a larger than expected 
amount. For example, it is possible that genes related to the transcription of heavy and light 
mRNA molecules were expressed at a higher level due to hyperosmotic induction, 
particularly at a later culture stage in comparison to cultures inoculated at hyperosmotic 
conditions. Consequently, despite the over-prediction in viable cell number by the hybrid 
model, the experimental antibody production values were still comparable to the simulation 
results. 
To take advantage of (i) the high cell density associated with normal osmotic 
conditions, (ii) the enhanced specific antibody productivity and (iii) the culture longevity 
observed at hyperosmotic conditions, the biphasic culture procedure needs further 
modifications. For example, increasing the medium osmolarity through a step-wise approach 
over a longer time period will allow the cells to adjust to the higher osmotic condition 
without triggering necrotic and apoptotic cell death mechanisms. The overall increase in the 
cumulative volumetric cell hour possible under this modified strategy is likely to result in 
further increases in total antibody titre. 
6.5 	Conclusions 
This chapter presented the validity of the hybrid model utilised for the predictions of 
intracellular and extracellular variables related to growth, metabolism and antibody 
production. The updated model was then utilised to estimate the optimal hyperosmotic 
induction time in a biphasic culture strategy aimed at improving antibody production yields. 
Comparisons between predicted (model) and experimental results showed that the hybrid 
model correctly estimated the optimal induction time for hyperosmolarity. However, the 
simple parameter "switchover" mechanism resulted in an over prediction of viable cell 
number, as it did not take into consideration the possible growth and death effects caused by 
osmotic shock. Consequently, further advancement of the description of the initial 
hyperosmotic effects would lead to improvements in the predictive capability of the model. 
Finally, hyperosmotic induction of normal condition cultures resulted in specific antibody 
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productivity values which were relatively higher than solely hyperosmotic cultures. This was 
evident as the increase of the total antibody titre from 157 mg/L to 199 mg/L for the optimal 
hyperosmotically induced culture was achieved over a comparatively shorter time period (8 
days for hyperosmotically induced culture compared to 12 days for culture inoculated in 450 
mOsm/kg medium) relative to cultures solely grown at 450 mOsm/kg. 
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Overall Conclusions and Future Work 
The main goal of this thesis was to derive a better understanding of the antibody production 
process, as well as improving antibody production yields from GS-NSO cells cultivated 
under both normal and hyperosmotic conditions. In the following sections, the overall 
conclusions obtained from the combined modelling and experimental study will be discussed 
and recommendations regarding future work will be provided. 
7.1 	Overall conclusions 
The overall conclusions derived from the combined study can be divided according to the 
four main objectives mentioned in Chapter 1. 
7.1.1 Development of hybrid model 
In this study, a hybrid model consisting of both unstructured and structured elements was 
first developed based on existing GS-NSO data pertaining to growth, extracellular 
metabolism and antibody accumulation in the medium. The model was constructed as a 
trade-off between the lack of detailed intracellular information characteristic of an 
unstructured cell culture model and the mathematical complexity associated with a highly 
structured model. The combined modelling approach provided a detailed description of the 
antibody production process, while still ensuring that the number of parameters was kept low 
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enough to allow for an in-depth model analysis. Additionally, the model also established a 
link between cell metabolic processes and the intracellular GS-NSO antibody production 
process, which was generally absent in previous unstructured and structured models. 
Predictions from the hybrid model using parameters estimated from literature agreed well 
with existing experimental information and were comparable to the predicted trends obtained 
from an up-to-date single cell model developed by Sanderson [1997]. 
7.1.2 In-depth model analysis 
The hybrid model was then subjected to a detailed model analysis using the Sobol' global 
sensitivity analysis (GSA) technique, which allowed for the identification of key model 
parameters with respect to antibody production, based on the computation of sensitivity 
indices. The sensitivity indices provided a quantitative measure of the relative effect that 
each parameter exerted on antibody production rates and were an indication of the 
importance of individual parameters to intracellular antibody synthesis. The key parameters 
derived from the GSA were those involved in the transcription and translation of heavy and 
light antibody molecules (SH, SL, THO,  TL0,  t112),  of which their combined sensitivity indices 
(both SI,„d and Sltot) represented more than 90% of the total value of all sensitivity indices. A 
representation of antibody production at hyperosmotic culture conditions was subsequently 
derived based on the GSA results as well as existing literature data on transcription and 
translation rates under hyperosmotic conditions in hybridoma cells. The GSA results also 
served as an important guide to the design of the experimental study of GS-NSO cells under 
normal and hyperosmotic conditions, described in the next section. 
7.1.3 	Experimental investigation of hyperosmotic effects on GS-NSO cells 
The experimental study on GS-NSO cells had two key goals. The first goal was to acquire 
estimates of the key parameters that were identified by the GSA under both normal and 
hyperosmotic conditions. Estimated values for specific transcription, translation and mRNA 
half-lives were successfully obtained from the cell culture experiments (detailed in Chapter 
203 
CHAPTER 7.0VERALL CONCLUSIONS AND FUTURE WORK 
5) and subsequently incorporated into the hybrid model. The second goal was to identify the 
mechanism through which hyperosmotic conditions resulted in increased antibody 
productivities. A number of hypotheses proposed in literature regarding the mechanism of 
hyperosmolarity were thus assessed based on the experimental results obtained in this study. 
The first hypothesis involved the shifting of cellular resource utilisation from cell growth to 
antibody production as a result of hyperosmolarity-induced cell cycle arrest, thereby causing 
antibody productivities to increase. This hypothesis was found to be unlikely in the case of 
GS-NSO cells, as analysis of cell cycle data with respect to specific productivities indicated 
that a positive correlation existed between productivity and proportion of cells in the S cell 
cycle phase, while a negative correlation was seen between productivity and the GO/GI cell 
proportion. These results suggested that specific productivities in GS-NSO cells were 
growth-associated and would improve further if the growth suppression at hyperosmotic 
conditions could be overcome. 
Another frequently used hypothesis purports that the increase in nutrients uptake at 
hyperosmotic conditions results in higher energy levels, which increase overall protein 
translation rates and cause the rise in specific productivities. However, the experimental data 
derived showed that the increase in specific glucose consumption rates in the growth phase 
could be attributed to a metabolic shift in cells towards less efficient energy production 
pathways. Consequently, no significant rise in cellular energy levels was observed and total 
protein concentrations under hyperosmotic conditions were not significantly increased, 
thereby suggesting that this was not the key route through which hyperosmotic conditions 
influenced specific productivities. 
The intracellular mRNA and IgG polypeptide chain analyses eventually indicated 
that the key reason for increased antibody productivities at hyperosmotic conditions was a 
result of heightened specific transcription rates, which was consistent with another 
hypothesis proposed by Lee and Lee [2000]. The authors suggested that the higher 
transcription rates were a result of the unbinding of histones from DNA at hyperosmotic 
conditions, which increased its accessibility to RNA polymerase, the enzyme responsible for 
mRNA transcription. The experimental findings also implied that the process of antibody 
production was likely to be rate-limiting at the translation step, particularly after the late- 
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exponential culture phase, as the increase in specific translation rates observed at the mid-
exponential phase was rapidly reduced to the rates at normal osmotic conditions. The 
experimental estimates for the specific transcription and translation rates, as well as the 
mRNA half-lives were then incorporated into the hybrid model. Comparisons of the 
simulated and experimental trends for key intracellular and extracellular variables indicated 
that the hybrid model gave a fairly accurate description of the intracellular antibody 
production process in GS-NSO cells. 
7.1.4 Use of hybrid model in biphasic culture strategy 
A biphasic culture strategy, consisting of a cell growth phase and an antibody production 
phase, was implemented on GS-NSO cells, with the aim of increasing total antibody titre 
beyond the amount achieved by cultures grown solely at hyperosmotic conditions. The 
hybrid model was utilised based on a simple parameter "switchover" strategy to predict the 
optimal time point during the culture for hyperosmotic induction, at which total antibody 
titre would be maximum. The best hyperosmotic induction time point predicted by the model 
was subsequently validated experimentally as being 72 hours into the culture. The total 
antibody titre at this optimal time point was more than 200% higher than normal osmotic 
conditions. The value was also 12% higher than solely hyperosmotic cultures and was 
achieved in 8 days instead of the 12 days required by the latter. The results highlighted the 
potential use of hyperosmolarity in conjunction with other product optimisation parameters 
such as glucose and amino acid feeds. 
7.2 	Recommendations for future work 
The combined modelling and experimental study has demonstrated that the implementation 
of hyperosmolarity results in a significant increase in total antibody production and 
highlights the potential use of modelling in the development of antibody product 
optimisation strategies. In this section, possible research directions are discussed, both with 
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regard to model improvement as well as the possibility of further elevating the total antibody 
titre achievable under hyperosmotic conditions. 
7.2.1 Hybrid model improvements 
The simple parameter "switchover" approach used on the hybrid model for the biphasic 
culture strategy enabled the optimal hyperosmotic induction time point to be determined. 
However, it was observed that the model constantly over predicted the number of viable cells 
present after hyperosmotic induction, as it did not take into account the probably shock 
effects caused by a sudden increase in osmolarity as the culture was progressing. A possible 
improvement to the model will be to introduce an "osmotic shock" factor, which will 
consider both cell cycle arrest and cell death through apoptotic and necrotic pathways. The 
introduction of such a factor can range from simply fixing the proportions of cells that 
become growth arrested or apoptotic (and necrotic), to the incorporation of cell cycle 
dynamics into the hybrid model. The latter approach will finally result in a population 
balance model, in which cells at the different cycle phases can be identified. In addition, the 
current hybrid model can also be adapted to study the effects of other environmental 
conditions, such as pH and temperature, on antibody production, as well as used to describe 
the behaviour of a fed-batch culture by the introduction of mathematical expressions 
describing the input of nutrient feeds and the removal of metabolites. 
An improved model consisting of the above features will be likely to have potential 
process engineering applications as it can then be used to identify the range of operating 
conditions that leads to the global optimal, in terms of total antibody titre. It will therefore 
serve as a useful guide in the design of further experiments and allow process development 
to become more time- and cost-effective. 
7.2.2 Hyperosmolarity and antibody production in GS-NSO cells 
It has been previously suggested that an increase in cell size under hyperosmotic conditions 
could be solely responsible for the increase in specific productivity. While this is unlikely to 
be true for this study (based on cell size estimation carried out by a previous study — see 
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section 4.4), a more detailed analysis into the relationship between cell sizes and specific 
productivities at different culture phases and different osmolarities would be beneficial in 
determining the extent to which the volume of cells actually affect antibody production. 
In this study, the underlying reason for improvement in antibody productivity under 
hyperosmotic conditions has been attributed to an increase in the specific transcription rates. 
Additionally, experimental observations suggested that mRNA stability decreased under 
hyperosmotic conditions, while the increases in specific translation rates were relatively 
small and not sustainable compared to the increase in transcription rates. Possible strategies 
to improve antibody production yield further should therefore focus on a number of areas: 
firstly, methods to overcome the specific translation rate limits are likely to result in higher 
specific productivities. Secondly, increasing the stability of the mRNA molecules will result 
in higher intracellular IgG mRNA concentrations and possibly allow for further 
improvements in antibody productivities. Thirdly, strategies aimed at alleviating the cell 
growth suppression under hyperosmotic conditions will also lead to increased total antibody 
titre. 
Increasing specific translation rates 
In Section 4.1.3, it was found that hyperosmolarity did not increase cellular energy levels 
substantially despite an increase in specific glucose consumption. The higher yield of lactate 
per mole of glucose consumed suggested that cells had the tendency to shift to less efficient 
energy producing pathways at hyperosmotic conditions. The possibility of this hypothesis 
was substantiated by a similar observation made by Devin et al. [1995], who had reported a 
reduction in oxidative phosphorylation efficiency (given by [ATP]/[O]) at hyperosmotic 
conditions in the mitochondria of rat liver cells. A more detailed analysis of the metabolic 
pathway shift should therefore be carried out and the possibility of shifting the metabolic 
pathways of hyperosmotic cells towards more energy-efficient pathways should be 
investigated, as this may lead to increased ATP production and therefore a rise in total 
protein translation rates, which will then increase specific productivities. Subsequently, the 
combination of nutrient feeding strategies with use of hyperosmotic culture conditions will 
also contribute towards the achievement of higher specific productivities. 
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Another strategy to improve specific translation rates involves the overexpression of 
translation-inducing genes for hyperosmotically grown cells. For example, recent work has 
been carried out on creating an expression vector that led to enhancement of the mRNA 
translation of the transfected gene when incorporated in HeLa human fibroblast, CEM-A 
human T and 293 human embryonic kidney cells. This was achieved by the addition of a 5'-
terminal post-transcriptional control element (PCE) onto the vector prior to cell transfection 
[Yilmaz, 2006]. The authors reported that the combination of PCE with the CMV IE 
transcription enhancer resulted in an 11- to 17-fold increase in protein yield for the various 
cell lines. The creation of such vectors will thus contribute greatly towards overcoming the 
upper limits of possible specific translation rates. 
Improvement of mRNA stability 
Another approach to increasing specific antibody productivities is to develop a strategy 
aimed at reducing the relative mRNA instability observed under hyperosmotic conditions 
and therefore increasing the number of mRNA transcripts in the cell. Currently, it is known 
that the determination of mRNA stability lies mainly in its 3' untranslated region (3'-UT), 
where the mRNA half-life is dependent on several factors [Ross, 1995]. One of the key 
determinants is the number of AU-rich elements (AURE) present in this region — the larger 
the number of AURE, the more unstable the mRNA becomes [Hollams et al., 2002]. 
Therefore, by changing the sequence of this 3'-UT region, it may be possible to improve the 
stability of IgG mRNA; for instance, it was found that 13-globulin lacking AURE were four 
times more stable than those containing AURE [Ross, 1995]. Additionally, it is also known 
that a number of hormones, growth factors and ions affect mRNA stability; however, at 
present, very little is known about the mechanism through which they affect mRNA stability. 
While some of these factors (phorbol esters) appear to affect the half-lives of most mRNA 
molecules, other factors like estrogen stabilises some mRNA while simultaneously 
destabilising other mRNA in the same cell type. As such information becomes available, 
there may be more possibilities in improving the stability of mRNA to obtain higher specific 
productivities. 
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Reducing hyperosmotic induced cell suppression effects 
Many strategies aimed at reducing the growth suppression effects of hyperomsolarity have 
been proposed over the years, as summarised in Section 6.1. However, these strategies 
tended to involve the trade-off between the reduction of growth suppression and achieving a 
high specific productivity. For instance, the addition of glycine betaine as an osmoprotectant 
reduced the suppression of cell growth but also resulted in a simultaneous decrease in 
specific productivities [Kim et al., 2000; Ryu et al., 2000]. Similarly, a gradual increase in 
osmolarity, while alleviating growth suppression, also resulted in a smaller increase in 
antibody productivities. A more long-term solution may be to overexpress genes that might 
reduce the growth suppression effect. At present, the only such approach to reducing cell 
growth suppression was to transfect cells with a protein belonging to the Bcl-2 family, which 
reduced apoptotic cell death in hybridoma [Perani et al., 1998] and CHO cells [Kim and Lee, 
2000]. A similar approach can be used for the overexpression of genes which are known to 
participate in the repair of DNA damage caused by high sodium chloride concentration (for 
instance, Mre 11, H2AX and Chkl) [Dmitrieva and Burg, 2005]. This strategy may help 
shorten the amount of time required for DNA repair to occur, thus leading to reduced G1 cell 
cycle arrest and improved growth rates in the culture. 
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Nomenclature 
D 	 total variance for sensitivity indices calculation 
f(x) 	 integrable function for sensitivity indices calculation 
f (x) 	ith order term in integrable function f(x) 
[GLC] 	glucose concentration (mmol 
[GLC]min 	minimum threshold glucose concentration (mmol L'') 
[H], [L] 	concentrations of free heavy (H) and light (L) chains in the ER 
(pp chain cell"') 
[11L] 	concentration of assembly intermediate species in the ER (pp chain cell"') 
[H2L2]ECM 	antibody concentration in the medium (mg L-1) 
[H2L2] ER 	antibody concentration in the ER (molecule cell-') 
[H2L2]G 	antibody concentration in the Golgi complex (molecule cell"') 
minimum specific death rate constant (hr-2) 
Kd,T 	specific death rate constant correlated to lactate concentration 
(L mmol'' hr-1) 
KD,XD 	specific lysis rate (SCM) (hr-1) 
kER 	 rate constant for antibody transport from ER to Golgi (h4) 
ko 	 rate constant for antibody transport from Golgi to medium (h.') 
KGL 	substrate uptake constant for glucose phosphorylation reaction 
(jamol L 
Kgic 	Monod constant for glucose (mmol 1:1) 
glucose consumption coefficient (mmol L-1) 
Kgic,max 	maximum glucose consumption coefficient (mmol 	cell-1 hr.') 
kd 	 specific death rate (hr') 
kd,max 	maximum specific death rate (hr-1) 
kH, kL 	degradation rates of heavy and light chain mRNA molecules (hr') 
kHH 	 H-H chain assembly rate constant (cell molecule' If') 
knL 	H-L chain assembly rate constant (cell molecule-1 WI) 
KI,LAC 	Growth inhibition constant by lactate (SCM) 	L cell"') 
specific lysis rate correlated to kd (dimensionless) 
k,,2 	 apparent lysis rate at kd = 0 (hr.') 
specific cell lysis rate (he') 
KSDR 	specific death rate (SCM) (hr') 
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NOMENCLATURE 
[LAC] 
Mglc 
Mlac 
mH, ML 
MWAB 
qglc 
(bac 
qAb 
RAb 
RH, RL 
RHL 
SH, SL 
Rind 
Sitot 
TH, Ti., 
t1/2 
t1/2, ER 
t112, G 
VCELL 
VM,AB 
VM,CELL 
VM,GL 
VM,GLN 
lactate concentration (mmol L-1) 
maintenance coefficient for glucose (mmol L-1 cell-1 h-1) 
minimum lactate production rate (mmol L-1 cell'' h"') 
intracellular heavy and light chain mRNA concentrations 
(mRNA molecule cell-1 ) 
molecular weight of antibody (SCM) (g) 
specific glucose consumption rate (mmol L-1 cell-1 h-1) 
specific lactate production rate (mmol L-1 cell-' h-') 
specific antibody production rate (mg L-1 cell-1 h-1) 
rate of antibody assembly in the ER (molecule cell"') 
consumption rates of heavy and light chains in antibody assembly 
(chain cell-' h-') 
production rate of antibody intermediate in ER (molecule cell-1 h-1) 
specific transcription rates of heavy and light chain mRNA 
(mRNA molecule 111) 
individual sensitivity index 
total sensitivity index 
specific translation rates of heavy and light polypeptide chains 
(pp chain (mRNA molecule)-1 hr-1) 
half-life of heavy and light chain mRNA molecules (hr) 
time required for 50% of antibody molecules to be transported from ER to 
Golgi (hr) 
time required for 50% of antibody molecules to be transported from Golgi to 
extracellular medium (hr) 
volume of cell (SCM) (4) 
Michaelis-Menten maximum rate term for antibody formation (SCM) 
(µmol L cell"' hr-1) 
Michaelis-Menten maximum rate term for cell formation (SCM) 
(µmol L cell-1 hr-1) 
Michaelis-Menten maximum rate term for glucose phosphorylation (SCM) 
(µmol L cell"' hr') 
Michaelis-Menten maximum rate term for glutamine conversion to 
glutamate (µmol L cell-1 hr-1) 
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NOMENCLATURE 
VM1,PY 
VM1,SER 
Xd 
XT 
Xv 
Ylac,g1c 
Michaelis-Menten maximum rate term for lactate formation 
(1.tmol L cell"' hr"1) 
Michaelis-Menten maximum rate term for Serine-Glycine exchange 
(pmol L cell"' hr"') 
concentration of dead cells (cells mU') 
total concentration of cells (cells mU') 
concentration of viable cells (cells mE1) 
yield of lactate from glucose (mmol mmol"') 
Greek letters 
specific growth rate (il) 
!Amax 	 maximum specific growth rate (111) 
E summation term 
i 
	
integration function 
Subscripts 
i,j,n,s 	any integer equal to or larger than 1 
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Appendix A 
Initial Parameter Values for Hybrid Model 
The growth and metabolism parameters are presented in Table A.1 below while the 
intracellular antibody production and transport parameters are summarized in Table A.2 on 
the next page. 
Parameter Values used 	 Values used  (normal condition) 	(hyperosmotic condition) 	References  
	
max 	 0.125 	 0.023 
[GLC].„, 8.2 9.62 
Kd, 1 
	 2.48 x 10-4 	 1.89 x 10-5 
Kd,T 
	 4.70x10 3 	 1.10x 10 3 
	 [Wu et al., 2004] 
k1,1  
k12 
;lc 
0.308 
2.84 x 10-3  
46.1 
0.252 
7.17 x 104  
2.81 
Kg1c,max 3.08 x 10-7 1.06 x 10-4 
Kglc,1 1.94 x 101 4.56 x 103  
III lc 3.16 x 10-8 4.1x 10.8  
Mlac 5.91 x 10.8  -4.5 x 10-8 
Ylac,g1c 0.968 2 
Table A.1. Growth and metabolism parameters for the hybrid model under normal 
and hyperosmotic conditions. 
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Parameter Reference values Values used (normal condition) 
Values used 
(hyperosmotic 
condition) 
References 
SH 
SL 
TH,0 
11,0 
kHL, 
kinjICHH 
tu2,ER 
tuzo 
ti/2 
MH,0 
mL,o 
[H]o 
[I-]o 
1200-3600 
1800-5400 
1020 
720 
11.5 
0.5-1 
0.083-0.5 
2-14 
2 x 104-4 x 104 
3 x 104-6 x 104 
4 x 107 - 4 x 109 
6 x 107 - 6 x 109 
1500 
2250 
1005 
715 
3.8 x 10.10 
11.5 
0.7 
0.333 
9 
2 x 104 
3 x 104 
4 x 108 
6 x 108 
2100 
3150 
1640 
1123 
1.2 x 
11.5 
0.7 
0.333 
6 
2 x 104 
3 x 104 
4 x 108 
6 x 108 
[Schibler et al., 1978] 
[Bibila, 1991] 
[Bibila, 1991] 
[Bibila, 1991] 
[Percy et al., 1975] 
[Choi et al., 1971] 
[Fries et al., 1984; 
Lodish, 1988] 
[Wallach and Laskov, 
1980] 
[Potter, 1972; Wallach  and Laskov, 1980] 
[Bibila, 1991] 
[Bibila, 1991] 
[Bibila, 1991] 
Table A.2. Antibody formation and transport parameters for the hybrid model under 
normal and hyperosmotic conditions. 
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Appendix B 
Derivation of Mathematical Expression for Estimation of 
IgG Polypeptide Specific Translation Rates 
The rate of accumulation of total intracellular heavy chain concentration is given by the sum 
of the rate of accumulation of all heavy chain-containing species: 
d[H] 
tota,  , _ d[H] ± d [
E] 4_ 2 (21{112 L2 1ER  ±2
d[1124 ]G 
dt 	dt 	dt 	dt 	dt 
(D.1) 
Individual rates of accumulations of the right-sided terms in equation (D.1) are given below: 
d 
d
[H] 
= TH mH - ,u[I-1]- RH 	 (D.2) 
t 
d [HZ] 
= RHL — 2R Ab — ,u [HL] 
Al = R Ab — k ER[H  2 L2 ]ER - [112 L2 ]ER  
d[H2L2]G  = kER [H 2 L2 ]ER kG [H2 L2 ]G du [H2 L2 ]G dt 
Additionally, 
RH = RL = RHL 	 (D.6) 
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dt 
d[II 2L2 ]ER  
dt 
APPENDIX B 
Substituting the individual accumulation rates from equations (D.2) to (D.5) into equation 
(D.1) and rearranging, we obtain: 
d[H]total = TH M H —/.1 f[11]±[Hn+ 2 [H2L2 L + 2 [H2L2 1;  1 — 2kG [H2L2 L (D.7) 
dt 
The total heavy chain concentration, [H]total, is given by: 
[-ff  Leal [111+PE1+ 2[112 L2 L + 2[1124]G 
In addition, 
1 d[H 2L2]Ecm  
kG [H 2L2 1G = 
X v 	dt 
where 
d[.1  - -I 2L2]Ecm = y _ 
V ci Ab dt 	-,.  
Therefore, 
kG {H2 L2 1G — q Ab 
(D.10)  
(D.11)  
Substituting equations D.8 and D.11 into equation D.7, the following expression is obtained: 
d[H] 
l'al 	 = TH M H — /1[11 , — 2qAb 	 (D.12) dt lotai 
Finally, the specific translation rate of heavy chains, TH, can be estimated by rearranging 
equation D.12: 
T 	= 	
1 ( d[111 tota,  , 	
\ 
H  
m 	dt 	± 11 [111mal + 2q Ab H \ 	 i 
(D.13) 
A similar expression for the light chain specific translation rate is obtained using the above 
derivation. 
(D.8)  
(D.9)  
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